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Aims: (1) To test the fetal origins of chronic disease by examining birth weight, 
current obesity, and odds of developing type 2 diabetes (T2DM) in African-American 
women 38-57 years.  (2) To assess birth weight and obesity in relation to fasting 
plasma glucose (FPG). 
Background: African-American women suffer disproportionately in prevalence and 
complications of T2DM.  According to the fetal origins of chronic disease, T2DM is 
related to low birth weight with subsequent adult obesity.  Several studies have 
substantiated this hypothesis; none have focused on African-American women. 
Outcome Measure: Self-reported physician diagnosis of T2DM. 
Exposure Measures: Birth weight, an indicator for fetal growth; waist-to-hip ratio, a 
marker for abdominal obesity.  Other factors: physical activity, body mass index 
(BMI), history of gestational diabetes, blood pressure. 
Design: Retrospective, case-control observational study. 
 
Method: Convenience sample of urban African-American women.  Cases (n=95) 
reported a physician diagnosis of T2DM.  Controls (n=186), matched on race and age, 
reported no T2DM diagnosis.  To verify control status, participants were screened for 
elevated FPG (cut-point, <126 mg/dL, as defined by the American Diabetes 
Association).  Vital and family records were sources for birth weight.  Current 
weight, height, and waist and hip circumferences were measured; BMI and waist-to-
hip ratio were calculated.  Confounding factors were collected on a 68-item 
questionnaire.  Logistic regression analysis tested the proposed model for the odds of 
having T2DM.  Multiple linear regression analysis was employed to assess FPG.  
Sample size was estimated. 
Results: The odds ratio for T2DM increased as waist-to-hip ratio increased 
(OR=1.13, 95% CI=1.08, 1.19, p<.0001).  Birth weight did not contribute 
independently to the model’s ability to examine T2DM (OR=0.92, 95% CI=0.74, 
1.14, p=.4409).  Birth weight and waist-to-hip ratio each contributed independently to 
assessing FPG. 
Conclusions: This study found an interaction between birth weight and abdominal 
obesity when examining T2DM in African-American women: those born small and 
who subsequently developed abdominal obesity had a greater odds for T2DM.  
Abdominal obesity, but not birth weight, was independently associated with T2DM.  
FPG significantly increased with increasing abdominal obesity and decreasing birth 
weight.  African-American women are cautioned to maintain healthy body measures 
(waist-to-hip ratio <0.80 and BMI <25) to address T2DM. 
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Chapter 1: Introduction 
Statement of the Problem 
Diabetes is a growing problem in the United States and is costly in terms of 
treatment, lost work productivity, decreased quality of life, and premature death.1-5  
African-American women suffer disproportionately from this disease in terms of 
prevalence and complications.6  When examining results from a nationally 
representative sample of African-American women between the ages of 40 and 55, 
the prevalence of combined diagnosed and undiagnosed diabetes exceeded 14%7  
Type 2 diabetes has reached near-epidemic proportions in African-American women 
over the age of 55 where 55% live with type 2 diabetes.6  African-American women 
between the ages of 40 and 55 were selected for the current study because of the need 
for practical interventions in this age group due to the sharp increase in the prevalence 
of diabetes that occurs after the age of 55. 
Type 2 diabetes is associated with low birth weight8,9-14 and abdominal 
obesity.9,13-22  It is important to prevent fetal under-nutrition to reduce the risk for 
developing diabetes and other related disorders later in life.8  The fetus may 
experience structural and functional adaptations that could make it more susceptible 
to diabetes once the individual reaches adulthood.8  Low birth weight, defined as less 
than 2,500 g (5 pounds, 8 ounces),23-24 has been shown to increase the risk for type 2 
diabetes.8-9,11-12  In 2002, low birth weight deliveries among African Americans was 
13.4% compared to 6.9% for European Americans and 7.8% for the general 
population of the United States.23
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A distinction must be made between low birth weight due to fetal under-
nutrition and low birth weight due to prematurity.14  By including gestational age as a 
study variable, an investigator can account for prematurity status in the analysis and 
improve the interpretation of the data as they relate to fetal under-nutrition.  The 
present study focuses on low birth weight due to under-nutrition as opposed to 
prematurity.  Prematurity and macrosomia (heavy at birth) were assessed through a 
brief interview by the investigator within the one-hour enrollment session.  Women 
who were born premature and women who had macrosomia at birth were included in 
the study if they met the study criteria. 
Macrosomia, defined as high birth weight or as birth weight >4,100 g 
(approximately 9 pounds), represents the other extreme of birth weight and, like low 
birth weight, has been implicated as a factor that increases the risk for the 
development of type 2 diabetes.25  Therefore, high birth weight has been examined as 
a possible confounding factor for predicting type 2 diabetes. 
Abdominal obesity, like low birth weight, has been shown to be another 
independent predictor for type 2 diabetes and for various precursors of type 2 
diabetes, including glucose intolerance, insulin deficiency, and insulin resistance.13-22  
Abdominal obesity, estimated by waist-to-hip ratio >0.80, has been shown to be a 
better predictor for chronic diseases in African-American women than has overall 
obesity.26-27  Body mass index (BMI) is an indicator for overall obesity.26-27  African-
American women have a greater tendency of having excessive accumulation of fat in 
their abdomen than do European-American women.17  This may be a contributing 
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factor to the excess risk experienced by African-American women compared to 
European-American women for developing type 2 diabetes.26-27
Low birth weight and abdominal obesity may be different expressions of the 
same phenomenon: fetal under-nutrition that results in exposure of the fetus to 
chronic hyperinsulinemia in response to maternal hyperglycemia.28  Maternal 
hyperglycemia is a consequence of uncontrolled diabetes during pregnancy.  The 
current study did not address the question of the maternal glycemic status of the 
participant’s mother while the mother was pregnant with the participant because 
maternal diabetes status was not routinely captured in vital records before the 
1980s.29  Consequently, the current study focused on participant birth weight as an 
indicator for fetal under-nutrition. 
The objective of this study was to test the fetal origins of chronic disease in 
African-American women.  This was accomplished through examining the 
relationship between the risk for developing type 2 diabetes and birth weight and 
current abdominal obesity status. 
Hypotheses 
The main hypothesis for this study was:  Birth weight and abdominal obesity 
interact to increase the odds ratio of type 2 diabetes among cases versus controls in 
African-American women 38 to 57 years of age, controlling for potential 
confounders.  There were three other hypotheses:  (1) Birth weight is independently 
associated with type 2 diabetes in African-American women; (2) Abdominal obesity 
is independently associated with type 2 diabetes in African-American women; and  
(3) Among African-American women without a physician diagnosis of type 2 
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diabetes, there is an association among birth weight, abdominal obesity, and fasting 
plasma glucose level. 
For the first three hypotheses, type 2 diabetes was the outcome variable of 
interest.  The interaction between participant birth weight and current abdominal 
obesity status was the primary covariate of interest.  In addition, birth weights of the 
study participants and current abdominal obesity status, as defined by waist-to-hip 
ratio, were examined as independent variables.  History of gestational diabetes, 
family history of diabetes, smoking, highest level of education attained, physical 
activity, body mass index, self-reported weight at age 25 years, blood pressure, and 
menopausal status were covariates whose associations with type 2 diabetes were 
examined. 
Significance 
This current study was the first to address the interaction of low birth weight 
and abdominal obesity when examining type 2 diabetes in African-American women.  
It was also the first to include verified birth weights to test this hypothesis in African-
American women, as opposed to being limited to self-reported birth weights.  The 
current study helped address knowledge gaps in what is known about risk factors for 
type 2 diabetes17,30-31
Studies conducted in Europe,13-14 India,21,32 and, to a more limited extent, the 
United States,17,33 have examined the combined effects of low birth weight and 
abdominal obesity in predicting the development of type 2 diabetes using documented 
birth weights.  However, no studies have been found that examined the combined 
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effects of low birth weight and abdominal obesity specifically in African-American 
women, using documented birth weights. 
Unlike the majority of industrialized countries that maintain national registries 
of birth data linked to individual births, the United States has over 50 registry 
systems, including those of the 50 states, and the District of Columbia, New York 
City, and the U.S. Territories.  The current study was designed with the intent of 
collecting documented birth data on nearly every participant.  However, it was more 
difficult than anticipated to collect this information, matching data from birth records 
of individuals born in various states with anthropometrical and biological data 
collected directly from these individuals during their middle adult years.  In contrast, 
researchers who used cross-sectional data from the Third National Health and 
Nutrition Examination Survey (NHANES III)34 could not examine birth weight and 
abdominal obesity and their relationship to type 2 diabetes for this age range because 
relevant birth data for study participants, ages 38 to 57 years, were not collected in 
that survey. 
Delimitations and Limitations 
The current study targeted U.S.-born African-American women in the 
Washington, D.C., Metropolitan Area.  Restricting participant selection to U.S.-born 
women not only facilitated the procurement of birth data from vital records offices, 
but also helped reduce variability due to environmental factors, including prenatal and 
child care practices, long-term dietary practices, and public policy factors that might 
have influenced the life-long health status of the participants.  In addition, standard 
procedures set forth by the National Center for Health Statistics (NCHS)29 for the 
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collection of data for specific birth variables are followed by the various vital records 
offices of the United States. 
Churches and other faith-based organizations with large congregations of 
African-Americans were the primary sources for the recruitment of study participants.  
Self-selection of participants for the study limited the generalizability of the study 
compared to random sampling; nevertheless, convenience sampling is frequently used 
in studies where random selection and random assignment are not feasible due to 
ethical, cost, and time considerations.  These considerations held true for the current 
study. 
Indicators for fetal under-nutrition (birth weight), overall obesity (BMI) and 
abdominal obesity (waist-to-hip ratio) were used in the current study.  Birth 
certificates are considered accurate sources for birth data, including birth weight.  For 
anthropometric data, the accuracy of the data is a function of the accuracy of the 
measurements and of the recording and data transmission processes.35  Computed 
tomography36-37 and dual energy x-ray absorptiometry (DEXA), more accurate 
indicators of abdominal fat, were not available for the current study.  Waist 
circumference and waist-to-hip ratio were used instead. 
The current study incorporated verified self-reported birth weights when vital 
records data were not available.  Participants verified their birth weights from copies 
of birth certificates or hospital records they had on hand or through obtaining their 
birth weights from their mothers.  Obviously when official birth weight data are not 
available, self-reported birth weight may be used, as was done for the Nurses’ Health 
Study (NHS).33  In studies where self-reported birth weights are used, the investigator 
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is advised to assess the accuracy of these self-reports compared to birth reports from 
official records.38-40  The reliability of self-reported birth weights was assessed for 
participants in the current study by running correlations and paired t-tests between 
birth weights obtained from vital records (n=63) and those obtained through verified 
self-report for the same participants. 
Serum high-density lipoprotein cholesterol (HDL-C), an independent risk 
factor for type 2 diabetes41 and the preferred measure of cholesterol status, was not 
collected because it is expensive and invasive.  Instead, for the current study, self-
reported hypercholesterolemia status was determined through a questionnaire to 
assess the associations between total serum cholesterol and type 2 diabetes. 
Assumptions 
The current study assumed there were no significant differences in 
demographics and health behaviors assessed in the study for African-American 
women in the Washington, D.C., Metropolitan Area who were members of churches 
or other faith-based organizations and those who were not members.  Church-going 
women represent a wide range of health status and health behaviors that reflect those 
of the general population of African-American women.42  Thus, findings from this 
community-based study may be more generalizable than if study participants had 
been recruited from clinics or hospitals where uninsured and underinsured African-
American women might not be reached. 
It was assumed that documented birth data would be available for the majority 
of the study sample.  Before the current study was launched, vital records offices of 
all 50 states and New York City and the District of Columbia were contacted to 
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confirm that birth weight data for women 40 to 55 years of age would be available.  
Contact information for each state was obtained through the website of the NCHS.43  
Once these state offices were contacted, it was learned that the availability of birth 
weight was dependent on both the year and the state or county in which participants 
were born.  However, at that point, it was believed that birth weight data would be 
available for the majority of the study participants. 
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Chapter 2: Literature Review 
This review of the literature covers the following topics:  (1) Overview of 
diabetes, its prevalence and the pathophysiology of type 2 diabetes; (2) assessment of 
type 2 diabetes; (3) the metabolic syndrome; (4) non-genetic transmission of type 2 
diabetes; (5) fetal programming; (6) abdominal obesity; (7) interaction between low 
birth weight and abdominal obesity and; (8) confounding factors. 
Overview of Diabetes 
Diabetes is a disease characterized by elevated levels of blood glucose that, if 
not controlled, may lead to long-term, irreversible macro- and microvascular damage 
that can result in renal failure, cardiovascular disease, blindness, and amputations.41  
There are three main categories of diabetes: type 1, type 2, and gestational.  
According to the Centers for Disease Control and Prevention (CDC),44 type 1 
diabetes represents approximately 10% of the cases of diabetes in the United States 
and is caused by an absolute deficiency of insulin secretion from the pancreas and is 
usually accompanied by evidence of pancreatic autoimmune pathology.  Most cases 
of type 1 diabetes are diagnosed during childhood and adolescence. 
In contrast, type 2 diabetes, which represents the majority (~90%) of the cases 
of diabetes, is generally diagnosed in adulthood.41  However, the median age for onset 
of this form of diabetes is decreasing dramatically.37-38,128,130  The increased 
prevalence of diagnosis of type 2 diabetes in childhood and adolescence corresponds 
to the increasing prevalence of obesity and reduced levels of physical activity in the 
U.S. population.45-49  Obesity and low physical activity levels are two significant 
correlates for type 2 diabetes.  Other correlates for type 2 diabetes are a family history 
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of type 2 diabetes, low levels of high-density lipoprotein cholesterol, being older than 
45 years of age, belonging to a high-risk ethnic group, abdominal obesity, and fetal 
under-nutrition.41,50
The third category of diabetes is gestational diabetes, defined as diabetes that 
is first diagnosed during pregnancy and that usually disappears immediately upon 
delivery.  Gestational diabetes is an important risk factor in women for the 
development of type 2 diabetes later in life.41 
The American Diabetes Association (ADA) and the World Health 
Organization (WHO) changed the terminology of diabetes to reflect etiology.  The 
old system of referring to type 1 diabetes as “juvenile diabetes” and type 2 diabetes as 
“adult-onset” diabetes is obsolete.  Likewise, ADA and WHO have abandoned the 
use of Roman numerals (I, II) and now use Arabic numerals (1, 2) to avoid confusion 
among patients.41  Focusing on etiology in nomenclature also avoids confusion when 
treatment regimens vary over time.  Finally, an emphasis on etiology can assist in 
identifying factors that can reduce the risk for diabetes in individuals and in 
populations.41
Prevalence of Diabetes 
In the year 2000, 17 million people in the United States were estimated to be 
living with diabetes (6.2% of the population).44  Of this number, 11.1 million people 
had been diagnosed with diabetes and 5.9 million had not been previously diagnosed 
and, thus, were considered “undiagnosed cases.”  In 2005, the prevalence of diabetes 
had increased to 20.8 million people (7% of the population) in the United States.  Of 
this number, 14.6 million had been diagnosed with diabetes and 6.2 million (9.6% of 
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the population) were undiagnosed cases.  Among all adults >20 years of age (20.6 
million cases), it is estimated that 30% of all cases of diabetes are undiagnosed.51 
In the United States, type 2 diabetes accounts for about 90% of all cases of 
diabetes.  Certain ethnic groups are at greater risk for developing type 2 diabetes.41,50  
Prevalence figures for diabetes in adults 20 years of age or older in these high-risk 
ethnic groups include African Americans (13%),41 Hispanic Americans (10%),44 
Asian Americans and Pacific Islanders (11%) and Native Americans,44 with 
prevalence rates for the Pima Indians of Arizona among the highest levels (age-
adjusted rate in men, 49%; in women, 51%).52-53  Native Americans who receive 
health care through the Indian Health Services have an overall prevalence of 15% for 
diabetes.44  These figures are in contrast to the lower prevalence for European 
Americans (7.8%).44
National prevalence data for diabetes come from various data sources.44,52-56  
Depending on the source, reported prevalence may or may not include undiagnosed 
cases of diabetes.  The Third National Health and Nutrition Examination Survey 
(NHANES III)55-56 provides data on diagnosed and undiagnosed cases of diabetes 
among a national sample of non-Hispanic whites, non-Hispanic Blacks, Hispanics, 
Mexican Americans, Native Americans/Alaskan Natives, and Asian 
Americans/Native Pacific Islanders.  Again, about one out of three persons with 
diabetes has not been diagnosed with the disease.44
The Behavioral Risk Factor Surveillance System (BRFSS),54,56 a state-based 
survey conducted by telephone, collects data on self-reported diagnosed cases of 
diabetes for the same populations surveyed in NHANES.  Information on 
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undiagnosed diabetes is not collected for this telephone-based survey where, in 
contrast to NHANES, glucose testing is not conducted.  In essence, the BRFSS 
collects information on self-report of a physician diagnosis of diabetes. 
Pathophysiology of Type 2 Diabetes 
The pathophysiology, or derangement of function, of type 2 diabetes can be 
divided into two major areas.  The first mechanism for the pathophysiology of type 2 
diabetes is dysfunction of the β-cells of the pancreatic islets where an insufficient 
amount of insulin is secreted in response to elevated levels of glucose in the 
bloodstream.  The second mechanism is insulin resistance (insulin insensitivity) 
where the action of insulin is impaired, even in the presence of elevated levels of 
insulin in the bloodstream (called hyperinsulinemia).  Long-term hyperglycemia leads 
to many of the toxic effects of type 2 diabetes.  Both β-cell dysfunction and insulin 
resistance contribute to hyperglycemia. 
Insulin resistance generally plays the more significant role in the development 
of type 2 diabetes, especially early in the course of the disease and even before the 
disease is diagnosed.  Some individuals can compensate for an impaired ability to 
maintain glucose homeostasis through enhanced insulin secretion by pancreatic  
β-cells.  Over time, when the pancreas can no longer compensate, these individuals 
may develop glucose intolerance, and ultimately, type 2 diabetes.57-58  Figure 1 is a 
schematic depiction of the development of type 2 diabetes.59
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Type 2 diabetes 
• Insulin resistance 
• ↑ Hepatic glucose output 
• ↓ Insulin secretion 






Acquired and environmental factors 
• Obesity 
• Sedentary lifestyle 
• Fetal environment 
Compensated insulin resistance 
(Normal glucose tolerance)
Impaired glucose tolerance 
(Carbohydrate intolerance) 
Islet β-cell failure 
Figure 1. The pathophysiology of type 2 diabetes.  (Adapted from Olefsky and 




Insulin resistance may be genetic, acquired, or both.  Much is still unknown 
about the role genetics plays in the development of type 2 diabetes.  Although the 
genetic markers for type 2 diabetes have not been well defined, they appear to be 
heterogeneous.  Frayling and Hattersley60 presented their “fetal insulin hypothesis” 
which states that low birth weight and type 2 diabetes are two phenotypes of the same 
genotype.  They suggested that gene variants that result in differences in insulin 
resistance or insulin secretion within the normal population may also affect birth 
weight and birth length through effects on insulin-mediated fetal growth. 
Studies that focused on twins61-62 or on multi-racial, multi-ethnic, or 
immigrant populations60 have provided data on the genetic components of type 2 
diabetes.  In addition, animal studies have provided data for much of what is known 
about the genetic component of type 2 diabetes.8,63  Molecular studies also have 
contributed to what is known about the genetics of type 2 diabetes.64-65 
Frayling and Hattersley60 noted that insulin plays a central role in both fetal 
growth and carbohydrate regulation and, thus, may share a common pathway for the 
influence of genes.  This team of researchers discussed specific gene defects that  
(1) alter fetal insulin secretion or fetal insulin resistance or (2) alter growth. 
Acquired conditions may be more important to the development of type 2 diabetes 
than are genetic factors alone.  These acquired, or environmental, conditions include 
obesity, a sedentary lifestyle, and a less-than-optimal fetal environment (Figure 1).  
Abdominal obesity is an indicator for visceral adiposity and has been shown to be 
superior to overall obesity as a predictor for chronic disease outcomes in African-
American women.26-27  Sedentary lifestyle, as indicated by a low physical activity 
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level, is an additional risk factor for type 2 diabetes.45  An environment that 
compromises the growth and development of the fetus has been shown to be an 
important acquired risk factor for type 2 diabetes.  In fact, much of the risk that 
previously had been attributed to genetics has been explained by the prolonged 
exposure of the fetus to elevated levels of glucose and insulin.8  Theories that focus 
on fetal under-nutrition and on cross-generational exposure to elevated levels of 
glucose and/or elevated levels of insulin in utero have been proposed to explain the 
higher incidence of type 2 diabetes in certain families and populations.8 
Elevated blood glucose levels characterize diabetes mellitus.  Hormonal 
factors that work to increase blood glucose levels include glucagon, growth hormone, 
epinephrine, and the corticosteroids (glucocorticoids).  Insulin is the only hormone 
that functions to counterbalance the effects of all the hormonal factors that increase 
blood glucose concentration.  Therefore, insulin is critical to the regulation of glucose 
metabolism.  Insulin is secreted by the β-cells of the pancreas and functions to lower 
rapidly the amount of glucose in the blood after the consumption of a meal so that the 
concentration of glucose is maintained within the normal physiological range.  During 
the postpandrial (fed) state, insulin also catalyzes reactions in the liver to reduce the 
amount of glucose that the liver releases into the bloodstream by causing the 
reduction of hepatic gluconeogenesis.  This reduction in gluconeogenesis occurs 
because high concentrations of glucose in the portal vein overshadow the 
counterregulatory effects of glucagon, a hormone that, in the fasting state, triggers the 
liver to produce glucose and to release it into the bloodstream. 
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The roles of insulin are (1) to stimulate glucose oxidation and (2) to stimulate 
non-oxidative glucose storage in insulin-sensitive tissues such as muscle and adipose 
tissue.66  In utero, insulin is an important anabolic factor and promotes fetal growth, a 
role taken over postnatally by growth hormone.67
Assessment of Type 2 Diabetes 
There are several ways to assess diabetes status.  According to the American 
Diabetes Association, for the purpose of the assessment of diabetes status, plasma 
blood is preferred over whole blood and venous blood is preferred over capillary 
blood, the latter of which is sensitive to hydration status.41  Analysis of fasting blood 
glucose is preferred over that of casual (random) blood glucose because the former 
gives less variable results than the latter.  However, fasting plasma glucose (FPG) 
used as a single test for detecting the presence or absence of diabetes is widely 
accepted for screening in place of the gold standard post-load value68 (Oral Glucose 
Tolerance Test, OGTT) which is not appropriate for most epidemiological studies 
because it involves multiple collection times and typically requires two hours to 
complete.  In addition, fasting plasma glucose results are more reproducible than 
results from the OGTT.41
Based on data from NHANES III for the U.S. population aged 40-74 years, 
the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus41 
reported that using only the FPG test to diagnose diabetes in persons without a 
medical history of diabetes would result in a lower prevalence of diabetes than would 
be obtained using the OGTT (4.35% versus 6.34%).  The Expert Committee noted 
that these prevalence estimates refer to results of testing on one occasion and that the 
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prevalence of diabetes confirmed by a second test would be lower regardless of which 
criterion were used. 
An important limitation with using capillary blood for determining FPG status 
is that both hematocrit and hydration status can affect the results.  Poirier and 
associates69 evaluated self-monitoring blood glucose meters.  They noted that ideally, 
hematocrit as a confounder should be addressed through screening controls for 
hematocrit levels at the same time as the FPG screening.  Due to the physiological 
difference between capillary whole-blood glucose and venous plasma glucose levels, 
Poirier and associates corrected their results for hematocrit according to the equation 
where whole blood glucose = plasma glucosex [1 – (0.0024) (hematocrit)].  The 
Expert Committee of the American Diabetes Association33 does not address 
hematocrit status as a priority for screening for diabetes.  In addition, pricking the 
fingers of participants more than once for a study might adversely affect recruitment 
efforts and might result in a dataset that is incomplete in terms of hematocrit and/or 
FPG. 
Incorrectly classifying study participants as cases can be reduced by not 
including cases of undiagnosed diabetes in the study.  The incorrect classification of 
study participants as controls can be limited by excluding from the study any 
participant who is without a previous diagnosis of diabetes and whose FPG is >126 
mg/dL (7.0 mm/L).  Many studies do not use medical records to verify self-reported 
diabetes.  Studies that use data from the Behavioral Risk Factor Surveillance System 
are based on a self-reported physician diagnosis of type 2 diabetes.54,56  However, the 
Nurses’ Health Study (NHS) study reported by Manson and associates70 revealed that 
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self-reported diagnosis of diabetes in study participants was valid, based on a blinded 
review of medical records by an endocrinologist. 
Plasma glucose levels are assessed clinically through blood extracted 
intravenously.  For research performed in non-clinical settings, blood is often drawn 
from a finger prick.  The advantages of obtaining blood through finger pricks versus 
through intravenous blood draws are as follow:71-73 
1. It is less invasive and less burdensome to the participants. 
2. It may result in a higher participation level by prospective study participants. 
3. It is safer with a lower risk of provoking injury or harm to the participant. 
4. There is no need for highly specialized training as a phlebotomist, nurse, or 
physician. 
5. It is less expensive. 
6. It is faster to collect and to analyze blood obtained from finger pricks because 
fasting blood can be measured immediately for glucose with a glucometer. 
7. There is lower risk for blood coagulating while awaiting analysis. 
According to various researchers, the disadvantages of obtaining capillary 
blood samples through finger pricks are as follow:71-73 
1. It provides a static measure of blood glucose concentration.  It gives information 
on current glucose levels and reveals nothing about glucose tolerance or insulin 
sensitivity.  These latter two functional assessments require multiple collections 
of blood. 
2. It is not as accurate as laboratory analyses conducted on intravenous blood. 
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3. Standards are set for the analyses of intravenous blood; therefore, results for 
capillary blood must be adjusted for interpretation.  However, the Hemocue 201 
glucometer automatically converts whole blood glucose values to plasma glucose 
equivalents.74 
4. It does not distinguish between those who do not have diabetes and those who 
have diabetes but whose blood glucose levels are under good control. 
Given that the purpose of the assessment of glucose levels is to screen for 
diabetes and not to make a diagnosis, the capillary plasma glucose screening is 
sufficient.41  Generally, glucose screening for epidemiological studies involves 
determining fasting whole blood glucose levels and not plasma glucose levels, the 
latter of which is the standard set by the American Diabetes Association.41  Again, the 
Hemocue 201 glucometer provides the investigator with plasma glucose 
equivalents.74
The glucometer, a device that measures glucose levels in whole blood, is an 
acceptable method for analyzing blood in epidemiological studies.  The Hemocue 201 
is a glucometer calibrated by the manufacturer to reflect the standard cut-point for 
elevated plasma glucose.  Fasting plasma glucose >126 mg/dL (7.0 mm/L) is the 
American Diabetes Association’s standard for categorizing an individual as having 
diabetes.41
The Metabolic Syndrome 
The metabolic syndrome, also referred to as syndrome X, metabolic syndrome 
X, or insulin resistance syndrome, manifests itself as type 2 diabetes, insulin 
resistance, hypertension, coronary heart disease, obesity, or a combination of these 
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conditions.  Though the symptoms of these diseases often do not present themselves 
until a person reaches adulthood, it is theorized that the origins of type 2 diabetes and 
several other chronic diseases lie in fetal or early postnatal development.  The “thrifty 
phenotype theory,” as proposed by Barker and others,75-76 links the diseases of the 
metabolic syndrome to fetal under-nutrition where the fetus responds to severe 
malnutrition by favoring the metabolic demands of the growing brain and heart at the 
expense of other tissues, including the pancreas, liver, somatic muscle, and bones. 
Nathanielsz77 proposed that the effects of fetal programming might cross 
generations through mechanisms that may not involve changes in genes.  In contrast, 
Neel78 hypothesized with his “thrifty genotype theory” that type 2 diabetes is a 
consequence of genetic adjustments to inter-generational starvation conditions over 
the course of human existence where those who carried this “thrifty gene” were more 
likely to survive in times of limited food resources, but in times of abundance, were 
more likely to develop chronic diseases such as type 2 diabetes.  In addition to fetal 
under-nutrition (theorized to be the result of non-genetic intrauterine factors) and 
genetics (thrifty genotype), postnatal environmental factors such as diet, low physical 
activity level, and obesity, have been proposed to explain the higher prevalence of 
type 2 diabetes among certain populations, most notably, the Pima Indians of 
Arizona,57 Asian Indians who migrated to urban settings,9 and African Americans in 
the United States.44,55 
The term “metabolic imprinting” was introduced in recent years and was used 
by Waterland and Garza79 to describe the basic biology that might underlie 
relationships between nutritional experiences of early life and later diseases.  
  20
According to these investigators, metabolic imprinting is a more precise definition 
than is fetal programming.  Metabolic imprinting encompasses adaptive responses to 
specific nutritional conditions early in life that are characterized by a narrowly 
defined critical developmental window, a time when the organism is susceptible to an 
altered metabolic state whose effect persists through adulthood.  In addition, there 
exist specific and measurable outcomes and a dose-response or threshold relationship 
between a particular exposure and an outcome.  Waterland and Garza79 noted that 
although fetal programming addresses the effects of early nutrition experiences, it 
does not highlight the concept of a narrowly defined “critical window” period.  
Holness and associates80 discussed the “critical periods” of growth.  Similarly to 
Barker and others,75 these investigators proposed that early adaptation to an adverse 
intrauterine environment may ensure survival in the presence of a restricted nutrient 
supply, but may lead to persistent, and even lifelong, changes in the physiology and 
metabolism of tissues because the development of certain organs, such as the brain, 
are favored over the development of other organs, including the pancreas, liver, 
bones, and skeletal muscle. 
A major problem with the fetal programming hypothesis is that the 
mechanisms of fetal programming are not yet fully understood.  These mechanisms 
may operate at the organ, cellular, or molecular level to store information over a 
lifetime, and thus, can affect the organism throughout life.  Waterland and Garza79 
added that experiments involving animal models support the epidemiologic evidence 
for fetal programming and may elucidate the underlying biology (mechanisms) that 
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links low birth weight to an increased risk for adult chronic diseases.  Animal models 
for type 2 diabetes include rats, mice, sheep, and baboons.63
There are alternate hypotheses that relate fetal under-nutrition and its 
concomitant low birth weight to the outcome of a specific or a constellation of 
chronic diseases.  Ben-Shloma and Smith81 put forth one such alternative hypothesis.  
They proposed that the same impoverished environment that leads to a high 
prevalence of perinatal mortality at later ages may act to predispose a population to 
elevated coronary heart disease mortality as individuals grow older.  Hattersley and 
Tooke82 also proposed an alternative hypothesis to fetal programming in response to 
maternal malnutrition.  They postulated that “genetically determined insulin 
resistance results in impaired insulin-mediated growth in the fetus as well as insulin 
resistance in adult life.”  They explained how low birth weight, insulin resistance, 
glucose intolerance, type 2 diabetes, and hypertension are phenotypes; that is, these 
conditions are observable characteristics of the same insulin-resistant genotype. 
Hattersley and Tooke82 added that fetal insulin-related growth reflects both 
maternal glycemia and fetal genetic factors that regulate the secretion of insulin by 
the pancreas and the sensitivity of fetal tissues to insulin.  These authors proposed 
that experiments be carried out to test whether the insulin resistance of the father 
shows an inverse correlation with the child’s birth weight, specific measures of 
insulin-mediated growth, and endothelial function.  They concluded that “a large 
component of variation in fetal weight may be explained by genetic control in the 
fetus of glucose sensing, insulin secretion, and insulin resistance.”  In addition, 
Gluckman and Liggins67 noted that the paternal contribution to birth weight is 
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expressed only through a father’s contribution to the fetus’s autosomal genes and sex 
while the maternal contribution to birth weight is expressed both through genes and 
through the effect of the mother’s own genotype on the fetal environment.  These 
authors concluded that the fetal environment is as important as the fetus’s genotype 
when it comes to birth weight.  They stated that during the first half of pregnancy, 
genetics predominate while in the second half, the importance of environmental 
constraints and stimuli increase. 
Evidence concerning the metabolic syndrome is supported by animal studies63 
and by human epidemiological and experimental studies (clinical trials).66  
Experimental animal studies with rats, mice, pigs, chickens, sheep, and guinea pigs 
revealed that animals that experienced under-nutrition during the fetal period were 
more likely to develop diabetes-like syndromes later in life.  The same has been 
shown for protein or caloric restrictions during the neonatal and later infancy periods.  
However, the strongest associations between under-nutrition and diabetes-like 
syndromes in animals are for the fetal period. 
Poulsen and associates61 and Bo and associates62 revealed through their 
human twin studies, that there is an inverse association between size at birth and type 
2 diabetes.  The prevalence of type 2 diabetes was greater among the smaller twin of 
the pair (homozygous or dizygous) than for the larger twin.  These twin studies 
supported the hypothesis that fetal size, irrespective of genetic influences, is a 
powerful predictor for type 2 diabetes.  However, Bennett57 pointed out that twin 
studies do not provide information as to whether type 2 diabetes is caused by one or 
many genes.  Bennett added that twin studies also fail to reveal the mode of 
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inheritance of type 2 diabetes.  Phillips and associates66 showed that the metabolic 
syndrome is strongly associated with resistance to the metabolic actions of insulin and 
suggested that insulin insensitivity (insulin resistance), and consequently, type 2 
diabetes, may be consequences of reduced fetal growth. 
Figure 2 outlines a proposed pathway between fetal under-nutrition and the 
metabolic syndrome.  The theorized mechanism starts with fetal malnutrition that is 
caused by either maternal malnutrition or by a reduced flow of nutrients to the fetus 
as a result of placental or maternal abnormalities.  Fetal malnutrition can then proceed  
Fetal Undernutrition
↓
Maternal undernutrition Maternal/placental abnormalities
Reduced placental blood flow
Reduced fetal beta cell mass/function
Reduced fetal growth
Postnatal undernutrition
















Type 2 diabetes Dyslipidemia
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Figure 2. Theoretical model for early under-nutrition and type 2 diabetes and 
the metabolic syndrome (Adapted from “Syndrome-X in Type 2 Diabetes” by 
Murthy and Sargur, 2003).83  GH, growth hormone; IGF, insulin-like growth 




in one (or more) of three sub-pathways.  The first sub-pathway from fetal 
malnutrition is thought to lead to fetal hormonal changes in the production of cortisol, 
growth hormone, and insulin-like growth hormone.  From there, insulin resistance 
may develop which may ultimately lead to type 2 diabetes in later life.  The second 
sub-pathway that is postulated to originate from fetal malnutrition initially produces a 
reduction in fetal β-cell mass and function.  This may lead to reduced fetal growth 
and possibly to early postnatal malnutrition.  The reduced mass and function of the  
β-cells persist through adulthood.  In the presence of food abundance, type 2 diabetes 
and/or dyslipidemia may occur in adulthood.  The last of the three proposed sub-
pathways for the metabolic syndrome arising from fetal malnutrition involves 
hormonal changes; however, in this case, the hormones in question are 
catecholamines and factors that involve the sympathetic nervous system.  This sub-
pathway is postulated to lead to hypertension.  The endpoints of these three 
pathways—type 2 diabetes, dyslipidemia, and hypertension—are only a few of the 
conditions that collectively comprise the metabolic syndrome.  Other proposed major 
components of this syndrome are coronary heart disease and obesity. 
Non-Genetic Transmission of Type 2 Diabetes 
It has been shown that women who experience hyperglycemia and the 
accompanying hyperinsulinemia during pregnancy have a greater risk for delivering 
offspring who will develop type 2 diabetes during adulthood.  Aerts and associates8 
referred to this as “non-genetic transmission” of type 2 diabetes.  Based on findings 
from rat studies, these investigators defined the transmission of impaired glucose 
tolerance, insulin resistance, gestational diabetes, and type 2 diabetes as the 
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transmission of a diabetetogenic tendency over consecutive generations, without any 
genetic interference.  These investigators added that non-genetic transmission of type 
2 diabetes can be prevented by normalizing maternal glycemia during pregnancy.  
They noted that this is true, not only for women who have been diagnosed with 
having gestational diabetes or type 2 diabetes during or prior to their pregnancies, but 
also for women who were assessed as being insulin resistant. 
Hyperinsulinemia is one mechanism proposed to explain why type 2 diabetes 
tends to be more prevalent in families where the mother had type 2 diabetes.  This 
relationship has not been shown to hold where the father had type 2 diabetes, 
especially in light of the intrauterine mechanism proposed by Aerts and associates.8 
Fetal Programming: Fetal Under-Nutrition and Macrosomia 
Figure 2 outlines a proposed pathway between fetal under-nutrition and type 2 
diabetes, the latter of which is one component of the metabolic syndrome.  Fetal 
under-nutrition has been found to be an independent risk factor for type 2 diabetes.  
Fetal under-nutrition has been defined in several ways:  low birth weight;61 small-for-
gestational age (to control for prematurity);84 shortness at birth, defined as a high 
ponderal index [birth weight (g)/birth length (cm3)]; thinness at birth (low ponderal 
index);66,85 low (or high) placental weight and; small head circumference.  In 
addition, maternal height and maternal weight gain during pregnancy have been used 
as predictors for size at birth.28
The indicators listed above indirectly measure fetal growth.  In animal studies, 
fetuses were measured directly at various points in gestation.  Cardel’s seminal 1955 
study86 is one of the few that directly measured hypertrophy and hyperplasia of 
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pancreatic islets in humans.  His subjects were fetuses of infants who were born 
stillborn or who died within 48 hours of birth.  In Cardel’s investigation, pancreatic 
tissues of infants who were born to mothers who had diabetes during the pregnancy in 
question were compared to pancreatic tissues of infants who were born to mothers 
without diabetes.  This investigator found an increase in the size of islet tissues of 
infants whose mothers had diabetes.  This suggested that the fetus compensated for 
increased exposure to glucose in their prenatal environment. 
In their review of the literature, Holness and associates80 showed that there are 
competing mechanisms to explain poor early growth and type 2 diabetes.  On the one 
hand, type 2 diabetes may take the form of impaired pancreatic β-cell function, while 
on the other hand, type 2 diabetes may be the result of impaired insulin action.  These 
authors noted that malnutrition in utero may retard islet functional maturation.  
Jackson28 also discussed how the achieved size of an organ is a crude marker for 
metabolic capacity and that the enzymatic capacity of a larger liver is greater than that 
of a smaller liver.  Thus, the larger liver and larger muscle mass have a greater 
capacity to remove glucose from the circulation and at a faster rate.28  Likewise, a 
pancreas that has reached its full potential size, and therefore its maximal metabolic 
capacity, would be able to maintain glucose homeostasis better than a pancreas that 
had been subjected to fetal under-nutrition. 
The influence of childhood size on the relationship between fetal under-
nutrition and type 2 diabetes, fetal under-nutrition and glucose intolerance, or fetal 
under-nutrition and insulin resistance have been presented in the literature.  Parallel to 
fetal under-nutrition and its concomitant low birth weight, macrosomia at birth has 
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been shown to be an independent risk factor for the development of type 2 diabetes 
later in life.  Babies born large for gestational age are most frequently born to mothers 
who had gestational diabetes.87  In her review of the role of insulin in prenatal 
growth, Fowden25 noted that insulin in utero has anabolic effects.  Infants born of 
mothers who have diabetes tend to have excessive secretion of insulin, and 
consequently, these infants tend to have increased amounts of body fat and to weigh 
more than normal newborns of similar gestational age.  Fowden25 noted that the 
anabolic effects of insulin on the fetus combine with those of insulin-like growth 
factor (IGF) and peptide-based growth factors to produce a macrosomic infant. 
In the United States, birth weight is the most available indicator of fetal under-
nutrition.  Again, ponderal index and weight-for-gestational age are two alternative 
proxies for fetal under-nutrition.  Ponderal index is a ratio that is comprised of birth 
weight divided by the cube of birth length.  In the United States, data on birth length 
are more difficult to obtain than birth weight.  For the current study, ponderal index 
could not be assessed because of the unavailability of birth length. 
Abdominal Obesity 
Abdominal obesity has been identified as an important risk factor for the 
development of type 2 diabetes.  Measures of abdominal obesity include waist 
circumference and waist-to-hip ratio.  Based on their experimental study with 27 
participants, Phillips and associates66 proposed a mechanism to explain how obesity, 
especially abdominal obesity, can affect glucose metabolism.  They concluded that in 
obese participants, the expanded fat mass may supply an excessive amount of 
oxidizable lipid substrates.  These lipid substrates, in turn, compete with glucose 
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metabolism in peripheral tissues and interfere with the ability of insulin to suppress 
hepatic glucose output.  The Phillips group hypothesized that decreased insulin 
sensitivity (increased insulin resistance) could be a “programmed” response to early 
growth restrictions. 
Lundgren and associates,20 Folsom and associates,22 Kohrt and associates,88 
and Björntorp89 examined the relationship between abdominal obesity and glucose 
tolerance, insulin resistance, and/or type 2 diabetes.  Obesity has been shown to have 
a significant impact on health status, particularly for chronic diseases, including type 
2 diabetes, coronary heart disease, hypertension, and hypercholesterolemia.  These 
conditions are components of the metabolic syndrome, also referred to as insulin 
resistant syndrome, discussed above. 
For numerous years, excess body weight, in terms of BMI, has been 
considered a strong risk factor for many chronic diseases.22  Stevens26 noted, that a 
high BMI, however, does not result in an increase in overall mortality for African-
American women as it does for European-American women. 
Stevens and associates90 questioned whether a single cut-point for obesity 
should be applied to all ethnic groups.  They studied the effects of four health 
outcomes (mortality, type 2 diabetes, hypertension, and hypertriglyceridemia) and 
three different measures of effect (incidence rate, rate ratio, and rate differences) in 
African-American and European-American women aged 45 to 64 years.  These 
investigators concluded that there was no significant association between BMI and 
mortality in African-American women. 
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At 48%, African-American women have the highest prevalence of overweight 
in the United States while European-American women have a prevalence of 32.9%.90  
In addition, the distribution of body fat among African-American women tends to be 
more central and abdominal than for European-American women.26  This translates 
into a higher prevalence of abdominal obesity among African-American women than 
among European-American women in the United States. 
Abdominal obesity has been found to be an independent risk factor for type 2 
diabetes and other chronic diseases among various populations.22,89  Abdominal 
obesity is also referred to as visceral obesity.  Little and Byrne91 concluded that 
abdominal obesity, measured either by waist circumference or by waist-to-hip ratio, is 
a better predictor for chronic diseases than is BMI.  Byrne stated that focusing on 
abdominal obesity can help to target those who are at greatest risk for developing type 
2 diabetes. 
Folsom and associates22 noted that waist circumference was accepted by an 
expert panel on obesity as the superior anthropometric measure of abdominal obesity 
because it is easier to measure and to interpret than is waist-to-hip ratio.  In addition, 
waist circumference correlates well with visceral fat measured by computerized 
tomography.  However, Folsom22 and associates concluded that waist-to-hip ratio is a 
better predictor for health outcomes given that waist circumference highly correlates 
with BMI and therefore reflects both overall and abdominal obesity. 
Folsom and associates22 reported findings from the Iowa Women’s Health 
Study where they focused on older women and considered multiple health outcomes, 
including type 2 diabetes and coronary heart disease, in terms of overall obesity and 
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in terms of abdominal obesity independent of overall obesity.  These investigators 
concluded that abdominal obesity is well reflected anthropometrically by either an 
increased waist-to-hip ratio or waist circumference for a sample of predominantly 
European-American women.  Relative risk based on BMI seemed comparable to 
measures of abdominal obesity for predicting risk for type 2 diabetes for the Iowa 
Women’s Health Study.  Relative risk results for this European-American population 
were measures of the strength of association between various measures of obesity and 
type 2 diabetes. 
Again, the Folsom study22 involved a population of predominantly European-
American women.  In contrast, Okosun17 measured waist circumference to determine 
abdominal obesity among American women of African Americans, European 
Americans, and Latin Americans ethnicity.  Both studies showed that abdominal 
obesity contributed more to African-American women’s risk for developing type 2 
diabetes than to the other two ethnic groups’ risks: 40, 24, and 16 percent of type 2 
diabetes could have been avoided in African-American, European-American, and 
Latin American women, respectively, if abdominal obesity were absent. 
Bennett57 showed that abdominal obesity is associated with an increased risk 
for type 2 diabetes.  He noted that hyperinsulinemia, (insulin resistance) may be the 
central feature of the cluster of abnormalities related to abdominal obesity.  Again, 
these metabolic disorders include type 2 diabetes, coronary heart disease, high serum 
triglycerides, low high-density lipoprotein (HDL) cholesterol, and hypertension. 
Figure 3 is a theoretical model that depicts how obesity, specifically 
abdominal obesity, can lead to type 2 diabetes.  This postulated mechanism suggests 
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that fat, most notably abdominal (visceral) fat, leads to an elevated blood level of free 
fatty acids.  These excess free fatty acids are deposited in muscle and liver tissues and 
contribute to the resistance of muscle and liver tissues to the action of insulin.  As a 
consequence of insulin resistance, type 2 diabetes may develop. 
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Figure 3. Theoretical model for type 2 diabetes and abdominal obesity (Adapted from 
Boden, p. 980)92
 
Interaction Between Low Birth Weight and Abdominal Obesity 
Studies reported in the literature show a relationship between low birth weight 
and type 2 diabetes.66,85  Phillips and associates66 hypothesized that the pathogenesis 
of type 2 diabetes begins in utero where fetal under-nutrition results in the 
development of reduced insulin sensitivity of peripheral tissues, especially skeletal 
muscle.  The infant is born small and tends to develop diabetes in adulthood, 
especially if insulin sensitivity is further impaired by obesity.  These investigators 
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used thinness at birth (low ponderal index) as the indicator for smallness at birth.  
Smallness at birth is the proximate surrogate for fetal under-nutrition.  Phillips and 
associates66 showed that reduced fetal growth is associated with an increased risk for 
developing type 2 diabetes.  They proposed that this relationship is mediated through 
insulin resistance and not through β-cell function and that it depends on an interaction 
with obesity in adult life.  Given that the incidence of low birth weight among 
African-American infants at 13.4% in 2002 was much higher than for the general 
population of the United States at 7.8%, and European Americans at 6.9%,23 the risk 
for developing type 2 diabetes as a consequence of fetal under-nutrition may be 
elevated for African Americans. 
It is now accepted that there is an association between abdominal obesity and 
type 2 diabetes.  This is a significant issue for African-American women who 
comprise the most obese segment of the U.S. population.  The obesity of African-
American women tends to be abdominal.26  This propensity for abdominal obesity 
further elevates this population’s risk for developing type 2 diabetes and other chronic 
diseases.  The proposed model for the interaction of birth weight with abdominal 
obesity to cause type 2 diabetes is shown in Figure 4.  Insulin resistance and food 
overabundance are common denominators for the separate models shown in Figures 2 
and 3.  Food overabundance can lead to abdominal obesity that, in turn, may lead to 







Maternal undernutrition Maternal/placental abnormalities
Reduced placental blood flow
Reduced Beta cell mass/function
Reduced fetal growth
Postnatal undernutrition




























Fat, most notably 
abdominal (visceral) fat
Type 2 diabetes










Figure 4. Combined model for interaction of early under-nutrition and abdominal 
obesity with type 2 diabetes83,92 
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Confounding Factors 
The literature revealed several confounders for the relationships among birth 
weight, abdominal obesity, and type 2 diabetes.6,22,70,93-102  With the exception of 
BMI, all the potentially confounding variables examined in the current study were 
collected using a 68-item validated questionnaire (Appendix A; the screeining 
questionnaire is located in Appendix B).  These factors included age, menopausal 
status, smoking, physical activity, personal history of gestational diabetes, and family 
history of diabetes. 
Halter93 wrote that aging has been shown to have an effect on glucose 
homeostasis and, consequently, an effect on the incidence and prevalence of type 2 
diabetes.  Clark94 reported that the prevalence of type 2 diabetes is positively 
associated with age.  Clark noted that prevalence among people over the age of 65 
years is eight times greater than the prevalence among people 20 to 40 years of age.  
The relatively narrow age range (~20 years) covered by the current study helped to 
reduce the confounding of age on the results.  Item 1 of the Birth Information section 
of the current study’s questionnaire was used to collect birth data. 
A high BMI was shown by Keyserling6 and Folsom22 to be associated with 
type 2 diabetes.6,22  Overall overweight, defined as BMI 25.0 to 29.9, and overall 
obesity, as BMI >30.0, have been used as covariates to examine the effect of 
abdominal obesity on type 2 diabetes.26  However, BMI was not the focus of this.  
Abdominal obesity was one of the two main exposure variables examined.  
Abdominal obesity is defined for women as waist-to-hip ratio >0.80 or waist 
circumference >88 cm (approximately 35 inches). 
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A large, randomized clinical trial conducted by the Diabetes Prevention 
Program (DPP) Research Group95 found that lifestyle changes, namely increased 
physical activity and weight loss, significantly reduced the incidence of diabetes in 
persons at high risk compared to those high-risk persons who received only the drug 
Metformin.  Boulé and associates,103 in their meta-analysis of controlled clinical 
trials, found that exercise training reduced glycosylated hemoglobin (HbA1c) despite 
finding no significantly greater change in body mass in the exercise group compared 
to the control group.  It should be noted that HbA1c is a measure of long-term (three-
month) blood glucose control. 
A study by Helmrich and associates96 involving middle-aged men showed that 
total energy expenditure during leisure time had a protective effect against the 
development of type 2 diabetes.  Wei and associates97 reported that physical inactivity 
and low physical fitness are modifiable risk factors that contribute to the development 
of type 2 diabetes.  They noted in their review of the literature, however, that physical 
activity also has been shown to be inversely associated with obesity and central fat 
distribution.  Physical activity was measured in the current study because of its likely 
role as a confounder for abdominal obesity. 
Another study that demonstrated the need to measure physical activity as a 
possible confounder was conducted by Manson and associates.70  These investigators 
utilized data from the Nurses’ Health Study (NHS) to document prospective evidence 
of the association between physical activity and subsequent incidence of diagnosed 
type 2 diabetes among 87,253 women aged 34 to 59 years of age who were followed 
for eight years. 
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The majority of questionnaires used for major epidemiological studies 
measure leisure-time physical activity.  However, leisure activity has been found to 
underestimate physical activity for women, particularly for women of color.104  The 
Lipid Research Clinics (LRC) physical activity instrument105 was adapted for the 
current study because, in addition to leisure activities, it measures non-leisure time 
activities that may play a significant role in energy expenditure for African-American 
women.  These non-leisure activities specifically include activities performed during 
the course of employment, household chores, and in childcare, family care, volunteer, 
and church activities.  Even though the physical activity items in the questionnaire did 
not provide information on specific activities, they implicitly measured intensity and 
duration, as interpreted by the study participant. 
The physical activity items in the current study’s questionnaire may be more 
appropriate for African-American women than are those used in the Behavioral Risk 
Factor Surveillance System (BRFSS)104 or in NHANES III104 because the latter two 
instruments are limited to leisure-time activities.  The article by Kriska and 
Caspersen106 addressed important aspects that should be considered when creating or 
adapting physical activity questionnaires.  Items 1 to 4 of the Personal Lifestyle 
section of the current study’s questionnaire addressed physical activity. 
Dietary assessment through food frequency questionnaires, 20-four hour 
recalls, or food diary may be time-consuming and burdensome for study participants.  
However, abdominal obesity, BMI, and physical activity are distinct proxies for 
dietary intake, especially in terms of the macronutrients—carbohydrates, fats, and 
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proteins.  Gillman and associates107 and Albanes and Conway and associates 108 found 
that physical activity and diet quality are associated behaviors. 
Gestational diabetes is known to increase the risk for subsequent development 
of type 2 diabetes.  Items 6 and 7 of the Personal Health History section of the current 
study’s questionnaire addressed gestational diabetes.  Family history of diabetes is 
another strong predictor for type 2 diabetes.  Twelve items (1 to 12) of the Family 
Diabetes History section of the questionnaire addressed this risk factor.  The 
questionnaire items that were used to assess family history of diabetes were adapted 
from a surveillance instrument developed by the National Health Service of the 
United Kingdom.109
Hypertension and hypercholesterolemia are two components of the clustering 
of diseases and disorders that comprise the metabolic syndrome.  Items 1 and 2, 
respectively, of the Personal Health History section of the current study’s 
questionnaire were designed to collect self-reported data on these variables.  In 
addition, blood pressure was measured by the investigator. 
Smoking and alcohol consumption are lifestyle factors proposed to affect the 
onset of complications of type 2 diabetes.  Smoking has been examined for its 
possible association with type 2 diabetes.100-101  For the current study, smoking was 
categorized as “never smoked,” “former smoker” (smoked more than 100 cigarettes 
in lifetime), or “current smoker.”  Items 5 to 7 of the Personal Lifestyle section of the 
current study’s questionnaire addressed smoking.  Alcohol intake was examined by 
Johnson and associates,101 Lee and associates,102 Wei and associates,110 and Ajani and 
associates.111  Items 8 and 9 of the Personal Lifestyle section of the questionnaire 
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solicited self-reported data on alcohol consumption.  The reliability of recalled 
physical activity, cigarette smoking, and alcohol consumption was examined by Lee 
and associates.102  They found that self-report of these lifestyle behaviors were 
reliable. 
In summary, the literature revealed that separately, low birth weight and 
abdominal obesity increase the risk for type 2 diabetes for certain populations.  
However, a search of the literature did not reveal any studies that examined whether 
low birth weight increases the risk for type 2 diabetes in African-American women.  
It also did not reveal any studies that examined the interaction of low birth weight and 
abdominal obesity in African-American women, a population whose risk for each of 
these factors is high.  The current study investigated whether the interaction of low 
birth weight and abdominal obesity is associated with type 2 diabetes for African-
American women. 
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Chapter 3: Method 
This chapter describes the design, recruitment and exclusion criteria, sample 
size determination, survey instruments, data collection procedures and statistical 
analyses used to address the study hypotheses.  In addition, the pilot study and 
limitations of birth data used in the study are addressed. 
Study Design 
This retrospective case-control, non-intervention observational study 
examined the relationships among birth weight, current weight status, and type 2 
diabetes in a convenience sample of 281 African-American women.  In addition, the 
relationship between type 2 diabetes, abdominal obesity, and birth weight was 
assessed.  A self-reported physician diagnosis of type 2 diabetes was the outcome 
measure.  Explanatory variables were birth weight and current waist-to-hip ratio.  
Covariates included body mass index (BMI), physical activity, family history of 
diabetes, personal history of gestational diabetes, blood pressure, self-reported weight 
at age 25, and smoking.  See Codebook (Appendix C) for collected and calculated 
variables. 
Recruitment and Participants 
A large-scale community outreach campaign was implemented to recruit 
participants.  Recruitment sites included, but were not limited to churches, a mosque, 
and other faith-based organizations, health clinics, worksites, recreation centers, 
social service and employment service centers, literacy programs, libraries, health 
fairs, beauty shops, private homes, public housing resident council offices, public and 
parochial schools, health food complexes and supermarkets (including the posting 
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and distribution of flyers inside and outside the facilities), parked cars, and university 
facilities.  Printed and electronic media were utilized, including newspaper articles 
and advertisements, newsletters and church bulletins, printed flyers, radio interviews 
and announcements, and the Internet.  Word-of-mouth was a major recruitment tool.  
See Appendix D for selected recruitment materials and resources. 
The initial sample was a convenience sample of 376 African-American 
women, 38 to 57 years of age, who were born in the United States between 1945 and 
1970 and recruited from the Washington, D.C., Metropolitan Area.  Race and birth 
date data were by self-report.  Age was based on last birthday completed at the time 
of enrollment.  (See Figure 5 for enrollment and categorization of study participants.)  
It was proposed that it would take five to eight months to enroll study participants.  
However, due to unanticipated recruitment challenges, the recruitment period lasted 
17 months (August 9, 2004, to January 14, 2006).  Recruitment challenges included 
the need for additional time to build relationships among the various faith-based 
organizations.  Women above the age limit of 57 years were generally very receptive 
to the idea of participating in the study; however, they did not meet the study protocol 
and could not be enrolled.  In addition, initially requiring that at least four to five 
women be available to enroll within one session that was scheduled outside of the 
university resulted in some lost opportunities for enrolling women in the study.  
Beginning around the ninth month of the study, a woman eligible for the study who 
had a self-reported physician diagnosis of type 2 diabetes would be enrolled at the site 
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Figure 5. Enrollment and categorization of study participants 
aUndiagnosed diabetes, FPG greater than or equal to 100 mg/dL and less than 126 mg/dL 
bFPG, fasting plasma glucose 
cCases (those with a self-reported physician diagnosis of type 2 diabetes) could have a non-fasting plasma 
glucose in place of a fasting plasma glucose.  The plasma glucose for cases could be any value for the 
purpose of categorization. 
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were the only enrollee scheduled for the session.  Finally, having one observer collect 
all the measurements slowed down the enrollment process for this study. 
Of the 376 women initially enrolled, 121 (32%) reported having a physician 
diagnosis of type 2 diabetes while 244 reported not having a physician diagnosis of 
diabetes and had fasting plasma glucose levels of <126 mg/dL.  Participants with 
prediabetes (fasting plasma glucose levels from 100 mg/dL to less than 126 mg/dL) 
were classified as controls because their fasting plasma glucose levels were less than 
the cut-point for diabetes (fasting plasma glucose >126 mg/dL). 
Only women for whom birth weight could be verified through official records 
or through verified self-report (95 cases, 186 controls) were retained for the study.  
Verified self-reported birth weights were obtained through asking participants to 
report the birth weights found on personal copies of their birth certificates, hospital or 
clinic records, crib cards, entries in family Bibles, or through getting reports of their 
birth weights from their mothers.  Eighty-four women were excluded from the study 
because verified birth weight could not be obtained for them.  Correlations and paired 
t tests analyses were conducted on the different sources of birth weights to determine 
whether verified self-reported birth weights and vital records birth weights could be 
pooled.  These results can be found in Chapter 4 of this dissertation. 
Eleven enrollees could not be categorized as cases or controls and were not 
included in the study.  Of the 11 enrollees excluded based on inability to be 
categorized as cases or controls, ten could not be classified because they presented as 
not having had a physician diagnosis of type 2 diabetes, but their fasting blood 
glucose levels measured >126 mg/dL.  However, a few hours after enrolling in the 
  43
study, one of these participants was diagnosed by a physician as having diabetes.  She 
reported visiting a hospital emergency room after feeling lightheaded because she 
then was able to recognize the symptoms of diabetic hyperglycemia.  (Note: 
Cognitive and motor impairment have been shown to be symptoms for hyperglycemia 
as well as for hypoglycemia.112)  This participant was reclassified as a case after she 
contacted the study investigator two days after her hospitalization. 
A second participant was diagnosed with type 2 diabetes after making an 
appointment with her health care provider upon the advice of the study investigator.  
This participant returned six months after her diagnosis to have new study 
measurements collected.  Data collected on her at her first enrollment appointment 
were not used in the study.  Nine of the 11 participants who could not be classified as 
cases or controls at the time of enrollment could not be reclassified as cases later.  
None of these participants were included in the study because they did not meet the 
study protocol’s definition of cases or controls. 
One participant reported that although she had lived for years believing that 
she had type 2 diabetes, her physician informed her two years ago that she actually 
has type 1 diabetes based on a genetics assessment.  No details were collected 
regarding the nature of the genetics assessment.  This woman was not included in the 
study. 
Written informed consent (Appendix E) was obtained from each participant.  
New York State required that participants who were born there sign a state-specific 
informed consent form.  Regulations pertaining to the Health Insurance Portability 
and Accountability Act (HIPAA)113-115 and appropriate state laws were followed 
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regarding data collection and storage.  Approval was granted from the Institutional 
Review Board (IRB) of the University of Maryland (Appendix E) and from IRBs of 
various vital records offices or State Centers for Health Statistics, where applicable. 
Exclusions 
Known cases of type 1 diabetes were excluded from the study.  Women who 
were pregnant at the time of enrollment or who had delivered a child within nine 
months preceding the scheduled enrollment date were also excluded given the 
possibility that these conditions could influence blood glucose and body 
measurements.  Potential participants who reported that they had major diseases such 
as cancer, liver or renal disease, myocardial infarction, or stroke within six months 
prior to their enrollment were excluded to avoid enrolling participants whose altered 
glucose metabolism or body measurements might be secondary to these diseases or 
treatments.  Two women who had recovered from these conditions more than six 
months before screening were eligible to enroll (one from a heart attack and one from 
cancer).  Women who reported major infections, including HIV and AIDS, were 
excluded from the study given that these infections might significantly alter plasma 
glucose results and current body measurements.  One recruit reported that she was 
HIV-positive.  She was not enrolled in the study; however, she received all the 
benefits that were provided to those women who were enrolled. 
Sample Size Determination 
Before the study was launched, an a priori sample size estimation was 
performed to determine the number of participants needed to conduct this case-
control study.  Initially, the sample size was estimated based on a power of 
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approximately .80; however, due to difficulty in obtaining birth weight data, the final 
power for the current study was .56.  A detailed description of the sample size 
estimation can be found in Appendix F.  The actual power of the current study was 
based on sample size (95 women with type 2 diabetes and 186 women without 
diabetes) and prevalence of low birth weight, defined as birth weight <2,500 g.  The 
prevalence of low birth weight for the sample was .13 among controls and .19 among 
cases.  For case-control studies, sample size estimations and power analyses are based 
on the prevalence estimates of the outcome of interest (for the current study, low birth 
weight) in persons without the condition (controls: women without diabetes). 
Instruments 
Tools used in the current study included equipment and materials for direct 
measurements (Appendix G), a 68-item questionnaire developed and validated by the 
investigator (Appendix A), a screening questionnaire (Appendix B), and official birth 
records obtained through vital records offices and State Centers for Health Statistics.  
These instruments are described below. 
Equipment and Materials 
Blood pressure was measured using the American Diagnostic Corporation 
(ADC) Model 6014 digital blood pressure device.  Blood pressure readings for 
various individuals were compared with readings from health center sphyngometers 
to access the accuracy of the blood measurements collected on study participants.  
Waist and hip circumferences were measured to the nearest 0.1 centimeter using a 
flexible measuring tape.  Height was measured to the nearest 0.1 centimeter using the 
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Seca Model 214 Road Rod stadiometer.  Weight was measured to the nearest 0.1 
kilogram using the self-zeroing Seca Model 770 digital scale. 
Hemocue provided training on the use of the Hemocue 201 glucometer.  In 
addition, the investigator received training from experts on the proper procedures for 
measuring blood pressures in research settings.  A videotape provided by the National 
Center for Health Statistics was used for body measurements training.116  In addition, 
the Anthropometric Standardization Reference Manual, edited by Lohman and 
associates,117 was consulted. 
The investigator participated in a university-based certification training course 
on the safe handling of biohazardous materials.  The investigator was certified by 
several sponsors of programs for human subjects protection in research, including that 
of the National Institutes of Health Clinical Center.  The investigator received 
training and certification for HIPAA through the District of Columbia Department of 
Health. 
Questionnaires and Data Collection Forms 
A 68-item self-administered questionnaire (Appendix A) was developed.  A 
panel of experts, focus group participants, and pilot study volunteers assessed the 
questionnaire for ease of understanding.  The panel of experts, comprised of nine 
researchers and practitioners in the area of nutrition and health, reviewed the 
questionnaire items for face validity.  That is, the panel assessed whether the 
questions were relevant to the study and if they were likely to adequately measure the 
characteristics of interest. 
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In addition, the investigator conducted five focus groups to assess the content 
of the questionnaire and its flow in order to increase the likelihood that the 
questionnaire would be completed by the participant and that accurate responses 
would be obtained.  Background information on focus group participants and selected 
findings are presented in Appendix H.  The first focus group (n=11) involved 
African-American women from an urban area in the Midwest region of the United 
States.  The remaining four focus groups (n=4, 6, 5, and 10, respectively) involved 
women in the Washington, D.C., Metropolitan Area.  In total, 36 women completed 
the questionnaire and reported their suggestions and comments verbally and/or in 
writing.  Suggestions and comments were incorporated in the questionnaire after each 
focus group interview in preparation for subsequent focus group sessions. Using the 
SMOG readability formula,118 the readability of the survey instrument was 
determined to be at the eighth grade level. 
A data form for recording direct measurements, including height, weight, 
blood pressure, and blood glucose was developed by the investigator (Appendix I).  
This form was tested for clarity and flow during the pilot study.  In addition, a 
personal measurements form on which the investigator recorded height, weight, waist 
and hip circumferences, blood pressure, and plasma glucose was developed 
(Appendix I).  Participants could then share this information with their health care 
providers.  This personal measurements form also served as a tool for participants to 
learn to convert metric-scale measures to U.S. equivalent measures. 
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Data Collection Procedures 
Participants were measured by the investigator.  In addition, they completed 
Items 1 to 11 of the Birth Information section of the 68-items questionnaire.  They 
were then interviewed to provide self-reported health and birth data.  In addition, vital 
records birth data were requested from vital records offices and State Centers for 
Health Statistics for each participant.  The investigator collected all primary 
measurements with the exception of current weight for one morbidly obese 
participant for whom body weight was collected at a clinic visit two days before the 
enrollment session.  The following is a summary of the data collection procedures 
used for the current study.  Given the sensitive nature of birth certicate data, a 
detailed data protection protocol was developed.  This protocol can be found in 
Appendix J. 
Primary Data: Blood Pressure, Plasma Glucose, and Body Measurements 
Primary data, including blood pressure, fasting blood glucose, height, and 
weight were collected by the investigator who held sessions at various enrollment 
sites, including churches, private homes, public housing resident council offices, job 
sites, and a university lab.  Privacy was maintained for each participant during 
measurement procedures through using free-standing screens or locked rooms or 
offices.  To minimize observer and participant bias, the study protocol was strictly 
followed.  The sequence of data collection was as follows:  after screening, informed 
consent was obtained.  Next, one drop of blood from a finger prick was collected and 
the plasma glucose level was analyzed immediately using the Hemocue 201 
glucometer.  Women with a self-reported physician diagnosis of type 2 diabetes 
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(cases) were allowed to provide a non-fasting blood sample, if preferred, to comply 
with the recommendations of their health care providers.  Controls were required to 
have fasted for at least eight hours before providing a drop of blood for analysis.  
Universal precautions were followed for the collection of blood and for the disposal 
of biohazardous materials. 
Diabetes, blood pressure, physical activity, and healthy eating were discussed 
with each participant.  Blood pressure was measured using the American Diagnostic 
Corporation (ADC) Model 6014 digital blood pressure device after the participant 
had been seated for at least five minutes, the time used in standard protocols for 
obtaining blood pressure readings.119  Waist and hip circumferences were measured to 
the nearest 0.1 centimeter using a flexible measuring tape.  Height was measured to 
the nearest 0.1 centimeter using the portable Seca Model 214 Road Rod stadiometer.  
Weight was measured to the nearest 0.1 kilogram using the portable self-zeroing Seca 
Model 770 heavy duty floor digital scale.  With the exception of the plasma glucose 
test, all measurements were taken in duplicate.  Measurements were written directly 
on a data collection form and were later typed into a text file.  Standard procedures 
were followed for the collection of all measurements.116-119  The guidelines of the 
manufacturers of the scales, glucometer, and blood pressure device were strictly 
followed. 
Collection of both primary and secondary data (not including follow-up self-
reported birth weights and vital records birth weights) took less than one hour for the 
average participant.  Within this one-hour time frame, nutrition education and 
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referrals were shared with participants.  Secondary data and nutrition education are 
discussed below. 
Secondary Data: Self-Report and Official Reports 
Participants completed a questionnaire that included items that addressed 
menopausal status history of being breastfed, physical activity level, and cigarette 
smoking.  Fourteen out of 376 women who presented for enrollment in the study 
required that the investigator or someone else (including volunteers of a church-based 
food pantry) to read all or some of the questionnaire items due to low literacy levels, 
poor eyesight, or for their convenience.  For the majority of participants, the 
questionnaire seemed clear, with only a few seeking clarification and most not 
skipping any responses.  Participant responses to questionnaire items were reviewed 
for completeness and accuracy. 
The investigator requested birth data for each participant from the appropriate 
vital records office and/or State Center for Health Statistics (n=32 states), including 
those of the District of Columbia and New York City.  Data were requested for the 
following birth variables: birth weight, length of gestation, prematurity status, 
plurality of birth, and whether or not the participant’s mother had diabetes during her 
pregnancy with the participant.  The section that follows gives a more detailed 
description of birth data collection. 
Access to Birth Data 
Requests for birth data variables on each participant were made to the 
appropriate state vital records office and/or State Center for Health Statistics.  
Procedures for requesting birth data varied among states.  These procedures were 
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strictly followed with the assistance of the National Center for Health Statistics 
website (www.cdc.gov) and/or with the appropriate contact person of the state-
specific vital records office or State Center for Health Statistics.  Six months were 
allocated for the request and receipt of birth data.  Extensive follow-up was required 
for vital records offices or State Centers for Health Statistics where personnel 
responsible for granting approval for and/or for processing birth data requests had 
experienced recent turnover. 
In addition, participants were asked to self-report their birth weights at the 
time of enrollment.  Self-reported birth weights were verified with birth weights from 
official sources or from a second report by participants when they were able to obtain 
their birth weights from a document or from a relative or some other source.  The 
verified self-reported birth weights were obtained through follow-up telephone calls, 
e-mails, or letters mailed through the U.S. Postal Service.  Participants were contacted 
through more than one method when available and if necessary. 
Once it was discovered that obtaining vital records birth weights was more 
difficult than had been anticipated, the investigator examined other documents to 
determine if she could abstract birth weights for any participants.  An attempt was 
made to obtain birth weights for District of Columbia-born participants from birth 
announcements in microfilm files of The Washington Post, The Evening Star, The 
Washington News, The Washington Times-Herald and The Washington Afro-
American, located in the Washingtonian collection and other collections of the Martin 
Luther King Memorial Library in the District of Columbia. This met with no success.  
Birth announcements for the years reviewed listed only the names of parents and the 
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gender of the infant.  Thus, these records could not be used to obtain birth weights for 
participants. 
Likewise, attempts to access birth data from hospitals located in the District of 
Columbia were unsuccessful.  Hospitals are not required to maintain records for 
patients after a given time.  None of the targeted District of Columbia hospitals 
reported having birth records for participants born between 1946 and 1964 when the 
investigator requested birth records from these hospitals.  Records maintained by 
hospitals and by a public library in the city where the majority of the study 
participants were born was not part of the original study protocol.  However, 
investigating them as possible sources of birth data indicated that the investigator was 
willing to go the extra mile to obtain birth data. 
In summary, the procedures for collecting birth data involved (1) collection of 
a self-reported birth weight at study enrollment, (2) re-contact of participants to 
obtain a second, presumably more accurate, self-reported birth weight and, (3) request 
for official birth data from vital records offices or State Centers for Health Statistics.  
Women without verified birth weights were not included in the study. 
Nutrition Education and Referral 
Within the one-hour data collection session, each participant received a brief 
individual nutrition consult and nutrition education from the investigator, a 
Registered/Licensed Dietitian.  In addition, they received two brochures on physical 
activity and healthy eating.120-121  Finally, each participant was given fact sheets on 
diabetes122 and high blood pressure.123  Participants were informed of how they could 
obtain additional copies of nutrition education materials, both study-related and non-
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study related, for themselves, their families, friends, church members, and others for 
free or at nominal cost from various government agencies. 
Participants received a copy of a form with their enrollment session 
measurements (Appendix I) and were encouraged to share these results with their 
health care providers.  Participants were encouraged to discuss their diabetes and high 
blood pressure risk levels with their health care providers.  For the 12 women who 
had no previous physician diagnosis of diabetes but whose fasting blood glucose 
levels were >126 mg/dL, the urgency of their visiting a health care provider was 
emphasized.  Women already diagnosed with diabetes, but with elevated fasting or 
non-fasting blood glucose levels were encouraged not to delay following up with their 
health care providers.  All participants with a physician diagnosis of type 2 diabetes 
received an explanation of why current recommendations for treatment of diabetes 
includes the aggressive treatment of patients with diabetes for hypertension and pre-
hypertension.  The concept of prediabetes was explained to all participants whose 
fasting blood glucose levels were greater than 100, but less than 126 mg/dL. 
Participants with high blood pressure levels were encouraged to visit their 
health care providers immediately.  Referrals were made to health care providers of 
free or low-cost care, as needed.  Information on local departments of health was also 
shared with participants, where indicated.  Nutrition education brochures and fact 
sheets were promoted as benefits and incentives for participation in the study. 
Pilot Study 
Before the launching of the study, a pilot study was conducted with 21 
women.  A description of the pilot study participants are presented in Appendix K.  
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This pilot study allowed the investigator to test the questionnaire for clarity and to 
assess the flow of procedures and the adequacy of the data collection processes and 
locations.  Two weeks were needed to conduct the pilot study with 21 volunteers 
while 17 months were needed to enroll 376 women in the full study.  Through the 
pilot study, it was ascertained that 40 to 60 minutes were required to enroll each 
participant.  In addition, information gathered during the pilot study resulted in the 
improvement of the data collection forms and enrollment procedures.  An example of 
this improved flow was that for the actual study, fasting blood glucose levels were 
collected before blood pressures.  This allowed participants to remain seated after the 
nutrition education session was conducted.  In addition, the order of the fasting 
question on the measurements form was changed to improve data entry flow. 
Statistical Analyses 
Logistic regression analysis tested the hypothesized model for assessing the 
odds ratio for type 2 diabetes.  Preliminary statistics were conducted to generate 
descriptive statistics and to run the appropriate diagnostics on the data.  A summary 
of the relationships of the study variables in statistical terms is as follows: outcome 
variable (type 2 diabetes), exposure variables (birth weight and waist-to-hip ratio), 
and covariates (including age, BMI, physical activity, history of gestational diabetes, 
family history of diabetes, hypertension, and weight at 25 years).  See Appendix C for 
the study codebook and the list of variables for which data were collected for the 
current study. 
Logistic regression analyses allowed adjustment for possible confounding 
variables.  Logistic regression analyses were used to test the proposed model for 
  55
measuring the odds for having type 2 diabetes using birth weight, abdominal obesity 
(waist-to-hip ratio >0.80), and the interaction of birth weight and abdominal obesity 
as explanatory variables.  The proposed logistic regression equation, without 
covariates, was: 
Natural log of (DIABETES/1-DIABETES) = (β1*birth weight) + (β2*WHR) + 
[β12*(birth weight * WHR)]. 
Multivariate logistic regression models were constructed using birth weight 
and waist-to-hip ratio, both singularly and in combination, to determine which set of 
anthropometric variables had the greatest explanatory power.  In addition, covariates 
were considered, including a diagnosis of high blood pressure, family history of 
diabetes, physical activity level, and smoking.  Multiple linear regression analyses 
were conducted to investigate the relationship between fasting plasma glucose and 
low birth weight and abdominal obesity.  The Satterthwaite t test was used for groups 
of unequal sample sizes to test the differences between cases and controls on various 
measures.  Alpha for all test statistics was set at the .05 level for two-sided tests.  All 
statistical analyses were conducted using SAS version 8.2 (SAS Institute, Cary, North 
Carolina).124 
Variability was reduced in several ways.  First, the investigator was the sole 
collector of current body measurements.  This eliminated inter-observer variability.  
Second, limiting the study participants to a single racial/ethnic group, one gender, and 
a narrow age range decreased variabilty.  Third, limiting blood pressure, blood 
glucose, and current anthropometric collection to morning hours reduced intra-subject 
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variation secondary to diurnal cycles.  Finally, the current anthropometrics and blood 
pressure were collected in duplicate to reduce variability. 
Hypotheses 
The current study addressed four research hypotheses. 
Hypothesis 1: Birth weight is independently associated with type 2 diabetes 
in African-American women 38 to 57 years of age. 
Hypothesis 2: Abdominal obesity is independently associated with type 2 
diabetes in African-American women 38 to 57 years of age. 
Hypothesis 3: Birth weight and abdominal obesity interact to increase the 
odds ratio of type 2 diabetes among cases versus controls in African-American 
women 38 to 57 years of age, controlling for potential confounders. 
Hypothesis 4: Among African-American women without a physician 
diagnosis of type 2 diabetes, there is an association among birth weight, abdominal 
obesity, and fasting plasma glucose level. 
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Chapter 4: Results 
Part one of this chapter presents descriptive statistics for the entire sample and 
is divided into the following eight sections: (1) demographics and lifestyle indicators; 
(2) birth weight; (3) current body weight and height measurements and body mass 
index; (4) self-reported physician diagnosis of high blood pressure versus measured 
systolic blood pressure; (5) health history; (6) fasting plasma glucose and prediabetes; 
(7) waist and hip measurements and waist-to-hip ratio and; (8) participants with a 
self-reported physician diagnosis of type 2 diabetes.  In part two, results from logistic 
regression analyses that address the study hypotheses are presented.  Logistic 
regression model-testing is presented in detail, followed by a presentation of the final 
model.  Part three presents results of additional analyses that further elucidate the data 
including, (1) fasting plasma glucose by birth weight and abdominal obesity;  
(2) a focus on low birth weight participants; (3) highlighting participants for whom 
vital records birth weights were obtained and; (4) fasting plasma glucose among 
cases: use of hypoglycemic agents; pre-menopausal status and body mass index, 
waist-to hip ratio, age, and fasting plasma glucose among cases and controls.  This 
chapter ends with a summary of the central findings (part four). 
Demographics and Lifestyle Indicators 
The sample consisted of 281 women for whom verified self-reported and/or 
vital records birth weights were collected, a retention rate of 77% (281/365).  Ninety-
five of the participants (cases) reported a physician diagnosis of type 2 diabetes and 
186 participants (controls) reported that they did not have a physician diagnosis of 
type 2 diabetes.  All controls had fasting plasma glucose levels <126 mg/dL. 
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Mean reported age of study participants was 49 years, SD=6.0 years.  Table 1 
presents the full sample of African-American women by decade of birth.  Twenty-one 
percent of the study participants were born in the 1940s (Table 1).  A majority (52%) 
were born in the 1950s, while 27% were born in the 1960s.  Those with diabetes 
(n=95; M=51 years, SD=5.4 years) were slightly older than the control group (n=186; 
M=48 years, SD=6.0 years), p =.0003.  A larger percent (27% versus 17%)) of cases 
than controls were born in the 1940s.  In contrast, more controls (32%) than cases 
(18%) were born in the 1960s.  These birth cohort differences were statistically 
significant between cases and controls, χ2(2)=8.1, p=.0175.  On the one hand, the 
availability of birth certificates was related to the decade in which the woman was 
born.  On the other hand, vital records data were more likely to be obtained for those 
who were born in the 1960s than for those born in earlier decades. 
Table 1. Decade of Birth for U.S.-Born African-American Women 38-57 Years of Age 
Decade All Cases Controls 
 n % n % n % 
1940s 58 21% 26 27% 32 17% 
1950s 146 52% 52 55% 94 51% 
1960s (and 1970 where n=1) 77 27% 17 18% 60 32% 
Total 281 100% 95 100% 186 100% 
Note. All information in this table based on women for whom pooled vital records and verified 
self-reported birth weights were obtained. 
χ2 was employed when comparing decades born for cases and controls. 
χ2(2)=8.1, p=.0175.  Bolded figures are significant. 
Table 2 presents the region of birth for women in the sample.  The majority of 
the participants reported being born in the southern region of the United States (85%) 
and delivered in hospitals (84%).  (See Table 2.)  Table 3 presents the educational 
background of the women in the sample.  Based on self-reported levels of educational 
attainment, this sample was highly educated.  The majority (77%) had attended 
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college (Table 3).  Cases (67%) were significantly less likely than controls (82%) to 
have attended college, p=.0070. 
 
Table 2. Frequencies of Background Characteristics: Locations of Birth 







Region of Birtha,b n (%) n % n % 
 Northeast 22 8% 2 2% 20 10% 
 Midwest 14 5% 4 4% 10 5% 
 South 240 85% 88 93% 152 82% 
 West 3 1% 1 1% 2 1% 
 State Unspecified (but born in U.S.A.) 2 <1% 0 0% 2 1% 
Specific Location of Deliveryb,c  % -- -- -- -- 
 Hospital Births 232 83% -- -- -- -- 
 Home Births 34 12% -- -- -- -- 
 Doctor’s Office 1 <1% -- -- -- -- 
 Not Specified 14 5% -- -- -- -- 
Note. All information in this table was by self-report.  Rounding resulted in totals different from 100%. 
aRegion was categorized according to U.S. Census standards.125
bTotal sample includes only women for whom vital records and verified self-reported birth weights were 
obtained, N=281. 
cHospital birth status of participants was not analyzed by diabetes status. 
 
Table 3. Frequencies of Background Characteristics: Education Attainment of  







 n % n % n % 
Level of Education Attained       
 Attended Collegeb 216 77% 64 67% 152 82% 
 Highest Year of School Completedc       
  Grades 1-8 (elementary) 2 <1% 2 <1% 2 1% 
  Grades 9-11 (some high school) 8 3% 8 3% 4 2% 
  Grade 12 or GED (high school  
  diploma/equivalency) 
38 14% 38 14% 21 11% 
  Technical/trade/vocational school  17 6% 17 6% 7 4% 
  Attended college, but did not graduate 67 24% 67 24% 41 22% 
  Associate degree 16 6% 16 6% 10 5% 
  Bachelor degree 61 22% 61 22% 44 24% 
  Graduate or advanced professional degree 72 26% 72 26% 57 30% 
Note. All information on education was by self-report. Total sample, n=281, with 95 cases and 186 controls. 
aTotal sample includes only women for whom vital records and verified self-reported birth weights were 
obtained, N=281.  Information in this table was obtained for all of the study participants. 
bχ2(1)=7.28, p=.0070 
cχ2(7)= 15.96, p=.0254 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Lifestyle indicators such as smoking, physical activity, and alcohol 
consumption are presented in Table 4.  In terms of lifestyle indicators, the majority of 
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the participants reported being non-smokers (89%) (Table 4).  There was no 
significant difference in the percentage of current smokers between controls (8%) and 
cases (16%), p=.0530.  Forty-two percent of the sample reported engaging in regular 
strenuous physical activity, with controls (47%) being significantly more likely than 
cases (30%) to have engaged in regular strenuous physical activity, p=.0083  
(Table 4).  The majority of participants (81%) reported having a history of drinking 
alcohol during their lifetime.  Twenty-eight percent reported drinking within the past 
seven days, 34% between 8-30 days and 45% within the past 31-90 days.  Significant 
differences between cases and controls on alcohol consumption variables were 
observed only for drinking within the past seven days: 16% of the cases reported 
drinking within the past seven days, compared to 35% of the controls, p=.0008.  No 
data on quantity of alcohol consumed were collected for the current study. 
Table 4. Frequencies of Lifestyle Indicators: Smoking, Physical Activity, Alcohol Consumption 
U.S.-Born African-American Women 38-57 Years of Age. 
Alla Casesb ControlscLifestyle Indicator 










Regular Strenuous Physical 
Activity/Hard Labord




 Ever drank 
 
 Drank within 7 days 
 
 Drank between 8 and 30 days 
 








































































Note. All information on smoking and drinking was by self-report. 
aN=278-281; bn=92-95; cn=185-186. Responses to these questionnaire items were not given by up to three women. 
dStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard physical labor or 
exercise where you sweat or your heart beats faster?” df = degrees of freedom; p is significant at α<.05, 2-sided test. 
Bolded figures are significant. 
Birth Weight 
As of July 21, 2006, official birth weights were obtained for 63 (22%) of the 
281 participants.  (Note: To date, a total of 84 birth certificates were obtained; 
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however, birth weights were missing from 21 of these certificates.  Hence, these 21 
birth certificates could not be used.)  Participants were born in 32 states.  Each of 
these states was contacted for vital records birth data.  Seventeen states (53%) were 
able to provide birth weights for all or some of the participants born within their 
jurisdiction.  Although 11 states with small numbers of study participants were able to 
provide birth weights for 100% of the study participants born there, the state where 
the majority of the participants were born could not provide vital records birth 
weights for any of them as of March 2007.  Table L1 (Appendix L) shows the 
percentages of birth weight records obtained for participants, by state of birth.  
Chapter 5 includes a discussion of birth weight collection challenges. 
Self-reported birth weights at enrollment were verified using two methods: 
(1) birth weight obtained from vital records/State Centers for Health Statistics and/or  
(2) self-reported birth weight that participants verified from other sources, such as 
birth weights that participants obtained from their mothers or from self-reports from 
hospital and other family records that participants possessed. 
Of the 281 study participants, 75 reported that they verified their self-reported 
birth weight from hospital or family records, 112 reported that they obtained their 
birth weight from their mothers, 62 from other sources (including other relatives), one 
did not know her birth weight, and 31 could not be reached through a follow-up 
contact.  Note that for some participants, birth weights were obtained from both 
official records and from verified self-report.  When both sources were available for a 
participant, birth weight from the official source was used.  Participants without vital 
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records birth weights were included in the study if their self-reported birth weight was 
verified by another source, such as hospital or family records. 
Comparisons between birth weights obtained from vital record and verified 
self-reported birth weights by source of self-reported birth weight are presented in  
Tables 5 to 9.  While Table 5 displays the mean, minimum, and maximum values of 
birth weights by source of birth weight data, Table 6 displays the correlations among 
birth weight data sources.  There was a significant positive association between 
verified self-reported birth weight and vital records birth weight, r =.70, p<.0001, 
n=32 (Table 6). 
Table 5. Means, Standard Deviations, and Minimum, Maximum Birth Weight Measurements 
U.S.-Born African-American Women 38-57 Years of Age 








 Birth weight, Enrollment Self-Report 3,063 
n=200 
621.8 1,020 4,564 
 Birth weight, Verified Self-Report 3,054 
n=250 
622.7 1,020 4,705 
 Birth Weight, Vital Records 3,301 
n=63 
470.1 2,183 4,507 
Note. 2,500 g = 5 pounds, 8 ounces;  




Table 6. Correlations Among Birth Weight Data Sources 
U.S.-Born African-American Women 38-57 Years of Age 











































r =Spearman correlation coefficient 
p=probability p is significant at alpha <.05, 2-sided test; 
n=number of participants included in the correlation analysis.  For correlations, the n is determined by the 
number of participants that have measures on both values being compared. 
Bolded figures are significant. 
To compare the difference between self-reported birth weights and those 
found from vital records, paired t tests were performed and the results are displayed 
in Table 7.  For participants for whom vital records and verified self-reported data 
could be obtained, a comparison between their birth weight collected from vital 
records and verified self-reported birth weight revealed no significant difference, 
paired t=0.89, p=.3792 (Table 7).  Birth weights from vital records and from verified 
self-report were, therefore, pooled.  Verified self-reported birth weights included birth 
weights obtained by participant from her mother or from records she had on hand, 
including personal copies of birth certificates, crib cards, and hospital/clinic records. 
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Table 7. Paired t Tests Between Vital Records Birth Weights, Self-Reported Birth Weights Collected at 
Enrollment, and Self-Reported Birth Weights That Were Verified 
U.S.-Born African-American Women 38-57 Years of Age 





Birth weight (Vital Records) vs. Birth weight 
(Self-Report at Enrollment), 
42 0.28(.848) 2.12 
(41) 
.0400 
Birth weight (Vital Records) vs. Birth weight 
(Verified Self-Report) 
32 0.16(1.02) 0.89 
(31) 
.3792 
Birth weight (Self-Report at Enrollment) vs. 
Birth weight (Verified Self-Report) 
179 -0.06(.607) -1.40 
(178) 
.1618 
Note. The birth weight variable used in the analysis is italicized.  The n for each paired t test includes women for 
whom both test categories of birth weight source was available.  Birth weight from all three sources were available 
for 21 women.  Total N does not add up to 281 since some participants had only one birth weight measure; these 
participants could not be included in t test analyses.  Verified self-reported birth weights were based on what the 
participant learned from her mother or other relative or from a document that she had on hand (hospital record, crib 
card, family Bible, etc. 
Paired t test between two different sources of birth weights 
df = degrees of freedom; p is significant at α<.05, 2-sided test. 
 
 
Birth weights obtained by participants from documents that they accessed 
were not statistically different from birth weights that the investigator obtained from 
vital records offices, t(10)=1.42, p=.1851 (Table 8).  Similarly, there was no 
significant difference between vital records birth weight and birth weight data that 
participants obtained from their mothers, t(5)=0.23, p=.8249, or from their informed 
recollections, t(10)=1.08, p=.3056.  The test for differences between vital records 
birth weights and those obtained from all other sources was based on fewer than five 
individuals, therefore, this test could not produce a stable t value. 
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Table 8. Comparisons of Vital Records to Self-Reported Birth Weights by Source of Birth Weight Data 
U.S.-Born African-American Women 38-57 Years of Age: Cases and Controls Combined 
Source of 
Birth Weight 





Birth weight (Vital Records) vs. Birth weight 














Birth weight (Self-Report at Enrollment) 






Birth weight (Vital Records) vs. Birth weight 














Birth weight (Self-Report at Enrollment) vs. 






Birth weight (Vital Records) vs. Birth weight 
(Self-Report at Enrollment) 
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Birth weight (Vital Records) vs. Birth 















Birth weight (Self-Report at Enrollment) vs. 






Birth weight (Vital Records) vs. Birth weight 















Birth weight (Self-Report at Enrollment) vs. 






Note. The “Other Sources” category includes birth weight reports from other relatives, mother’s friend, missing, 
and “Don’t Know.” 
The total number of participants in this study was 281.  If a participant had multiple sources for self-reported birth 
weight, only the more accurate source was used in this analysis.  A source from a document superseded a mother as 
a source which superseded other relatives which superseded participant’s informed recollection. 
aDocument: Hospital discharge papers, hospital crib card, family Bible entry, baby book, or read from personal 
copy of birth certificate. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
 
Table 9 presents the mean birth weight of women in the sample, based on vital 
records and self report data.  In particular, mean birth weight for the combined sample 
(cases and controls, n=281) was 3,079 g (6.8 pounds), SD=593.0 g, with a range from 
1,020 g to 4,564 g (Table 9).  There was no significant difference between birth 
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weight for cases (M=3,046 g (6.7 pounds), SD=680.8 g) and controls  
(M=3,095 g (6.8 pounds), SD=543.9 g, p=.5380 (Table 9). 
Table 9. Mean Birth Weights: Vital Records and Self-Report 
U.S.-Born African-American Women 38-57 Years of Age 
 All Cases Controls   
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Note. 2,500 g = 5 pounds, 8 ounces; 3,200 g ~ 7 pounds; 4,100 g ~ 9 pounds 
The birth weight variable used in the analysis is italicized. 
There was overlap among the different birth weight variables given that some participants self-reported birth 
weights at enrollment and/or verified self-reported birth weights through follow-up communication and/or an 
official birth weight obtained from vital records or State Centers for Health Statistics. 
The n’s represent the number of participants for whom a birth weight from a specific source could be obtained.  
The totals n’s exceed 281 because birth weights were obtained for some participants from more than one 
source. 
For the analyses, vital records birth weights were used, where available.  Where vital records birth data were 
not available, verified birth weights were used. 
Women for whom only a birth weight at enrollment was obtained were not included in this total of 281 
participants; they were excluded from the study. 
Satterthwaite t test for unequal sized groups; df = degrees of freedom; p is significant at α<.05, 2-sided test. 
Mean birth weight by category of birth weight (low, normal, high) for cases 
and controls combined is presented in Table 10.  Variability among low birth weight 
and normal birth weight births was low (SD=397 g and 361 g, respectively).  Table 11 
sorts the sample by case-control status into three categories of birth weights: low, 
normal and high.  The birth weight for the majority of cases (n=70, 74%) and controls 
(n=155, 83%) was considered “normal” weight (Table 11).  Among the 281 
participants in the study, 18 cases (19%) and 25 controls (13%) were born low birth 
weight, while seven cases (7%) and six controls (3%) were born high birth weight.  
These differences were not statistically significant, χ2(2)=4.3, p=.1159. 
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The sizes of the subsamples of participants whose birth weights were 
categorized as “high” or “low” compared to those whose birth weights were 
categorized as “normal” weight were so small that the validity of results between any 
of these birth weight groups would be questionable.  Among the 63 participants for 
whom vital record birth weights were obtained, three cases (14%) and two controls 
(5%) were born low birth weight.  This subsample was too small to determine 
whether the differences between cases and controls in terms of low birth weight were 
significant. 
Table 10. Mean, Minimum and Maximum Birth Weight by Birth Weight Category 
U.S.-Born African-American Women 38-57 Years of Age, Cases and Controls Combined 




 Low Birth Weighta 43 2,122(397) 1,020-2,494 
 Normal Birth Weightb 225 3,190(361) 2,502-4,025 
 High Birth Weightc 13 4,321(194) 4,082-4,564 
Note. Data are based on pooled vital records and verified self-reported birth weights. 
aLow birth weight defined as <2,500 g at birth; bNormal birth weight defined as 2,500-4,000 g; cHigh 
birth weight defined as >4,000 g at birth 
2,500 g = 5 pounds, 8 ounces; 4,000 g ~ 9 pounds; 1,020 g ~ 2.25 pounds; 4,564 g ~10 pounds 
 
Table 11. Frequencies: Low Birth Weight, Normal Birth Weight, High Birth Weight by 
Diabetes Status 
U.S.-Born African-American Women 38-57 Years of Age 
All Cases Controls Category of Birth Weight 
n (%) n (%) n (%) 
 Low Birth Weighta 43 (15%) 18 (19%) 25 (13%) 
 Normal Birth Weightb 225 (80%) 70 (74%) 155 (83%) 
 High Birth Weightc 13 (5%) 7 (7%) 6 (3%) 
Total 281  95  186  
Note. All data are based on pooled vital records and verified self-reported birth weights. Total cases, 
n=95 and total controls, n=186 
aLow birth weight defined as <2,500 g at birth (5 pounds, 8 ounces) 5 pounds 
bNormal birth weight defined as between 2,500 g and 4,000 g (5 pounds, 8 ounces to ~9 pounds) 
cHigh birth weight defined as >4,000 g at birth (~9 pounds) 
cRounding resulted in total different from 100%. 
χ2 was generated when comparing cases and controls among three levels of birth weights: low, normal, 
and high; χ2(2)=4.3, p=.1159; df = degrees of freedom 
p is significant at α<.05, 2-sided test 
Birth weight data and participant pregnancy outcomes are presented in  
Table 12.  Twenty percent of the cases (n=15) and 4% of the controls (n=5) reported 
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having gestational diabetes.  This difference was statistically significant (χ2[1]=14.27, 
p=.0002). 
Table 12. Frequencies: History of Gestational Diabetes or Delivering a Baby Greater than Nine Pounds 
U.S.-Born African-American Women 38-57 Years of Age 
All Cases Controls Variable 
n (%) n (%) n (%) 
χ2(df) P 
Gestational diabetes during 
pregnancya  
20 (7%) 15 (20%) 5 (4%) 14.27 
(1) 
.0002 
Delivered baby who weighed 
over 9 pounds at birthb  
31 (11%) 19 (24%) 10 (7%) 12.11 
(1) 
.0005 
Gestational diabetes and/or 
baby over 9 poundsc  
44 (16%) 28 (13%) 14 (10%) 20.36 
(1) 
<.0001 
Note. Frequencies do not include women who never delivered a baby. 




df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Current Body Weight and Height Measurements and BMI
All current adult body measurements were taken by the investigator at the 
time of enrollment; the descriptive statistics are shown in Table 13.  Current adult 
body measurements and indices, including current weight, body mass index (BMI), 
and blood pressure were significantly greater for cases than for controls (Table 13).  
There was no significant difference for height.  Height, along with current body 
weight, was used to calculate BMI. 
Mean body weight of sample participants (n=281) was 91 kg, SD=24.63 kg, 
range=49 kg to 252 kg (Table 13).  Cases were significantly heavier than controls, 
100 kg versus 85 kg, p=.0001.  Mean BMI for the sample was 34, SD=9.3, range=19 
to 82 (Table 13).  Mean BMI for case was 38, compared to a mean BMI of 32 for 
controls.  A BMI of above 30 signifies obesity.  Therefore, even though cases, on 
average, were more obese than controls (p=.0001), both groups, on average, are 
considered obese.  Cases weighed more than controls at age 25 years based on 
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weights reported by the study participants (Table 14).  For cases, mean self-reported 
weight at 25 years was 70 kg (SD=21.5 kg) compared to a mean of 63 kg, (SD=12.9 
kg) for controls.  (In terms of pounds, weights for cases and controls were 154 and 
139 pounds, respectively.)  This difference was significant, p=.0015.  (Note: The 
median weight at age 25 for this sample was 60 kg.  For cases, the median weight at 
age 25 was 64 kg [141 pounds], while for controls, it was 59 kg [130 pounds]). 
There were strong-to-weak significant associations among several indicators 
for obesity.  Notably, waist measured at the smallest diameter and its corresponding 
waist-to-hip ratio were moderately associated with one another, r =.62, p<.0001.  
Waist at smallest diameter was strongly associated with BMI (r =.90, p<.0001), while 
waist-to-hip ratio and BMI were weakly associated (r =.34, p<.0001).  It should be 
noted that waist-to-hip ratio is an indicator for abdominal obesity, a measure that was 
hypothesized for this study as elevating the risk for type 2 diabetes among the study 
participants.  Waist-to-hip ratio is discussed below in more detail. 
Table 13. Mean, Minimum and Maximum Blood Pressure and Current Body Measurements 






























































Note. Body mass index is calculated by dividing weight in kilogram by height in meters squared. 
49 to 252 kg = 108 to 554 pounds 
Satterthwaite t test for groups of unequal size 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
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Table 14. Mean, Minimum and Maximum Self-Reported Weight at Age 25 Years 


























Note. Questionnaire item: “About how much did you weigh when you were 25 years of age? ___ pounds” 
Participants who did not respond to this questionnaire item were not included in the calculation. 
38 to 159 kg = 84 to 350 pounds 
Satterthwaite t test for groups of unequal size. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Self-Reported Physician Diagnosis of High Blood Pressure Versus Measured 
Systolic Blood Pressure 
The literature identified blood pressure as a covariate of type 2 diabetes and 
other chronic diseases.  Table 15 compares two types of information: (1) information 
based on self-reports of a physician diagnosis of high blood pressure and (2) 
measurements collected at the time of enrollment in the study.  At enrollment we 
measured high blood pressure based on systolic and diastolic blood pressures.  Table 
15 shows that 38% percent of the participants had a self-reported physician diagnosis 
of high blood pressure.  The results in Table 15 indicate that a majority of cases 
(62%) were more likely than controls (25%) to have had a self-reported physician 
diagnosis of high blood pressure, χ2(1)=34.7, p<.0001.  In addition, 68% of the 
participants overall had elevated measured systolic blood pressure levels (>120 mm 
Hg; Table 15).  Moreover, cases (79%) were more likely than controls (63%) to have 
had elevated measured systolic blood pressure levels, χ2(1)=7.48, p=.0062.  Although 
46% of the participants had elevated measured diastolic blood pressure levels (>80 
mm Hg), the difference in the prevalence of elevated measured diastolic blood 
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pressure levels between cases (51%) and controls (44%) was not statistically 
significant, χ2(1)=1.05, p=.3057. 
It is important to look at the difference between measured diastolic and 
measured systolic blood pressure levels.  Twenty percent of the participants had high 
measured systolic blood pressure levels (>140 mm Hg).  Cases (32%) were 
significantly more likely than controls (14%) to have had a high measured systolic 
blood pressure level, χ2(1)=12.2, p=.0005.  Overall, 14% of the participants had high 
measured diastolic blood pressure levels (>90 mm Hg).  The difference in the 
prevalence of high measured diastolic blood pressure levels between cases (14%) and 
controls (13%) was not statistically significant, χ2(1)=0.00, p=.9550. 
 
Table 15. Comparing Self-Report of a Physician Diagnosis of High Blood Pressure to 
Measured Elevated and Measured High Blood Pressure Based on Systolic and Diastolic Blood 
Pressures Collected at Enrollment, by Diabetes Status 
U.S.-Born African-American Women 38-57 Years of Age 







 n(%) n(%) n(%)   






  34.70(1) <.0001 






  7.48(1) .0062 






  12.20(1) .0005 






  1.05(1) .3057 






  0.00(1) .9550 
Note. Systolic and diastolic blood pressures were measured directly by investigator.  Self-reported high 
blood pressure was collected by the questionnaire completed by the participants. 
aHBP, High Blood Pressure from Self-Report of Physician Diagnosis 
bSBP, Systolic Blood Pressure: 120 mm Hg is the cut-point for pre-hypertension; 140 mm Hg is the cut-
point for hypertension. 
cDBP, Diastolic Blood Pressure: 80 mm Hg is the cut-point for pre-hypertension; 90 mm Hg is the cut-
point for hypertension. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Table 16 presents a comparison of self-reported physician diagnosis of high 
blood pressure and measured diastolic blood pressure levels at enrollment.  Note that 
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in this table the cases and controls are combined for ease of discussion.  Fifty-nine 
percent of the participants with a reported physician diagnosis of high blood pressure 
had measured diastolic blood pressure levels >80 mm Hg, while 36% who reported 
no physician diagnosis of high blood pressure had elevated diastolic blood pressure 
levels, χ2(1)=13, p=.0003 (Table 16).  Overall, 84% of the participants who reported 
a physician diagnosis of high blood pressure had measured systolic blood pressure 
levels >120 mm Hg, while 58% who reported no physician diagnosis of high blood 
pressure had elevated measured systolic blood pressure levels, χ2(1)= 21, p<.0001. 
Perhaps this discrepancy between self-report of a physician diagnosis and blood 
pressure measured upon enrollment into the study could have been a result of a 
participant memory lapse of earlier diagnosis or simply due to measurement error by 
a health care professional who may or may not have followed standard procedure for 
collecting blood pressure. As a result, systolic blood pressure (as opposed to self- 
 
Table 16. Self-Reported Physician Diagnosis of High Blood Pressure and Elevated and High Blood 
Pressure Defined Using Categorized Systolic and Diastolic Blood Pressures Measured at Enrollment: 
U.S.-Born African-American Women 38-57 Years of Age, Cases and Controls Combined 
















Elevated SBP (>120 mm Hg)b 183(68) 86(84) 97(58) 21(1) <.0001 
High SBP (>140 mm Hg)c 52(20) 37(36) 15(9) 31(1) <.0001 
Elevated DBP (>80 mm Hg)b 121(46) 60(59) 61(36) 13(1) .0003 
High DBP (>90 mm Hg)c 35(14) 24(24) 11(7) 16(1) <.0001 
Note. Systolic and diastolic blood pressures were measured directly by investigator.  Self-reported high blood 
pressure were collected by questionnaires completed by participants.  Eleven participants for whom self-reported 
physician diagnosis of high blood pressure could not be collected were excluded from this analysis.  The 
comparisons were based on participants for whom both a measured SBP or DBP and a self-reported physician 
diagnosis of high blood pressure were available.  The self-reported questionnaire item was the limiting factor 
given that measured blood pressures were collected on all participants. 
aHBP, High Blood Pressure 
bSBP, Measured Systolic Blood Pressure: 120 mm Hg is the cut-point for pre-hypertension; 140 mm Hg is the 
cut-point for hypertension. 
cDBP, Diastolic Blood Pressure: 80 mm Hg is the cut-point for pre-hypertension; 90 mm Hg is the cut-point for 
hypertension. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
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reported physician diagnosis of high blood pressure) was used in the statistical 
models because systolic blood pressure is a direct measure, is continuous, and may be 
more accurate than self-report of a physician diagnosis of high blood pressure.  In 
addition, Systolic and diastolic blood pressures were moderately correlated for the 
281 study participants, r =.72, p<.0001.  Diastolic blood pressure was not included in 
any logistic or linear statistical models because of multicollinearity; that is, this 
measure highly correlates with the systolic blood pressure. 
Health History 
For health history, cases and controls differed significantly on a number of 
variables, including hypertension, premenopausal status, twin status, and family 
history of diabetes p<.05 (Table 17).  Cases were more likely than controls to have 
had these conditions, except for premenopausal status, where controls were more 
likely than cases to have had one menstrual period within the past 12 months. 
Table 17. Frequencies: Health History Variables from Self-Reported Data 
U.S.-Born African-American Women 38-57 Years of Age, N=281 







High blood pressure 102(38%) 57(62%) 45(25%) 34.5(1) <.0001 
Premenopausal statusa 144(52%) 33(36%) 111(60%) 13.8(1) .0002 
Family history of diabetes 186(66%) 76(80%) 110(59%) 12.2(1) .0005 
Twinb 11(4%) 4(7%) 7(2%) 4.6(2) .0329 
Breastfed as infant or child 95(41%) 39(49%) 56(37%) 2.9(1) .0865 
Premature birthb,c 28(10%) 15(16%) 13(7%) 6.4(2) .4025 
Note. All data in this table were by self-report.  The frequencies displayed in this table are for women who 
answered “Yes” to the questionnaire item. 
a“Had at least one period within past 12 months” is an indicator for premenopausal status. 
bUnreported values for twin status n=3.  Unreported values for premature status, n=31 (12%).  
cSelf-reported prematurity collected from two questionnaire items: (1) Yes/No to question as to whether 
participant was born premature and (2) number of months or weeks of gestation. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Table 18 presents prevalence of medication use for diabetes among women in 
the sample. The majority of participants (66%) reported current use of medication  
(Table 18).  Thirty-four percent of all participants reported no current use of 
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medication.  Controls (51%) were more likely than cases (2%) to have reported no 
current use of medication, p<.0001.  (Note: Cases who took no medication for 
diabetes reported that they controlled their diabetes with exercise and/or diet alone or 
that they were not complying with the medical orders of their health care provider.)  
Fifty-three percent of the cases and 17% of the controls reported current use of 
medications for high blood pressure.  This difference was significant, p<.0001.  More 
cases (72%) than controls (44%) reported current use of medications for other than 
diabetes or hypertension.  This difference was significant, p<.0001. 
 
Table 18. Frequencies: Medication Use Among Cases and Controls 
U.S.-Born American Women 38-57 Years of Age, N=281 






Medication-free 92(34) 2(2) 90(51) 66.24(1) <.0001 
Medication use:      
   Blood pressure medications 81(30) 51(53) 30(17) 39.03(1) <.0001 
   Other medications 146(53) 69(72) 77(44) 20.14(1) <.0001 
Note. Medication measures by self-report.  Some participants presented medication containers for investigator 
to copy names of drugs.  Percentages do not sum to 100% because current users of blood pressure medications 
may or may not have been taking other medications.  Other medications included those for asthma, arthritis, 
allergies, etc. Medication use was collected on 95 cases and 177 controls. 
aMedication was not reported for nine controls. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Fasting Plasma Glucose 
Fasting plasma glucose is used in the screening and diagnosis of diabetes.  
Elevated fasting glucose levels (>126 mg/dL) are considered abnormal and indicate 
diabetes.  Fasting glucose levels below 100 mg/dL are considered normal.  For those 
with type 2 diabetes, the goal for good plasma glucose control is to approach the 
normal level of below 100 mg/dL. 
Mean fasting plasma glucose for those with type 2 diabetes in this study was 
147 mg/dL, SD=54.7 mg/dL.  This was significantly higher than for study controls 
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whose mean fasting plasma glucose was 97 mg/dL, SD=12.8 mg/dL, p<.0001  
(Table 19). 
Of those who were classified as controls for the study (n=186), 15% had 
fasting plasma glucose levels equal to or greater than 100 mg/dL, but less than  
126 mg/dL as measured at enrollment.  This range designates prediabetes. 
 
Table 19. Fasting Plasma Glucose 



















Fasting plasma equivalent 
glucose 
115(60.2) 147(54.7) 97(12.8) 7.61 
(73) 
<.0001 
Note. Plasma Glucose was tested by investigator at enrollment using Hemocue 201 Glucometer. 
Satterthwaite t test for groups of unequal size 
aFasting plasma glucose was not collected on 24 cases and 4 controls at their initial enrollment sessions.  
Cases were not required to have a fasting plasma glucose.  The four controls for whom a fasting plasma 
glucose was not collected at the initial session had a fasting glucose test at a subsequent visit.  Only fasting 
plasma glucose results from initial enrollment were used in this analysis. 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
 
Waist and Hip Measurements and Waist-to-Hip Ratio 
Mean waist circumference, at smallest diameter, for cases was 105 cm, 
SD=19.0 cm, significantly greater than mean waist circumference at smallest diameter 
for controls, 91 cm, SD=15.4 cm, p<.0001 (Table 20).  Mean waist-to-hip ratio using 
waist measurement at smallest diameter and hip at largest circumference was 
significantly greater for cases (M=0.84, SD=0.070) than for controls (M=0.79, 
SD=0.062), p<.0001.  Abdominal obesity in women is defined as a waist-to-hip ratio 
above 0.80.  On average, both cases and controls had abdominal obesity, though the 
extent of abdominal obesity for cases was 5% greater than for controls.  Fifty percent 
of the sample had a waist-to-hip ratio greater than 0.80.  This translates to 68% 
percent of cases and 41% of controls with abdominal obesity. 
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An additional waist measurement, waist one inch above the umbilicus, was 
collected in the current study.  Waist measured at the smallest diameter and waist 
measured one inch above the umbilicus were highly correlated, r =.96, p<.0001, for 
the 251 women for whom both measures were collected.  Waist-to-hip ratio using the 
two different measures of waist circumference were also associated, r =.80, p<.0001.  
Mean waist circumference measured one inch above the umbilicus, was not included 
in the statistical models because this measure was not collected on all participants. 
Table 20. Mean, Minimum and Maximum Current Circumference Measurements and Waist-to-Hip 
Ratio. U.S.-Born African-American Women 38-57 Years of Age 
 All Cases Controls   









































































Note. 60 cm = 24 inches; 197 cm = 78 inches 
aWaist at smallest diameter according to standards in Lohman, Roche & Martorell, 1988117 
bWaist at 2.54 cm (1”) above umbilicus measured according to procedures used by Folsom et al, 200122 and 
Anderson et al, 2001126 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
The waist-to-hip measures were transformed from ratios to percentages.  This 
resolved the challenge of obtaining an inflated odds ratio for waist-to-hip ratio for the 
logistic regression model.  “The interpretation of odds of the continuous variable is 
that as the independent variable changes by one unit, the dependent variable changes 
by the magnitude of the odds” (Min Qi Wang, Professor of Biostatistics, Department 
of Public and Community Health, University of Maryland, College Park.  Private 
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correspondence, October 2006).127  With the non-transformed waist-to-hip ratio data, 
the difference between the largest value and the smallest value was less than one.  Per 
Wang, the recommended solution was to change the score by multiplying it by 100, to 
obtain a percent measure.  Transforming the waist-to-hip ratio to a percentage did not 
alter the odds ratios for any other variable in the model. 
Participants with a Self-Reported Physician Diagnosis of Type 2 Diabetes 
Table 21 presents information on a number of factors related to the diagnosis 
of diabetes for 95 women in the sample.  The first panel of the table presents the 
mean age at diabetes diagnosis, followed by the weight status of the woman at 
diagnosis.  The next two panels of the table present information on the duration of 
diabetes and methods used to control diabetes.  There were 95 participants with a 
physician diagnosis of type 2 diabetes.  The mean age at diagnosis for type 2 diabetes 
was 44 years (SD=8 years), with a range of age at diagnosis from 17 to 57 years.  
Only four (4%) of the cases were diagnosed with type 2 diabetes before the age of 30 
years. 
Eighty-eight percent of the cases reported being overweight at the time of 
diagnosis (Table 21).  This report by participants of being overweight was based on 
their subjective determination of overweight; participants may or may not have been 
aware that overweight is defined as a BMI 25 to 29.9.  Based on actual measurements 
made by the investigator, 81% of the cases were categorized as obese (defined as a 
BMI >30) at the time of enrollment.  This percentage of obesity at enrollment for 
cases based on current measurements was significantly greater than the 58% obesity 
rate at enrollment for controls, p=.0006. 
  78
The majority of the 95 cases (71%) reported taking oral hypoglycemic 
medications and more than one quarter (26%) of all cases took insulin to control 
blood glucose.  In total, 77 (88%) of the cases reported using some form of 
hypoglycemic agent.  Fifteen percent of the cases had no prescription for diabetes 
medications as indicated on their screening questionnaire.  The discrepancy between 
total cases who reported hypoglycemic agent use on the screening questionnaire and 
the total who reported no use of hypoglycemic agents at enrollment was the result of 
the multiple ways information on diabetes medication use was collected from 
participant (screening questionnaire versus verbal report at time of blood glucose test 
during enrollment). 
Seventy-eight percent of the cases used a diet or diet plan, 68% exercised, and 
62% reported weight loss as part of their regimen to control their blood glucose 
levels.  (They may or may not have lost weight.)  Three percent of the cases reported 
using an alternative treatment, including controlling stress or taking herbs and/or 
vitamins.  Many cases reported using more than one method for controlling their 
diabetes (Table 21).  Some cases reported that though their health care providers had 
prescribed various lifestyle changes, they had not begun making these changes or had 
stopped following their doctor’s orders. 
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Table 21. Means, Medians, and Frequencies for Diabetes-Related Variables 
U.S.-Born African-American Women 38-57 Years of Age, with Type 2 Diabetes, n=95 
Mean Age, Diagnosis and Years Duration of Diabetes Mean (SD) Min-Max 
Age at diagnosis of type 2 diabetes, years 44.4 (8.0) 17-57 
Year first diagnosed 1998 (6.6) 1967-2005 
Duration of type 2 diabetes, years 6.2a (6.6) <1 yr to 38 
Frequencies: Self-Reported Overweight at Diagnosis, Duration, and Methods for Controlling 
Diabetes, n=95 
Weight at diagnosis (Based on participant’s definition)b,c  
 Overweight 88% 
 Normal weight 11% 
 Underweight 1% 
Duration of diabetesd  
 5 years or less 59% 
 5.1 to 10 years 25% 
 10.1 to 15 years 8% 
 15.1 to 20 years 4% 
 20.1 to 38 years  4% 
Methods for controlling diabetese  
 Oral diabetes medications 71% 
 Insulin 26% 
 Diet change/Diet Plan 78% 
 Exercise (strenuous, 3 times per week)f 68% 
 Lose weight 62% 
 Other 3% 
Note. All information in this table was from self-report. 
BMI, Body Mass Index. Obesity defined as BMI >30.  Overweight defined as BMI >25 but less than 30. 
aOne extreme value increased mean and standard deviation for diabetes duration. 
bWeight at diagnosis for 10 participants with diabetes was not collected. (That is, weight at diagnosis was 
not found on their questionnaire). 
cThis table displays overweight, normal weight, or underweight as self-reported by participant.  Obesity 
is based on observed measures was 81% for cases and 58% for controls. 
dDuration of diabetes was not collected for 2 participants with diabetes. 
eMethods for controlling diabetes was not collected for 2 to 7 participants.  
fStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard 
physical labor or exercise where you sweat or your heart beats faster?” 
Study Hypotheses: Logistic Regression Analyses 
The hypotheses used to answer three of the research questions are as follow: 
Hypothesis 1: Birth weight is independently associated with type 2 diabetes in 
African-American women 38 to 57 years of age. 
Hypothesis 2: Abdominal obesity, in terms of waist-to-hip ratio, is independently 
associated with type 2 diabetes in African-American women 38 to 57 years of age. 
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Hypothesis 3: Birth weight and abdominal obesity interact in their association with 
type 2 diabetes in African-American women 38 to 57 years of age. 
Results for Hypotheses 1 to 3 are reported as odds ratios.  Chi square (χ2) test 
results are reported for comparisons between cases and controls for non-continuous 
variables and t tests are reported for continuous variables.  Degrees of freedom for  
t tests, correlations, and χ2 are presented in parentheses next to the statistic.  Logistic 
regression analyses were repeated after the removal of the case with the most extreme 
value of current body weight and body mass index.  Given that the odds ratio results 
were similar to when this case was included, the original results with this case 
included are presented. 
Independent variables chosen to be analyzed for inclusion in the model were 
selected based on the diabetes literature previously discussed in this dissertation.  
(See Chapters 1 and 2 of this dissertation.)  Enter was the selection method used for 
the logistic regressions.  The Hosmer and Lemeshow Goodness-of-Fit test statistic is 
reported for logisitic regression.  A Goodness-of-Fit test statistic of <.05 indicates a 
rejection of the null hypothesis that there is no difference between the observed and 
predicted values of the dependent variable.  If this statistic is >.05, the null hypothesis 
that there is no difference is not rejected.  Therefore, the conclusion would be that the 
data fit the specified model. 
Model Testing 
The initial logistic regression model tested was as follows: 
The natural log of (DIABETES/1-DIABETES) = β0*Intercept + β1*BW + β2*WHR + 
β3*PERIOD + β4*HBP + β5*WT25 + β6*GDM + β7*AGE + β8*FAMILY HX + 
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β9*EDUCATION + β10*SMOKING + β11*STRENUOUS PHYSICAL ACTIVITY + 
β12*TWIN+ β13*BMI + β14*TWIN + β15*PREMATURE. 
Key: DIABETES = probability of having type 2 diabetes; 1-DIABETES = probability 
of not having type 2 diabetes; BW = birth weight; WHR = waist-to-hip ratio; 
PERIOD = menopausal status; HBP = high blood pressure; WT25 = weight at age 25 
years; GDM = gestational diabetes; AGE = age at enrollment; FAMILY HX = family 
history of diabetes; EDUCATION = education level attained; SMOKING = current 
smoker; STRENUOUS PHYSICAL ACTIVITY = strenuous physical activity;  
TWIN = born a twin; BMI = body mass index; PREMATURE = born premature. 
Single Covariate Testing 
Each indicator variable was assessed to discover its relationship with type 2 
diabetes and was used as a baseline model, not taking into account covariates (Table 
22).  Covariates such as current smoker and prematurity status were excluded at this 
stage because they were not significant.  Big baby and the combination of birth 
weight and big baby were redundant with gestational diabetes and therefore were not 
included.  Although age and premenopausal status were highly correlated, neither 
variable was dropped from the model at this point because the investigator needed to 
assess their relationships for this sample.  Twin status was not included in the model 
given that only 11 of the 281 participants (4%) reported being born a twin.  This 
number included seven cases and four controls. 
Although it was not significant, birth weight was retained for the next stage of 
model testing because it was part of the hypothesis being tested.  Other variables 
retained for model testing at this stage were abdominal obesity, systolic blood 
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pressure, gestational diabetes, weight at age 25 years, BMI, age, premenopausal 
status, family history of diabetes, strenuous physical activity, and college education. 
 
Table 22. Model Testing: Odds Ratios for 16 Single Independent Variables 





Odds Ratio 95% Confidence 
Interval 
p 
Birth Weight 95 186 1.00 1.00, 1.00 .5064 
Abdominal Obesitya 
(WHR*100) 
95 186 1.12 1.07, 1.17 <.0001 
Gestational Diabetesb 95 186 6.79 2.39, 19.3 .0003 
Big Babyb 95 186 5.00 2.24, 11.1 <.0001 
Gestational Diabetes/Big 
Baby Combined Variableb
95 186 5.67 2.83, 11.4 <.0001 
Body Mass Index (BMI) 95 186 1.09 1.05, 1.12 <.0001 
Premenopausalb,c 91 185 0.38 0.23, 0.64 .0003 
Weight at age 25, kgb 94 183 1.03 1.01, 1.05 .0005 
Ageb 95 186 1.08 1.03, 1.13 .0006 
Family History of Diabetesb 95 186 2.76 1.55, 4.94 .0006 
Systolic Blood Pressure 95 186 1.03 1.01, 1.04 .0008 
College Educationb 95 186 0.46 0.26, 0.82 .0076 
Strenuous Physical Activityb,d 94 186 0.50 0.29, 0.84 .0089 
Twinb 94 184 3.62 1.03, 12.7 .0445 
Current Smokerb 95 183 2.10 0.98, 4.51 .0569 
Prematureb 95 186 1.09 0.95, 1.24 .2280 
aAbdominal obesity is defined as WHR >0.80. Another measure of abdominal obesity used for women is waist 
circumference >88 cm; WHR, waist-to-hip ratio.  Overall obesity is indicated by a BMI >30.  A BMI between 25 
and 25.9 is considered overweight.  A BMI between 18 and 24.9 is considered normal. A BMI < 18 is considered 
underweight.26 
bSelf-reported data: Data not reported on questionnaire for 0-3 participants. 
cParticipants were asked if they had had a period within 12 months.  Having had a period for more than 12 months 
is an indicator for premenopausal status. 
dStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard physical 
labor or exercise where you sweat or your heart beats faster?” 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Birth Weight and Abdominal Obesity with an Additional Covariate 
The next step for model testing was to run an analysis that included both birth 
weight and abdominal obesity (Table 23).  The remaining covariates were entered 
into the model to ascertain their contributions to the model that examined the 




Table 23. Odds Ratios from 10 Logistic Regression Models with Birth Weight and Abdominal Obesity, 
Plus an Additional Covariate (BMI, Age, Gestational Diabetes, Premenopausal Status, Weight at Age 
25, Family History of Diabetes, Strenuous Physical Activity, Systolic Blood Pressure, College 
Education, Twin) 







χ2 Goodness of Fit 
Test (df), p 
Body Mass Index (BMI) 1.06 1.03, 1.10 .0002 8.35(8), .4001 
Age 1.08 1.03,1.13 .0002 6.89(8), .5490 
Gestational Diabetesa 9.81 3.23, 29.8 .0003 6.60(8), .5805 
Premenopausal Statusa,b 0.36 0.21, 0.62 .0003 16.46(8), .0363 
Weight at age 25 years, kga,c 1.03 1.01, 1.05 .0026 8.62(8), .3753 
Family History of Diabetesa 2.35 1.27, 4.34 .0062 11.69(8), .1654 
Strenuous Physical Activitya,d 0.56 0.32, 0.98 .0406 9.43(8), .3070 
Systolic blood pressure 1.02 1.00, 1.03 .0553 10.16(8), .2540 
College Educationa 0.58 0.32, 1.06 .0761 9.34(8), .2761 
Twina 2.58 0.67, 9.92 .1665 11.68(8), .1662 
Note. Number of cases and controls for each covariate was as follows: Premenopausal: 91 cases, 185 controls; 
Weight at age 25: 94 cases, 183 controls; Strenuous physical activity: 94 cases, 186 controls; Twin: 94 cases, 184 
controls.  Birth weight, Abdominal obesity, BMI, Age, Gestational diabetes, Family history of diabetes, Systolic 
blood pressure and, College education, 95 cases and 186 controls. 
aSelf-reported data 
bParticipants were asked if they had had a period within the last 12 months.  Having had a period within the last 12 
months is an indicator for premenopausal status. 
cQuestionnaire item: “About how much did you weigh when you were 25 years of age? ___  pounds” 
dStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard physical 
labor or exercise where you sweat or your heart beats faster?” 
The Hosmer and Lemeshow χ2 Goodness of Fit Test examines the strength of the model to explain the relationship 
between the dependent variable and the independent variables. 
Enter was the selection method used. 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Several variables in Table 23 were found to be statistically significant in 
predicting the odds of having type 2 diabetes among African-American women.  In 
particular, the covariates that made significant contributions to a model that included 
birth weight and abdominal obesity were body mass index, age, gestational diabetes, 
premenopausal status, weight at age 25 years, family history of diabetes, and 
strenuous physical activity (Table 23).  Systolic blood pressure, college education, 
and twin were excluded because their odds ratios were not statistically significant 
(Table 23). 
Gestational diabetes was excluded as a candidate covariate for the final model 
because it had a relatively wide confidence interval (OR=9.81, CI=3.23, 29.8, 
  84
p=.0003), an indication of an unstable point estimate which may have been attributed 
to the small number of participants who had gestational diabetes.  In fact, only 15 
(16%) of the cases and five (3%) of the controls out of 95 and 186 cases and controls, 
respectively, reported having had gestational diabetes. 
Selecting the Most Powerful Model 
The final step was to select the most powerful model for determining the odds 
of having type 2 diabetes.  A series of logistic regression analyses were conducted 
that began with an analysis that included all nine covariates that remained from the 
previous stage of analysis.  These variables were birth weight, abdominal obesity, 
body mass index, age, gestational diabetes, premenopausal status, weight at age 25 
years, family history of diabetes, and strenuous physical activity.  The Hosmer and 
Lemeshow Goodness-of-Fit test reveals the strength of a model to go beyond the data.  
In other words, this test ascertains the ability of the model for future studies to explain 
the odds of having the outcome variable.  In this study, the outcome variable is type 2 
diabetes. 
Table 24 reveals the results of a series of logistic regression analyses where 
one or two covariates were removed.  Including the nine covariates listed below in the 
model resulted in a χ2 Goodness-of-Fit statistic of 10.4(8), p=.2391.  Given the wide 
confidence interval for gestational diabetes, the investigator began by removing it 
from the model.  Removing gestational diabetes from the model increased the power 
of the model (χ2[8]=4.58, p=.8010).  The most powerful model involved removing 
strenuous physical activity (χ2[8]=2.35, p=.9685); however, when both gestational 
diabetes and strenuous activity were removed, the model’s power decreased 
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(χ2[8]=9.13, p=.3316).  Therefore, the final model that was selected included eight of 
the nine covariates that independently explained the association between birth weight, 
abdominal obesity, and type 2 diabetes.  When weight at age 25 years was not 
removed from the model, the result was one of the weakest of the models, second 
only to the model where age was removed (χ2[8]=11.4, p=.1787). 
Table 24. Linear Regression Analyses for Explaining Type 2 Diabetes.  Covariates: Body Mass Index, 
Age, Gestational Diabetes, Premenopausal Status, Weight at Age 25 Years, Family History of 
Diabetes, Strenuous Physical Activity 
U.S.-Born African-American Women 38-57 Years of Age 





of Fit Test (df) 
 
p 
Strenuous Physical Activitya,d 90 182 2.35(8) .9685 
Gestational Diabetesa 89 182 4.58(8) .8010 
Body Mass Index (BMI) 89 182 5.00(8) .7579 
Family History of Diabetesa 89 182 5.20(8) .7360 
Premenopausal Statusa,b 93 182 6.29(8) .6141 
Gestational Diabetes, Strenuous Physical 
Activity 
90 182 9.13(8) .3316 
None 90 182 10.4(8) .2391 
Weight at age 25 years, kga,c 90 182 10.5(8) .2313 
Age 89 182 11.4(8) .1787 
Note. Numbers of cases and controls for each covariate were as follow: Premenopausal: 91 cases, 185 controls; 
Weight at age 25: 94 cases, 183 controls; Strenuous physical activity: 94 cases, 186 controls; Twin: 94 cases, 184 
controls.  Birth weight, Abdominal obesity, BMI, Age, Gestational diabetes, Family history of diabetes, Systolic 
blood pressure and, College education, 95 cases and 186 controls. 
aSelf-reported data 
bParticipants were asked if they had had a period within 12 months.  Having had a period for more than 12 months 
is an indicator for premenopausal status. 
cQuestionnaire item: “About how much did you weigh when you were 25 years of age? ___  pounds” 
dStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard physical 
labor or exercise where you sweat or your heart beats faster?” 
The Hosmer and Lemeshow χ2 Goodness of Fit Test examines the strength of the model to explain the relationship 
between the dependent variable and the independent variables.  A Goodness-of-Fit test where p>.05 signifies that 
the data fit the model; p values closest to 1.0 are better fits. 
Enter was the selection method used; p is significant at α<.05, 2-sided test. 
The results from the final logistic regression model for examining the associations 
between birth weight, abdominal obesity, and type 2 diabetes, revealed that 
abdominal obesity and family history of diabetes were significant contributors to the 
ability of the logistic regression model to explain the relationship between the 
covariates and type 2 diabetes in African-American women (Table 25).  For every 1% 
increase in waist-to-hip ratio, there was an 8% increase in odds of type 2 diabetes, 
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OR=1.08, 95% CI=1.03, 1.13, p=.0014.  Having a family history of diabetes 
increased the odds of type 2 diabetes 2.43 times that of women with no history of 
gestational diabetes, 95% CI=1.24, 4.76, p=.0149.  The odds of having type 2 
diabetes was not explained by body mass index, OR=1.00; 95% CI=1.00, 1.00, 
p=.0096. 
 
Table 25. Final Logistic Regression Model: Relationship Between Type 2 Diabetes, Birth Weight, 
and Abdominal Obesity, Controlling for Covariates, Including Body Mass Index, Age, Gestational 
Diabetes, Premenopausal Status, Weight at Age 25 Years, Family History of Diabetes, Strenuous 
Physical Activity 
U.S.-Born African-American Women, 38-57 Years of Age 
Covariate Odds Ratio 95% Confidence Interval p 
Abdominal Obesity 
(WHR*100) 
1.08 1.03, 1.13 <.0001 
Family History of Diabetesa 2.43 1.24, 4.76 .0149 
Body Mass Index (BMI * 100) 1.00 1.00, 1.00 .0096 
Premenopausala,b 0.55 0.24, 1.01 .0548 
Age 1.06 0.99, 1.13 .0899 
Strenuous Physical Activitya,c 0.61 0.33, 1.13 .1163 
Weight at Age 25 Yearsa 1.02 0.99, 1.04 .1892 
Birth Weight 1.00 1.00, 1.00 .1902 
Note. Eighty-nine cases and 182 controls were included in this analysis; WHR, waist-to-hip ratio. 
aSelf-reported data. 
bParticipants were asked if they had had a period within 12 months.  Not having had a period for more than 12 
months is an indicator for postmenopausal status. 
cStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard 
physical labor or exercise where you sweat or your heart beats faster?” 
dQuestionnaire item: “About how much did you weigh when you were 25 years of age? ___  pounds” 
Likelihood Ratio Test: 73.4(1), p<.0001 
Hosmer and Lemeshow Goodness-of-Fit Test: χ2(8)=4.58, p=.8010 
The Hosmer and Lemeshow χ2 Goodness of Fit Test examines the strength of the model to explain the 
relationship between the dependent variable and the independent variables. 
Enter was the selection method used. 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Other covariates included in the final model that did not independently 
contribute to the ability of the model to explain the odds of having type 2 diabetes 
were age, weight at 25 years, premenopausal status, and strenuous physical activity.  
Birth weight was not shown to independently contribute to the power of this 
regression model to determine the odds of having type 2 diabetes.  The Hosmer and 
Lemeshow Goodness-of-Fit test indicated that the overall logistic regression model fit 
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the observed data well, χ2(8)=4.58, p=.8010.  Again, when the Goodness-of-Fit test 
statistic has a p value of >.05, the implication is that the model has the power to 
examine associations using data beyond that of the current study; that is, using data 
from similar studies. 
Fasting Plasma Glucose by Birth Weight and Abdominal Obesity 
The fourth, and final hypothesis addressed by the current study is as follows: 
Hypothesis 4: Among African-American women without a physician diagnosis of 
type 2 diabetes and with fasting plasma glucose levels <126 mg/dL (controls), there is 
an association among birth weight, abdominal obesity, and fasting plasma glucose 
level. 
To test Hypothesis 4, a multiple linear regression analysis was conducted to 
examine the association between fasting plasma glucose and the explanatory variables 
of the final logistic model described above that explored the association of these 
variables with type 2 diabetes.  The multiple linear regression analysis involved the 
use of actual fasting blood glucose levels, not self-reported physician diagnosis of 
type 2 diabetes.  In addition to birth weight and abdominal obesity, the covariates 
included in the model were weight at age 25 years, body mass index, family history 
of diabetes, age, premenopausal status, strenuous physical activity.  Only the 186 
women without a reported physician diagnosis of type 2 diabetes were included in the 
analysis. 
Table 26 shows that the independent variables help to explain 16% of the 
variability in the regression model.  That is, 16% of the variation in fasting plasma 
glucose between cases and controls was attributable to this multiple linear regression 
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model (R2=.16, p=.0002, Table 26).  The two independent variables that were 
statistically significant were weight at age 25 years and body mass index (BMI).  The 
negative sign suggests that lower weight at age 25 reduces the odds of developing 
type 2 diabetes.  In contrast, the positive sign on the BMI variable indicates that the 
odds of contracting this disease increase as BMI increases. 
Table 26. Multiple Linear Regression Analysis of Fasting Plasma Glucose Examining the 
Association Among Birth Weight, Abdominal Obesity, and Covariates (Body Mass Index, Age, 
Premenopausal Status, Weight at Age 25 Years, Family History of Diabetes, and Strenuous 
Physical Activity) 
U.S.-Born African-American Women, 38-57 Years of Age, Controls, Only (N=181) 
Variable df Parameter 
estimate 
Std Error t value p 
Intercept 1 106.0 17.0 6.22 <.0001 
Weight at Age 25 Years 1 -0.38 0.1 4.04 <.0001 
Body Mass Index (BMI*100) 1 0.01 0.0 -4.58 <.0001 
Family History of Diabetes 1 2.94 1.9 -1.56 .1200 
Age 1 -0.21 0.2 1.03 .3039 
Premenopausal Status 1 2.03 2.4 -0.85 .3982 
Strenuous Physical Activity 1 0.95 1.9 -0.50 .6164 
Birth Weight 1 0.00 0.0 -0.42 .6716 
Abdominal Obesity (WHR*100) 1 -.054 0.2 0.34 .7337 
Note. This analysis was based on data collected on 181 of the 186 controls. Five controls with no response 
to a questionnaire items(family history of diabetes, premenopausal status, weight at age 25 years, and/or 
strenuous activity) were not include in this analysis. 
WHR, waist-to-hip ratio 
Enter was the selection method used. 
R2=.16; adjusted R2=.12; F(8,172)=3.65, p=.0002 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
A Focus on Low Birth Weight Participants 
Descriptive statistics for continuous variables for low birth weight participants 
are presented in Tables 27 to 30.  Forty-three participants (15%) had birth weights 
<2,500 g (5 pounds, 8 ounces).  Low birth weight cases were significantly older than 
low birth weight controls, M=52 years, SD=4.6 years versus 48 years, SD=5.9 years, 
t(40.8)=2.21, p=.0259.  There was no statistically significant difference between the 
mean birth weight of low birth weight cases (n=18) and low birth weight controls 
(n=25), t(28.5)=1.71, p=.5134.  However, there was a significant difference in the 
mean waist-to-hip ratio of low birth weight cases and low birth weight controls, 
  89
t(28.2)=5.61, p=.0208 (Table 27).  Comparison between low birth weight cases and 
low birth weight controls showed no significant differences in terms of history of 
gestational diabetes, premenopausal status, family history of diabetes, strenuous 
physical activity level, and education.  Finally, among low birth weight participants, 
cases had significantly higher mean fasting plasma glucose than did controls 
t(13.4)=2.18, p=.0475 (Table 30). 
 
Table 27. Mean, Minimum and Maximum Age, Current Circumference Measurements Among Low 
Birth Weight (<2,500 g) Women: 














































Note. 70 to 168 cm = 28 to 66 inches 
aWaist at smallest diameter according to standards in Lohman, Roche & Martorell, 1988 171 
Satterthwaite t test for groups of unequal size 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
 
Table 28. Mean, Minimum and  Maximum Current Body and Blood Pressure Measurements Among 
Low Birth Weight (<2,500 g) Women 
U.S.-Born African-American Women 38-57 Years of Age, N=43 
 All, n=43 Cases, n=18 Controls, n=25   


























































Note. All measurements in this table were collected at the time of enrollment by the investigator. 
49 to 252 kg = 108 to 554 pounds 
113 to 184 cm = 44 to 72 inches 
Satterthwaite t test for groups of unequal size 





Table 29. Mean, Minimum and Maximum Self-Reported Weight at Age 25 Among Low Birth 
Weight (<2,500 g) Women 
U.S.-Born African-American Women 38-57 Years of Age, N=43 
 All, n=43 Cases, n=18 Controls, n=25   


















Questionnaire item: “About how much did you weigh when you were 25 years of age? ___  pounds” 
45 to 159 kg = 99 to 350 pounds 
Satterthwaite t test for groups of unequal size. 
df = degrees of freedom; p is significant at α<.05, 2-sided test. 
 
 
Table 30. Mean Fasting Plasma Glucosea Among Low Birth Weight (<2,500 g) Women:  



















Fasting plasma equivalent 










Note. Comparing cases to controls: Six cases had no FPG.  One control had no FPG for this comparision, 
but a FPG was collected on her at a subsequent visit. 
aFasting Plasma Glucose tested by investigator at enrollment using the Hemocue 201 Glucometer. 
FPG (fasting plasma-equivalent glucose) 
Satterthwaite t test for groups of unequal size 
df = degrees of freedom; p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
The results from the logistic regression model for examining the associations 
for type 2 diabetes among low birth weight participants (n=43) revealed that family 
history of diabetes was independently associated with type 2 diabetes in African-
American women (Table 31).  For women who were born with low birth weight, 
having a family history of diabetes increased the odds of having type 2 diabetes by 
1.22, OR=1.22, 95% CI=1.02, 1.48, p=.0345.  Other variables in the model included 
self-reported weight at age 25, current weight, age, body mass index, premenopausal 
status, abdominal obesity, and birth weight.  These are the same variables that 
comprised the final logistic model used when examining the full range of birth 
weights (n=281). 
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This model could not be utilized for participants who were born with a high 
birth weight because of the small size of that subsample (n=8 cases and 6 controls).  
Any estimates from such a small sample size would be unstable and not useful. 
Table 31. Logistic Regression Model: Relationship Between Type 2 Diabetes, Birth Weight, 
and Abdominal Obesity, Controlling for Covariates, Including Body Mass Index, Age, 
Gestational Diabetes, Premenopausal Status, Weight at Age 25 Years, Family History of 
Diabetes, Strenuous Physical Activity 
U.S.-Born African-American Women, 38-57 Years. of Age, Low Birth Weight (<2,500 g) 
Women, N=43 
Covariate Odds Ratio 95% Confidence Interval p 
Family History of Diabetesa 1.22 1.02, 1.48 .0345 
Age 0.23 0.04, 1.32 .1005 
Premenopausala,b 1.00 1.00, 1.00 .2031 
Body Mass Index (BMI * 100) 2.84 0.24, 19.18 .2836 
Abdominal Obesity 
(WHR*100) 
1.08 0.38, 1.26 .3151 
Strenuous Physical Activitya,c 1.00 1.00, 1.00 .8742 
Birth Weight 0.88 0.14, 5.61 .8933 
Weight at Age 25 Yearsa 1.00 0.94, 1.06 .9717 
Note. All 18 cases and 25 controls with low birth weights were included in this analysis; 
WHR, waist-to-hip ratio. 
aSelf-reported data. 
bParticipants were asked if they had had a period within 12 months.  Not having had a period for more 
than 12 months is an indicator for postmenopausal status. 
cStrenuous Physical Activity questionnaire item: “Do you regularly engage in strenuous activity or hard 
physical labor or exercise where you sweat or your heart beats faster?” 
dQuestionnaire item: “About how much did you weigh when you were 25 years of age? ___  
pounds” 
Likelihood Ratio Test: 16.4(8), p=.0365 
Hosmer and Lemeshow Goodness-of-Fit Test: χ2(9)=6.13, p=.7266 
The Hosmer and Lemeshow χ2 Goodness of Fit Test examines the strength of the model to explain the 
relationship between the dependent variable and the independent variables. 
Enter was the selection method used. 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
The results from a series of logistic regression analyses using individual 
independent variables revealed that abdominal obesity was a significant factor for 
explaining the odds of having type 2 diabetes among African-American women 
(Table 32).  For every 1% increase in waist-to-hip ratio, there was a 1.15 increase in 
the odds of type 2 diabetes (OR=1.15, 95% CI=1.01, 1.29, p=.0303).  In other words, 
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among African-American women who were born low birth weight, waist-to-hip ratio 
was found to provide some explanation of the difference in odds of having type 2 
diabetes.  Age was also statistically significant in explaining the odds of type 2 
diabetes among this group of women.  For every one year increase in age, there was a 
1.16 increase in the odds for having type 2 diabetes (OR=1.16, 95% CI=1.00, 1.34, 
p=.0446).  As with the model developed for the full sample and described above 
(n=281), birth weight was not a significant contributor to the model that was 
developed for women born with low birth weight (n=43). 
Other covariates from the model developed using the full sample (n=281) 
were not included in this model developed for women with low birth weight (n=43).  
There are several reasons for this.  The first is that as the sample size decreases, a 
large number of independent variables may increase the error of the estimate.  
Another reason is that a series of logistic regression analyses for women born low 
birth weight resulted in models that were not statistically significant when family 
history of diabetes, BMI, strenuous physical activity, weight at age 25, and 
premenopausal status were also included. 
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Table 32. Logistic Regression Model: Relationship Between Type 2 Diabetes and Abdominal 
Obesity, Controlling for Age 
U.S.-Born African-American Women, 38-57 Years of Age, Low Birth Weight (<2,500 g) 
Women,: N=43 
Independent Variable Odds Ratio 95% Confidence Interval P 
Abdominal Obesity (WHR*100) 1.15 1.01, 1.29 .0303 
Age 1.16 1.00, 1.34 .0446 
Birth Weight 1.00 1.00, 1.00 .6746 
Note. All 18 cases and 25 controls with low birth weights were included in this analysis. 
WHR, waist-to-hip ratio 
Likelihood Ratio Test: 11.3(3), p=.0102 
Hosmer and Lemeshow Goodness-of-Fit Test: χ2(9)=8.53, p=.4817 
The Hosmer and Lemeshow χ2 Goodness of Fit Test examines the strength of the model to explain the relationship 
between the dependent variable and the independent variables. 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
Highlighting Participants for Whom Vital Records Birth Weights Were Obtained 
Most of the results presented above involved the final sample (N=281).  The 
final sample of pooled participants consisted of individuals with birth weights 
obtained from vital records and those verified through secondary self-report.  
Specifically, at enrollment, all participants were asked to self report their birth 
weights.  The protocol required that these self-reported birth weights be confirmed 
with birth weights obtained from vital records offices.  However, it turned out that 
vital records data were not available for the majority of respondents.  Therefore, 
participants were asked to confirm their self-reported birth weights with a second 
source (i.e. mother, birth certificate, another family member, etc.)  For 63 
respondents, self-reported birth weights were compared to birth weights obtained 
from vital records to assess whether birth weights from different sources could be 
pooled. 
The following are results for those participants for whom vital records birth 
weight data were obtained (n=63).  These participants are referred to as the vital 
records sample in this section of the results. 
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The mean age for women for whom vital records birth weights were obtained 
was 49 years (SD=5.4 years).  Among these participants with vital records birth 
weights, cases (n=22) were significantly older (M=52 years, SD=4.1 years) than 
controls (M=48 years, SD=5.6 years), t(55.2)=3.02, p=.0038.  Among the vital 
records subsample, there was no significant difference between the cases (M=3,272 g, 
SD=572.2 g) and the controls (M=3,317 g, SD=412.1g) in terms of birth weight, 
t(33)= -0.33, p=.7421.  The majority (87%) of the vital records subsample was 
normal weight at birth (n=55), eight percent were born low birth weight (n=5), and 
five percent were born high birth weight (n=3). 
Mean current body weight for the vital records sample was 99.2 kg (SD=24.65 
kg) for cases and 88.8 kg (SD=24.65) for controls.  The difference in current body 
weight was not significant, t(37.6)=2.94, p=.1039.  Mean waist-to-hip ratio for cases 
(M=0.81, SD=.079) was significantly greater than for controls (M=0.79, SD=.068), 
p=.0056.  Likewise, mean fasting plasma glucose for cases (M=165 mg/dL, SD=15.5 
mg/dL) was significantly greater than for controls (100 mg/dL, SD=13.9 mg/dL), 
t(15.3)=2.87, p=.0115.  Systolic blood pressure approached significance, 
t(45.1)=2.01, p=.0625, with mean systolic blood pressure for cases (M=134 mm Hg, 
SD=15.5 mm Hg) significantly higher than that for controls (M=125 mm Hg, 
SD=16.3 mm Hg), t(45.1)=2.01, p=.0502.  There were no significant differences 
between cases and controls when examining body mass index, t(35.7)=1.87, p=.0692, 
or diastolic blood pressure, t(49.5)=0.76, p=.4488. 
Table 33 fits the final model (discussed earlier in the Model Testing section) 
to the data obtained from the vital records subsample (n=63).  The Goodness-of-Fit 
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Test indicated that the overall logistic regression model fit the observed data for the 
vital records birth weight subsample (Goodness-of-Fit χ2[8]=14.0, p=.0816) and that, 
therefore, the model was acceptable for examining associations between type 2 
diabetes, birth weight, and abdominal obesity.  In other words, knowing  a woman’s 
age and her abdominal obesity helps to explain the odds of her contracting type 2 
diabetes: for every one year increase in age, there was a 20% increase in the odds of 
having type 2 diabetes, OR=1.20, 95% CI=1.02, 1.42, p=.0266).  Abdominal obesity 
also contributed independently to this model: for every 1% increase in waist-to-hip 
ratio, there was a 12% increase in odds of type 2 diabetes in, OR=1.20, 95% CI=1.00, 
1.26, p=.0482).  Therefore, when examining the 63 participants for whom vital 
records data were obtained, the hypothesis stating that type 2 diabetes is associated 
with abdominal obesity holds. 
Table 33.  Logistic Regression Model: Relationship Between Type 2 Diabetes, Birth Weight, and 
Abdominal Obesity, Controlling for Covariates, Including Body Mass Index, Age, Gestational 
Diabetes, Premenopausal Status, Weight at Age 25 Years, Family History of Diabetes, Strenuous 
Physical Activity 
U.S.-Born African-American Women, 38-57 Years, of Age Participants for Whom Vital Records 
Birth Weights Were Obtained, N=63 
Covariate Odds Ratio 95% Confidence Interval p 
Age 1.20 1.02, 1.42 .0266 
Abdominal Obesity, WHR*100 1.12 1.00, 1.26 .0482 
Family History of Diabetesa 4.79 0.89, 25.7 .0681 
Weight at Age 25 Yearsa 1.03 0.96, 1.10 .3764 
Birth Weight 1.00 1.00, 1.00 .4392 
Strenuous Physical Activitya,c 0.66 0.17, 2.56 .5439 
Premenopausala,b 0.83 0.17, 4.10 .8229 
Body Mass Index (BMI * 100) 1.00 1.00, 1.00 .8680 
Note. WHR, waist-to-hip ratio.  Sixty-two of 63 women for whom vital records birth weights could be obtained (22 cases 
and 40 controls) were included in this analysis. 
aSelf-reported data 
bParticipants were asked if they had had a period within 12 months.  Having had a period for more than 12 months is an 
indicator for premenopausal status. 
Likelihood Ratio Test: χ2(8)=23.5, p=.0028 
Hosmer and Lemeshow Goodness-of-Fit Test: χ2(8)=14.0, p=.0816. 
p is significant at α<.05, 2-sided test.  Bolded figures are significant. 
When we tried to examine the same hypothesis to a sample of women for 
whom we could obtain vital records and who had low birth weights, the percentage 
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was less than 10%.  Specifically, only five (8%) of the 63 participants for whom vital 
records data were obtained had birth weights <2,500 g (5 pounds, 8 ounces).  Three 
were cases and two were controls.  This number of low birth weight participants 
among participants for whom vital records were obtained was too small to detect a 
significant difference between cases and controls in terms of the relationship of 
abdominal obesity to type 2 diabetes.  Therefore, the hypothesis could not be tested 
for the vital records subsample of low birth weight women. 
Fasting Plasma Glucose Among Cases: Hypoglycemic Use 
Among the 95 cases from the full sample of 281 participants, 52 used oral 
medications and no insulin, six used insulin and no oral medications, 14 used both 
oral medications and insulin, and 14 controlled their blood glucose levels by diet and 
exercise alone.  Two cases had stopped taking diabetes medications per the order of 
their physician, while three stopped contrary to the order of their physician.  Table 34 
shows that among cases, there was no significant difference in mean fasting plasma 
glucose levels between those who used hypoglycemic agents to control their glucose 
levels (mean fasting plasma glucose=149 mg/dL, SD=57.8 mg/dL) and those who did 
not use hypoglycemic agents (mean fasting plasma glucose=140 mg/dL, SD=42.4 
mg/dL, p=.4960). 
Table 34. Mean Fasting Plasma Glucose by Hypoglycemic Agent Use,a
U.S.-Born African-American Women 38-57 Years of Age, Cases, Only 
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aHypoglycemic Agent Use was by self-report. 
bFour cases were not included because no hypoglycemic medication use data were obtained on them.  Twenty cases were not 
included because no fasting plasma glucose measurement collected on them. 
df = degrees of freedom; p is significant at α<.05, 2-sided test. 
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Among the cases for whom fasting plasma glucose was collected, 31 (44%) 
had fasting plasma glucose levels <126 mg/dL, while 40 (56%) had elevated fasting 
plasma glucose levels.  This revealed that approximately half of the cases had 
elevated fasting plasma glucose levels regardless of whether they received treatment 
with oral hypoglycemic medications, insulin, or with exercise and/or diet. 
Summary of Results for the 281 Participants, Including Subsamples 
The final model used to test associations of various covariates with type 2 
diabetes in a sample of 281 African-American women 38 to 57 years of age included 
birth weight, waist-to-hip ratio, family history of diabetes, weight at age 25 years, 
strenuous activity level, age, body mass index, and premenopausal status (measured 
by self-report of having had a menstrual cycle at least once in the past 12 months).  
This model held similar results for the subsample of 63 participants for whom vital 
records birth weights were obtained. 
Hypothesis 1: Birth weight is independently associated with type 2 diabetes in 
African-American women 38 to 57 years of age. 
This hypothesis was not supported in the current study. 
Hypothesis 2: Abdominal obesity, in terms of waist-to-hip ratio, is independently 
associated with type 2 diabetes in African-American women 38 to 57 years of age. 
The current study found that waist-to-hip ratio, an indicator for abdominal 
obesity, was associated with type 2 diabetes for African-American women 38 to 57 
years of age. 
Hypothesis 3: Birth weight and abdominal obesity interact in their association with 
type 2 diabetes in African-American women 38 to 57 years of age. 
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This hypothesis was not supported by the study for the full spectrum of birth 
weights.  However, when restricting the logistic regression analysis to women who 
were born low birth weight, n=43, low birth weightcases were 1.15 times more likely 
than low birth weight controls to have developed abdominal obesity, (95% CI=1.01, 
1.29, p=.0250; Table 32).  In other words, those who were born low birth weight and 
developed type 2 diabetes had higher waist-to-hip ratios (abdominal obesity) than 
those who had not developed type 2 diabetes.  It follows that those who were born 
small and who then developed abdominal obesity later in life were more likely to 
have type 2 diabetes.  Thus, for the women in the current study who were born low 
birth weight, n=43, the theory of the fetal origins of chronic disease (born small, grew 
large = higher risk for chronic diseases) in terms of the outcome of type 2 diabetes in 
African-American women was supported. 
Hypothesis 4: Among African-American women without a self-reported physician 
diagnosis of type 2 diabetes and with a measured fasting plasma glucose levels  
<126 mg/dL, there is a clear association among birth weight, abdominal obesity, and 
fasting plasma glucose level. 
The multiple linear regression model that included birth weight and waist-to-
hip ratio explained 13% of the variation in fasting plasma glucose levels among the 
study controls (n=185).  However, birth weight and waist-to-hip ratio did not 
independently contribute to this model.  Independently, they were not statistically 
significant in explaining the difference in fasting plasma glucose levels among 
controls (the women in the study who did not have type 2 diabetes). 
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Chapter 5: Discussion and Conclusions 
The overall purpose of the current study was to better understand factors that 
influence type 2 diabetes among African-American women born between 1946 and 
1964 who were 38 to 57 years of age at the time of enrollment.  This project began by 
examining the fetal origins of chronic disease (specifically type 2 diabetes) among 
African-American women, utilizing birth weights from vital records and directly 
measuring current weight, height and waist and hip circumferences.  In addition, 
fasting plasma glucose was examined in greater detail. 
This discussion begins with a comparison between findings from the current 
study and previous studies.  Issues raised regarding vital records birth weights are 
then addressed.  Next, vital records birth weights for the United States and the District 
of Columbia are presented.  The issue of utilizing verified self-reported birth weight 
for the current study is also discussed.  The findings on abdominal obesity as it relates 
to type 2 diabetes are highlighted.  This is followed by a look at obesity in African-
American women.  Next, the relationship between birth weight, abdominal obesity, 
and type 2 diabetes is discussed as is the relationship between birth weight, 
abdominal obesity, and fasting plasma glucose.  Finally, a discussion of undiagnosed 
diabetes and blood pressure in African-American women is presented.  This chapter 
is capped with a list of the study limitations and strengths.  It ends with 
recommendations for future investigators and practitioners. 
The first hypothesis of this case-control study stated that birth weight is 
independently associated with type 2 diabetes in African-American women 38 to 57 
years of age.  Like the cohort study by Lithell and associates85 that looked at the 
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relationship between size at birth and type 2 diabetes in Swedish-born men aged 50 to 
60 years of age, the current study was unable to support the hypothesis that birth 
weight is independently associated with type 2 diabetes.  Lithell and associates85 
obtained birth weights from hospital records for 718 of their 1585 (45%) participants.  
Diabetes status was based on blood glucose cut-points and drug treatment for 
diabetes.  Lithell and associates85 found that the prevalence of diabetes at age 60 
years was 8% in men whose birth weights were less than 3,250 g (~7 pounds) 
compared to 5% in men with birth weights 3,250 g or more; however, this difference 
was not significant (95% CI for difference -.03% to 6.8%, p=.08).  This Swedish 
study85 did find a difference in the prevalence of diabetes for those at the lowest fifth 
of ponderal index (12%) compared to those in the other four-fifths of ponderal index 
(4%), 95% CI=3.0%, 12.6%, p=.001.  The current study did not measure ponderal 
index because birth lengths were not available. 
Although findings in this study were similar to those in the Swedish study,85 
not all studies on birth weight and type 2 diabetes came to the same conclusions with 
respect to no significant association between these two variables.  The Rich-Edwards 
and associates33 study involving nearly 70,000 women 30 to 70 years of age who 
were part of the Nurses’ Health Study found contradicting results to the current study.  
They found that when controlling for age, women who were born small (<2.50 kg) 
had an increased risk for developing type 2 diabetes compared to the reference group 
(birth weight 3.16 to 3.82 kg).  The Relative Risk was 1.55 (95% CI=1.32, 1.83, 
p<.0001) for those born 2.25 to 2.48 kg and 1.88 (95% CI=1.59, 2.21, p=.0001) for 
those born less than 2.25 kg.  Although the Rich-Edwards and associates33 study used 
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self-reported data for type 2 diabetes, birth weight, and current weight, height, waist 
and hip circumferences, their large sample size yielded a relatively stable estimate.  
However, the Rich-Edwards study33 did not focus on African-American women: their 
study involved a sample that was approximately 95% European-American.  In 
contrast, this current study included only African-American women who fell within a 
relatively narrow age range (38 to 57 years).  This study confirmed the Rich-Edwards 
findings in that among the current study’s sample, individuals in the small subgroup 
who were born small and who then developed abdominal obesity later in life were 
more likely to have type 2 diabetes.  It is possible that the relationships between birth 
weight, abdominal obesity, and type 2 diabetes would have been less ambiguous for 
this current study if fewer participants from the current study’s original sample of 376 
had not been excluded due to lack of a verified birth weight.  This issue is discussed 
in more detail below. 
Despite their large sample size, Rich-Edwards and associates33 did not 
measure adominal obesity: they used the self-report of study participants.  It is 
possible that the interaction of birth weight and abdominal obesity is truly the factor 
that explains a significant proportion of cases of type 2 diabetes rather than low birth 
weight alone.  Without considering this interaction, Rich-Edwards and associates33 
overlooked the possibility that low birth weight may be simply a proxy measure for 
adominal obesity.  This has great implications given that 15% of the current study’s 
participants were born low birth weight (<2,500 grams) and 50% were categorized as 
having abdominal obesity. 
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There are many methodological differences between the current study and the 
two studies cited above.  The Swedish study85 involved men only and the Nurses’ 
Health Study33 involved primarily European-American women.  Despite the 
availability of birth weights obtained from hospital records, Lithell and associates85 
did not find an association between birth weight and type 2 diabetes.  Rich-Edwards 
and associates33 did find an association between these two variables, but they divided 
birth weight into categories in which birth weight differences ranged from one-half 
kilogram (500 g, or one-half pound) to one and one-half kilogram (a range of 1,500 g, 
or one and one-half pound).  This current study utilized three categories of birth 
weights that followed the standard cut-points for low birth weight, normal birth 
weight, and high birth weight.  Given the relatively small sample size of this study, a 
larger number of birth weight categories would serve to reduce further the power of 
the statistical analyses. 
A study by Fall and associates14 examined the relationship between size at 
birth, maternal weight, and type 2 diabetes in 506 Asian-Indian men and women, 
aged 39 to 60 years.  They defined type 2 diabetes as “already known to have Type 2 
diabetes” or as having a 120-minute glucose concentration of >11.1 mmole/liter.  
Two investigators collected all current body measurements used in their study.  Birth 
weights were obtained from one hospital in Mysore, South India.  As with the current 
study, the prevalence of type 2 diabetes in the Fall and associates14 study was not 
shown to be related to birth weight, unadjusted or adjusted for age, sex, and body 
mass index.  However, Fall and associates14 did find that the risk for type 2 diabetes 
fell with increasing birth length and rose with increasing ponderal index.  These 
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results were simlar to the Swedish study85 where birth length was examined.  Again, 
the current study did not collect birth lengths for the calculation of ponderal index. 
A longitudinal study by McCance and colleagues128 examined the relationship 
between birth weight and type 2 diabetes in 1,179 Pima Indians of Arizona, ages 20 
to 39 years.  Similar to to study by Rich-Edwards and associates33, McCance and 
colleagues128 found that compared to the reference group where birth weights ranged 
from 2,500 to 4,499 g, those who were born low birth weight (<2,500 g) were more 
likely to have type 2 diabetes, OR=3.81, 95% CI=1.70, 8.52, p=.001.  Those with 
high birth weights (>4,500 g) were not more likely to have type 2 diabetes, when 
controlling for the diabetes status of their mothers during pregnancy, p=.269.  The 
diabetes status during the pregnancy of the mothers of participants of this current 
(n=281) study was not available. 
The current study attempted to examine the interaction of birth weight and 
abdominal obesity as an indicator of odds for the development of type 2 diabetes.  
This is the only study to date that examined this interaction in African American 
women specifically.  However, the question regarding the relationship between low 
birth weight, abdominal obesity, and type 2 diabetes could not be answered 
definitively as the results were mixed, depending on the subsample examined.  For 
the full spectrum of birth weights (n=281), the investigator was unable to uncover any 
interaction between birth weight, abdominal obesity, and type 2 diabetes, if such an 
interaction exists.  For the subsample of 43 participants who were born low birth 
weight, results confirmed those of the study by Rich-Edwards and associates33 for 
women in the current study with low birth weights who developed abdominal obesity 
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later in life, the odds of having type 2 diabetes was 1.22 times greater than for those 
who did not develop abdominal obesity. 
Vital Records and Verified Self-Reported Birth Weight for Study Sample 
Initally, vital records birth weight information was to be collected for each 
study participant.  Unfortunately, official birth weights could not be obtained for the 
majority of study participants because the technology for data storage in earlier years 
was limited.129  Vital records data systems now in place are more sophisticated than 
those available from 1946 to 1964, the years during which study participants were 
born.  Several vital records offices retained only those parts of the birth certificates 
they were required by law to keep.  In many instances, confidential data, including 
birth weights, were not captured, or when recorded, not retained due to budgetary 
constraints for storing and archiving large amounts of data for long periods of time.129
Therefore, statistical tests were conducted to compare self-reported birth 
weights with official birth weights for the 63 participants for whom vital records data 
were available.  Birth weights reported at enrollment did not agree closely with vital 
records birth weights.  However, birth weights that were reported after participants 
were able to refer to written documents or after they had conferred with their mothers 
(what is referred to in this study as “verified birth weights”), agreed closely with 
official birth weights.  Because there was no statistically significant difference 
between the verified birth weights and the vital records birth weights, it was 
determined the verified birth weights could be used as a proxy measure for the vital 
records data.  Thus the majority of participants for whom vital records data were not 
available could still be included in the study sample. 
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Given the small number of participants for whom vital records birth weights 
were obtained, the issue of the accuracy of birth weights used in this study needed to 
be addressed.  Andersson and colleagues39 showed poor agreement between self-
reported birth weights and birth weights from original records in adult women.  
Checking against actual birth records, these investigators found that for self-reported 
birth weights, 53% were incorrect by >250 g (~1/2 pound) and 31% were incorrect by 
>500 g (~1 pound).  Allen and associates40 found that 25% of their 244 respondents 
reported their birth weight within four ounces of their official birth weight, 28% 
reported it inaccurately, and 47% did not know their birth weight.  These 
investigators found that having a living mother and a low birth weight (less than six 
pounds or 2,722 g) increased the likelihood of the availability of a self-reported birth 
weight.  The accuracy of self-reported birth weights was higher among those who 
were the youngest or the eldest child. 
This current study also quantified the variability between birth weights from 
vital records and those from other sources.  It was found that birth weights from 
verified sources and birth weights from vital records were correlated, r =.70,  
p<.0001 (Table 6). 
Vital Records Birth Weight for United States and the District of Columbia 
District- and national-level birth weight statistics support the investigator’s 
focus on African Americans when addressing the issue of the fetal origins of chronic 
disease.  First, the percentage of women in this sample who were born low birth 
weight (15% overall: 13% for controls and 19% for cases) parallels the percentages of 
African Africans who were born low birth weight during the years in which study 
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participants were born.  Second, given that African Americans are at greater risk for 
being born low birth weight, if the fetal origins of chronic disease holds (where being 
born low birth weight and subsequently developing abdominal obesity put one at 
greater risk for type 2 diabetes later in life), then interventions that address low birth 
weight in this population may be needed even more. 
A by-product of this current study was that the investigator compiled a table 
that shows low birth weight rates and ratios among black and white persons, by year, 
from 1950 to 1970 and 1972 (Table M1, Appendix M).  Data on birth weights were 
not available at the national level before 1950; therefore, the birth weights of the 
study participants who were born before this date could not be placed within an 
historical context. 
Birth weight distributions for the United States and Washington, D.C., by race 
for 1950 through 2001 are presented in Appendix M (Tables M1 and M2).  In the 
United States from 1950 to 1970, the percentage of whites with low birth weight was 
between 6.5% to 7.2%.  By comparison, for non-whites, those rates were between 
10.1% and 14.4%.  Between 1950 and 1970, 12.1% to 17.0% of non-white males and 
females who were born in the District of Columbia were born low birth weight.  For 
whites, this range was 6% to 11% (Table MI, Appendix M).  National and District of 
Columbia birth weight distributions and low birth weight ratios revealed that non-
white, including black, persons were more likely than white persons to have been 
born low birth weight (ratios 1.5 to 2.1) between 1950 and 1970, years in which 79% 
of the participants in the current study were born.  No birth weight distribution data 
were available between 1945 and 1949, the years in which the remaining participants 
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were born.  In total, 85% (n=238) of the participants were born between 1946 and 
1964, while 7% (n=19) were born before 1948 and 9% (n=24) were born between 
1965 and 1970.  Nationally, disparities between whites and blacks continued from 
1980 to 2002 (Table M2, Appendix M). 
Table M3 of Appendix M displays the population distribution of the United 
States and of the District of Columbia by race and Hispanic origin.  It gives an 
historical context of the changing racial composition of the District of Columbia, 
compared to the population at the national level.  The statistics for the District of 
Columbia were highlighted because of the large number of study participants who 
were born there. 
Abdominal Obesity and Type 2 Diabetes 
The second hypothesis tested in the current study stated that abdominal 
obesity, in terms of waist-to-hip ratio, is independently associated with type 2 
diabetes in African-American women 38 to 57 years of age.  The current study 
revealed that those with type 2 diabetes had a 1.13 odds of having abdominal obesity 
compared to women without type 2 diabetes (CI=1.08, 1.19, p<.0001).  Similar to this 
current study, Okosun17 found that abdominal obesity, based on waist circumference, 
was associated with an increased risk for type 2 diabetes.  Okosun employed data 
from a nationally representative sample of 429 African-American women who 
participated in the Third National Health and Nutrition Examination Survey 
(NHANES III).  His model included abdominal obesity, age, smoking, and alcohol 
use. 
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Okosun17 found that for African-American women, the population attributable 
risk fraction of abdominal obesity was 39.9%.  That is, nearly 40% of the risk for type 
2 diabetes in African-American women could have been avoided if abdominal obesity 
were absent.  Okosun estimated that the risk for type 2 diabetes contributed by 
abdominal obesity was significant, OR=3.85, 95% CI=1.41, 10.44, p<.01.  When the 
model was adjusted for body mass index, the results were similar, OR=2.27, 95% 
CI=1.23, 4.69, p<.01. 
Similarly, Lundgren and associates20 found that abdominal obesity was 
associated with type 2 diabetes in Swedish women.  These findings were confirmed 
by using a waist-to-hip ratio measure instead of the waist circumference measure used 
by Okosun.  In particular, Lundgren and associates20 found that the incidence of 
diabetes for women in the upper quintile of waist-to-hip ratio increased by 13.6 times 
compared to those in the lowest quintiles, p<.001. 
The current study utilized waist-to-hip ratio, instead of waist circumference, 
as an indicator for abdominal obesity.  Other investigators (for example, Folsom and 
associates22) found that waist-to-hip ratio is a better predictor for health outcomes 
than waist circumference alone.  Lundgren and associates,20 McKeigue and 
associates,19 and Okosun17 also employed waist-to-hip measure as the indicator for 
abdominal obesity in their studies. 
The use of waist-to-hip ratio in this current study was appropriate for 
examining the relationship between this factor and the outcome, type 2 diabetes.  The 
sample as a whole had abdominal obesity.  The mean waist-to-hip ratio for the sample 
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(n=281) was 0.80, the cut-point for abdominal obesity.  The population examined by 
this study was similar to the population examined by Okosun. 
Obesity in African-American Women 
The high prevalence of obesity among participants of the current study 
parallels that of African-American women who participated in national studies, such 
as that of Okosun,17 where NHANES III data were utilized.  Most participants in the 
current study presented as overweight or obese despite efforts to include more 
normal-weight individuals through a comprehensive recruitment campaign.  The 
mean body mass index for women in the current study was 34 (SD=9.3, n=281).  This 
was above 30, the cut-point to indicate obesity.  For abdominal obesity, indicated by a 
waist-to-hip ratio of 0.80 or greater, the sample of 281 participants (50%) had 
abdominal obesity (waist-to-hip ratio>0.80).  Despite the fact that the study sample as 
a whole was obese, the current study was able to reveal the association of abdominal 
obesity with type 2 diabetes. 
Abdominal obesity has been defined in several ways in the literature.  In the 
current study, three versions of waist measurements were collected on either all or a 
fraction of the study participants.  First, waist at the smallest diameter was obtained 
for each participant.  Secondly, waist measured one inch above the umbilicus was 
collected, but not on the first 38 participants.  Finally, in this study, waist was 
measured at the midpoint between the lower rib and the iliac crest for only a small 
number of participants in the pilot study and in the full study.  The lower rib-iliac 
crest method was used by NHANES to measure waist circumference.34 This 
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NHANES method proved to be impractical for the current study because of its 
invasiveness.  Therefore, it was not continued for the remainder of the study. 
The smallest diameter at waist was used in the current study because based on 
the standard method proposed by Lohman117 and on findings from the pilot study, it 
appeared to be the most feasible method for a community-based study.  Waist 
measured one inch above the umbilicus was collected on the majority of study 
participants to address the concerns of participants about the actual location of their 
waist and to compare this measure with the study’s originally proposed waist 
circumference measure.  There was a strong correlation (r =.96) between waist at the 
smallest diameter and waist one inch above the umbilicus.  Therefore, it is apparent 
that for African-American women, comparisions of the results between studies that 
measured waist at the smallest diameter and those that measured waist one inch above 
the umbilicus can be made. 
Birth Weight, Abdominal Obesity, and Type 2 Diabetes 
The third hypothesis of this study stated that birth weight and abdominal 
obesity interact in their association with type 2 diabetes in African-American women 
38 to 57 years of age.  Though the current study was not able to support this 
hypothesis for the full spectrum of birth weights, when restricting the analyses to 
women who were born low birth weight, cases were more likely than controls to have 
developed type 2 diabetes.  Thus, for the current study’s participants who were born 
low birth weight, the fetal origins of chronic diseases hypothesis as first proposed by 
Barker75 was supported.  In other words, for those who were born low birth weight 
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and who subsequently developed abdominal obesity, the odds increased for the 
development of type 2 diabetes. 
The findings of this study are important to health care providers and 
policymakers.  Given the high risk for African-American women to develop type 2 
diabetes and to be overweight or obese, it is imperative that factors that have been 
shown to be related to this disease be addressed.  Not only should low birth weight 
and abdominal obesity be targeted independently, but as this study has shown, the 
interaction of these two factors must be considered when planning how to make the 
most of limited resources.  Therefore, women who were born low birth weight should 
be especially cautioned to avoid developing abdominal obesity.  Though this study 
could not address any cause-and-effect issues for the development of type 2 diabetes, 
it does provide insight into how body measurements at birth and later in life might be 
associated with this devastating disease. 
Birth Weight, Abdominal Obesity, and Fasting Plasma Glucose 
The fourth and final hypothesis of the current study stated that among 
African-American women who were without a physician diagnosis of type 2 diabetes 
and with fasting plasma glucose levels <126 mg/dL (controls, n=181), there is an 
association among birth weight, abdominal obesity, and fasting glucose level.  This 
study found that 16% of the variation in fasting plasma glucose between cases and 
controls was attributable to the multiple linear regression model that included birth 
weight and abdominal obesity (R2=.16, p=.0002).  However, neither birth weight nor 
abdominal obesity contributed independently to the multiple linear regression model 
that explained the variation in fasting plasma glucose levels.  This model also 
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included weight at 25 years of age, body mass index, family history of diabetes, age, 
premenopausal status, and strenuous physical activity. 
Though birth weight was not found to be an independent explanatory variable 
for fasting plasma glucose in the current study, other studies involving various 
populations have shown birth weight to be an explanatory variable for glucose 
intolerance or insulin resistance.13,18,19,66  A study by Phipps and associates13 revealed 
the association between impaired glucose tolerance in adult life and low birth weight 
in men and women born in the United Kingdom.  Birth weights were obtained from 
hospital records.  Among women, those who were born weighing less than 2.50 kg 
(<5.5 pounds) were more likely (OR=12.1, 95% CI=2.0, 73) to have impaired glucose 
tolerance compared to those who were born >3.41 kg (reference group).  The 
increased risk for women who were born 2.50 to 2.95 kg was about half that for 
women who were born low birth weight, (OR=6.2, 95% CI=1.1, 35), while those who 
were born between 2.95 and 3.41 kg were not significantly different from the 
reference group in terms of risk for impaired glucose tolerance.  (The χ2 value for 
trend among all the birth weight categories was 9.9, p=.002.) 
In contrast to the Phipps and associates13 study, the current study did not 
measure glucose intolerance, but used fasting plasma glucose levels as an outcome 
variable to test this hypothesis.  Perhaps because of a difference in methodology and 
in sample size, this current study could not confirm that low birth weight 
independently explained plasma glucose levels in controls. 
These findings suggest that although birth weight and abdominal obesity 
combined did not reveal an independent association with type 2 diabetes in this study, 
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these two factors contributed to a model that explained 16% of the difference in 
fasting plasma glucose between women with type 2diabetes and those without 
diabetes.  It is suggested that African-American women 38 to 57 years of age have 
regular fasting plasma glucose tests given their elevated risk for developing diabetes.  
In addition, higher fasting glucose levels increase one’s risk for developing type 2 
diabetes.  Added to their increased risk for being born low birth weight and for having 
abdominal obesity, health care providers must aggressively screen for elevated 
plasma glucose in this population. 
Undiagnosed Diabetes 
The Centers for Disease Control and Prevention reported that in 2000, for the 
general U.S. population, one out of every three persons with diabetes was 
undiagnosed.44  Through measurements obtained from blood glucose screening, the 
current study, as did NHANES III,34 uncovered cases of undiagnosed diabetes among 
the study participants.  In NHANES III, the category of undiagnosed diabetes was 
comprised of people who initially presented as having no physician diagnosis of 
diabetes but who subsequently were found to have diabetes through a blood glucose 
test. 
In the current study, two women who were diagnosed and treated for type 2 
diabetes soon after enrollment were categorized as cases and retained in the study.  
This is an important, though indirect, consequence of the study.  Two women who 
otherwise would have continued living with diabetes without treatment were 
identified.  Making an immediate difference to the lives of individual study 
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participants is one of the ways that community-based research studies can make 
positive contributions to society. 
Blood Pressure in African-American Women 
Though measured systolic blood pressure levels were significantly different 
between cases and controls in the current study, the means for both groups fell below 
the cut-point (140 mm Hg0 used to identify those with hypertension.  This cut-point 
was established by the National High Blood Pressure Education Program Work 
Group119 to denote Stage I hypertension.  The mean systolic blood pressure for 
women 38 to 57 years in this study was 128 mm Hg, (SD=17.1) with the mean for 
cases at 133 mm Hg (SD=17.5) and the mean for controls at 126 mm Hg (SD=16.3).  
A study by Brown and his colleagues,130 based on NHANES data, showed similarly 
low mean systolic blood pressure readings (121 mm Hg, SE=0.49) for a national 
sample of African-American women 40 to 59 years of age.  For women with 
BMI>30, as is true for the current study’s sample, Brown130 and associates found that 
mean systolic blood pressure was 129 mm Hg, SE=0.75.  This suggests that the 
current study’s sample of African-American women, on average, had better systolic 
blood pressure control than a national sample of women of various races and 
ethnicities. 
This study revealed that among a highly-educated group of African-American 
women, blood pressure was well controlled.  This may be an indication of their 
understanding of the importance of controlling blood pressure.  On the other hand, it 
could be an indication that most of the women in the study had adequate health 
insurance so that any problems with blood pressure could be identified and corrected 
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in a timely manner.  Had the sample contained more women who were less educated 
and who were poor, the blood pressure findings might have been different. 
This study also found that although this sample of African-American women 
was highly educated, on average, the women were obese in terms of waist-to-hip ratio 
and body mass index.  In contrast to adhering to medication regimens as prescribed 
by health care providers, lifestyle changes, such as reducing caloric intake and 
increasing physical activity, are more difficult.  Perhaps this is why there were not 
more normal weight women in the study, something one might expect in a hightly 
educated sample. 
This community-based study was able to support the message of controlling 
blood pressure by providing each participant with the results of her blood pressure 
measurements.  In addition, each woman received information on how to reduce her 
risk for developing high blood pressure and/or how to improve control of her high 
blood pressure if she already had a physician diagnosis of this condition. 
Limitations 
As with any study some limitations exist with the current study.  Most 
important, the investigator was unable to obtain vital records data for the entire 
sample.  Information based on vital records is more accurate than self-reported 
accounts of retrospective events.  Nonetheless, with considerable effort researchers 
can rely on respondents to provide reliable information on their background.  In the 
current study, respondents verified their information with their parents and family 
documents to increase data accuracy.  Many studies like that of Rich-Edwards and 
associates33 utilized data from the Nurses’ Health Study and, thus, also relied on self-
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reported birth weights.  These studies help to support the claim of the current study’s 
investigator that this approach is viable if not 100% reliable.  Because national studies 
often involve thousands and tens of thousands of participants, obtaining self-reported 
data is the the most feasible way to collect information.  In the present study which 
involved a few hundred participants, it was possible to obtain vital records 
information for 63 (22%) of the participants and to collect verified self-report for the 
remainder. 
Another limitation was that although the current study supported the 
hypothesis that abdominal obesity in the presence of low birth weight (n=43) may 
increase the odds for the development of type 2 diabetes, no causation could be 
determined given that this was a retrospective case-control study.  In addition, since 
the current study involved convenience sampling, birth weights may not have been 
distributed similarly to birth weights for the population of U.S.-born African-
American women who were 38 to 57 years of age.  The rate of low birth-weight 
births among a national sample of non-white births ranged between 10.1% and 14.4% 
from 1950 to 1969, the years in which the participants were born.  In contrast, the rate 
of low birth-weight births for whites ranged from 6.4% to 7.1%.  (See Table M1.131)  
For this study, a higher percentage (15.3%, n=281) of the sample compared to whites 
was born low birth weight, although the percentage is similar to the national rates 
found among non-whites. 
It is also likely the study sample was biased given the high level of 
educational attainment of participants (54% had obtained a bachelor’s degree or 
higher) and the region where the women were born (mainly in the South).  The results 
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of the current study cannot be generalized for several reasons, including to women 
living and working outside of the region or to women with a lower educational level.  
In addition, the reader is reminded that the results of the current study cannot be 
generalized to men or to non-African Americans.  Finally, given that birth weight 
data could not be verified for each of the 368 women who initially were eligible to 
participate in the current study, the sample size was reduced by 84 participants, 
leaving a final sample of 281 women.  This resulted in a smaller power than initially 
intended for the study.  Despite the reduced sample size, relationships among birth 
weight, abdominal obesity, and type 2 diabetes were still observed for specific 
subgroups. 
Strengths 
The current study has several strengths.  It was designed to measure the 
relationship between birth weight and abdominal obesity and type 2 diabetes in a 
sample comprised exclusively of African-American women, a population at high risk 
for this disease.  In addition to controlling for race and gender, the current study 
examined an age range of approximately 20 years.  Self-reported body measurements 
were not used in the current study; instead, all body measurements were uniformly 
measured by one observer.  This eliminated inter-observer variation and the use of 
self reported data for these measures.  Again, although vital records birth data were 
not obtained for all participants, vital records birth weights were obtained for nearly 
one quarter of respondents (22%). 
Other strengths of this study were that the instruments and procedures were 
pilot-tested to allow for an efficient and accurate method of collecting data.  In 
  118
addition, having an investigator who was of the same race and ethnicity as the 
participants may have positively impacted recruitment efforts.  The investigator was a 
Registered Dietitian with over 20 years experience working in community and public 
health settings, providing participants with a benefit that may not have been realized 
for similar studies.  This benefit was that each participant received an individualized 
nutrition consult that was based on her diabetes status, her blood pressure, and her 
weight.  The nutrition consult also increased word-of-mouth referral to the study.  
Future studies similar to the current study should consider a service component to 
help increase word-of-mouth referral and to guide participants to take charge of their 
health. 
Future Recommendations 
Investigators of future studies should note that obtaining birth records 
information from State Centers for Health Statistics and from vital records offices 
should prove to be less difficult for individuals born beginning in the 1990s when 
birth weights were recorded on the face of birth certificates in all states and not 
relegated to the reverse side of the certificate or to supplemental files that might have 
been destroyed within one to 10 years, on average.  (This information was gathered 
from private conversations with officials from several vital records offices.)  In 
addition, electronic storage of birth weights and other birth data will make the 
retrieval of birth data less costly and more rapid.129 Collecting official birth weights 
involves many steps, including for many states, application for IRB approval.  Future 
researchers should build in a lag time of six to nine months to obtain available birth 
weights for the majority of their study participants. 
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Future studies that have greater access to vital records birth weights will be 
better able to address the contribution that birth weight has for examining the 
associations of type 2 diabetes in African-American women.  Despite the limitation of 
collecting vital records birth weights for the majority of participants, the current study 
suggests that for those who are born low birth weight, extra vigilance should be taken 
to help prevent the development of abdominal obesity later in life. 
In addition, the problem of the elevated risk for low birth weight faced by 
African Americans must be addressed.  African Americans are more likely than 
European Americans to be born low birth weight.44  This study was not able to 
unambiguously uncover the relationship between type 2 diabetes and low birth 
weight.  However, based on the literature and results from a subsample of participants 
in the current study, if African-American women who were born low birth weight can 
avoid developing abdominal obesity later in life, perhaps they might reduce their risk 
for developing type 2 diabetes.  Stevens26 and Railey27 also found that it is important 
to prevent abdominal obesity in African-American women to reduce their risk for 
developing type 2 diabetes.  However, their studies did not examine the fetal origins 
of chronic disease as this current study did. 
The importance of finding an increased odds for type 2 diabetes among 
women who were born low birth weight and who subsequently developed abdominal 
obesity cannot be understated, especially given that the risk for being born low birth 
weight is elevated for African Americans.  Among women who were born low birth 
weight (n=43) in this study the odds of having abdominal obesity was 1.13 times 
more likely than for those without type 2 diabetes.  Another approach would be to 
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identify those women who were born low birth weight and to utilize intensive 
prevention and intervention strategies to combat the development of abdominal 
obesity in this high-risk population of women. 
Conclusions 
The current study is the first to test the fetal origins of chronic disease in 
African-American women.  When focusing only on those women who were born low 
birth weight, the results show that those with a self-reported physician diagnosis of 
type 2 diabetes had a larger mean waist-to-hip ratio than those without a self-reported 
physician diagnosis of type 2 diabetes.  Data collected from this study support earlier 
studies that showed how abdominal obesity, as indicated by waist-to-hip ratio, is 
associated with type 2 diabetes in African-American women.  The current study did 
not validate the role of birth weight in type 2 diabetes for African-American women 
when looking at a wide spectrum of birth weights (n=281).  This lack of a positive 
finding does not mean, however, that no difference in birth weight exists between 
African-American women with and those without a self-reported physician diagnosis 
of type 2 diabetes.  A reduction in the size of the sample due to challenges with 
obtaining vital records or verified self-reported birth weights for 85 of the original 
enrollees (n=376) may have obscured relationships between birth weight and type 2 
diabetes.  Continued efforts will be made to obtain birth weights for participants born 
in the state with the largest number of study participants.  In fact, as of March 2007, 
this state is attempting to extract birth weights for participants from a national 
database. 
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The current study demonstrated that it is difficult, though not impossible, to 
conduct investigations that involve matching data from birth records of individuals 
born throughout the United States in the 1940s, 1950s, and 1960s, with objective and 
subjective data collected directly from individuals who are now in their middle adult 
years.  When studies are restricted to a single state, the percent of women for whom 
vital records birth weights are obtained may be significantly higher than for this 
current study. 
In sum, this study demonstrated that community-based research can contribute 
not only to the body of literature on the specific questions addressed in this study, but 
that they can work to improve knowledge and change health behaviors in participants 
and their families.  Finally, it was consistent with studies that addressed the fetal 
origins of chronic disease: those who were born small and became overweight or 
obese in adulthood had greater odds for having type 2 diabetes than those who were 
not born small. 
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Appendices 
The appendices contain information supplemental to the full study. 
 
Appendix A. Screening Questionnaire 
Appendix B. Study Questionnaire 
Appendix C. Variable List and Codebook 
Appendix D. Selected Recruitment Materials and Resources 
Appendix E. Informed Consent Forms and IRB Approval Memorandum 
Appendix F. Sample Size Estimation 
Appendix G. Study Equipment 
Appendix H. Focus Groups: Findings and Forms 
Appendix I. Forms: Measurements, Vital Records, Personal Measurements 
Appendix J. Data Protection Protocol 
Appendix K. Pilot Study Descriptive Tables 
Appendix L Vital Records Obtained, by State 
Appendix M Vital Statistics: National and District of Columbia 
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Appendix A. Study Questionnaire 
 
 




Study Title:  Birthweight and Current Weight Status in African American Women and Their 






Thank you for your interest in helping us to learn more about health issues in African American 
women.  Please answer each question on pages 2 to 6 as completely as you can. Let us know if  
any question is unclear. 
 
Confidentiality:  The information you provide is confidential.  Your name will not be revealed at  
any time.  Your information will be grouped with the information of others for any reports.   
Your information will be stored in a locked drawer in the Nutrition Department of the University  
of Maryland.  Only the researcher will be able to open this locked drawer. 
 
 
For more information or for a copy of the study report,  
please contact: 
Michelle Harris, MS, RD, MPH 
Nutrition Program, University of Maryland 
Room 0112 Skinner Hall 
College Park, MD  20742 
Phone: 202-291-1798 / E-mail:bharris2@umd.edu 
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Birth Information 
 
We need the information listed below so we can get your birth records from the Vital Records Office 
of the state where you were born.  For example, we need official information on your birth weight, 
whether you were born before your due date, whether you were a twin, and whether your mother had 
diabetes when she was pregnant with you.  The study needs to collect official birth information to 
assure that birth data are collected for all participants in the same way.  Your information will be used 
for this research project, only. 
 
Please answer as many items as you can.  Please print your answers. 
 
 
1. What is your date of birth?     
          (Month)   (Day)     (Year) 
 91  
      For example, a person born on  
      May 16, 1949 would write: 
                   (Month)   (Day)     (Year) 
1 6 1
2. What is your current name?  ___________________________________________________________ 
First Name(s) Middle Name(s)  Last Name(s) 
 
3. What is the name on your birth certificate?  _______________________________________________ 
First Name(s) Middle Name(s)  Last Name(s) 
 
4. What is your birth mother’s name?  _____________________________________________________ 
First Name(s) Middle Name(s)  Last Name(s) 
 
5. What was your birth mother’s maiden name?  _____________________________________________ 
First Name(s) Middle Name(s)  Last Name(s) 
6. In what state/country was your mother born?  _____________________  /  ______________________ 
 
7. What is your birth father’s name?  ______________________________________________________ 
First Name(s) Middle Name(s)  Last Name(s) 
 
8. In what state were you born?  _______________________________________________________________ 
        If you were born in the District of Columbia, please write “DC” or “District of Columbia” 
 
9. In what county, borough, or parish were you born?  ______________________________________________ 
        If you were born in the District of Columbia, please write “DC” or “District of Columbia” 
 
 
10. In what city or town were you born?   ____________________________________________________ 
      If you were born in the District of Columbia, please write, “Washington” 
 
11. In what hospital were you born?   _______________________________________________________ 
 
If you were not born in a hospital, where were you delivered?  _______________________________  










   
   
  
 
















0 5 9 4 9 
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Personal Health History 
 
Do you now have any of the conditions listed in questions 1-5?  Please circle your response.  Circle  
“Not sure” if you are not sure of your answer or if you do not know the answer. 
 
1. High blood pressure (hypertension)             Yes          No       Not sure 
 
2. High blood cholesterol (hypercholesterolemia)         Yes        No       Not sure 
 
3. High blood lipids (hyperlipidemia,           Yes         No        Not sure 
    high blood fat, high blood triglycerides) 
 
4. Heart disease               Yes         No       Not sure 
 
5. Type 2 diabetes (“adult-onset diabetes” or     Yes          No        Not sure 
   “non-insulin-dependent diabetes”) 
 
If you have type 2 diabetes, please continue.  If you do not have type 2 diabetes, please skip to  
question 15. 
 
6. What year did you first learn you had type 2 diabetes? 19 ___  ___  or  20 ___  ___. 
7. What was your age when you first learned you had type 2 diabetes? __________  years. 
8. What was your weight status when you first learned you had type 2 diabetes?  Please circle your 
    answer. 
 
Underweight Normal Weight Overweight Not sure 
1 3 5 9 
 
 
What do you currently use to control your diabetes?  Please circle your answer(s). Circle all that apply. 
9. Oral diabetes medications  (hypoglycemic agents, pills)      Yes          No        Not sure 
10. Insulin (shots)                      Yes          No        Not sure 
11. Diet change/Diet Plan              Yes           No        Not sure 
12. Exercise                 Yes           No        Not sure 
13. Lose weight                Yes           No        Not sure 
14. Other (please write in): _____________________________________________________ 
 
15. Did you ever have gestational diabetes?         Yes     No        Not sure  N/A 
   (diabetes while you were pregnant) 
16. Did you ever have a baby who weighed         Yes     No         Not sure  N/A 
   over 9 pounds at birth? 
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17. About how much did you weigh when you were 25 years of age?  ______________  pounds 
18. Have you lost weight within the last 6 months?              Yes         No      Not sure 
19. Were you trying to lose weight within the last 6 months?                Yes         No          Not sure 
20. How much weight did you lose within the last 6 months?    ______________  pounds 
21. Have you gained weight within the last 6 months?                         Yes         No           Not sure 
22. Were you trying to gain weight within the last 6 months?                 Yes         No         Not sure 
23. How much weight did you gain within the last 6 months?    ______________  pounds 
 
24. Are you going through menopause now? (“the change”)            Yes         No          Not sure 
25. Have you gone through menopause?                 Yes         No          Not sure 
26. Have you had a hysterectomy? (your uterus removed               Yes         No           Not sure 
              or both of your ovaries removed) 
27. Did you have at least one period (menstrual cycle)                        Yes        No        Not sure 
   within the past 12 months? 
28. Are you on hormone replacement therapy (HRT)?                              Yes         No         Not sure 
 
29. Were you breastfed when you were an infant or child                           Yes         No           Not sure 
30. For how long were you breastfed when you were an infant or child?  (Please circle your answer  
   below.) 
 



















Please go to the next section on the next page (page 5) when you are finished with this page. 
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Family Diabetes History 
 
The questions on this page ask about diabetes in your family.  Please include information only about  
the family members related to you by blood. 
 
Please write the correct number on the line beside each question.  Circle “don’t know” if you do 
not know the number of brothers and sisters or children or grandchildren who have diabetes. 
 
1. How many brothers do/did you have?    ____________ Don’t know 
2. How many of your brothers have/had diabetes?  ____________ Don’t know N/A 
3. How many sisters do/did you have?     ____________ Don’t know 
4. How many of your sisters have/had diabetes?   ____________ Don’t know N/A 
5. How many children do/did you have?    ____________ 
6. How many of your children have/had diabetes?  ____________ Don’t know N/A 
7. How many grandchildren do/did you have?   ____________ Don’t know N/A 
8. How many of your grandchildren have/had diabetes? ____________ Don’t know N/A 
Please circle Yes, No, or Don’t Know to the following questions. 
9. Does/did your mother have diabetes?     Yes       No      Don’t know  
10. Does/did your father have diabetes?      Yes       No      Don’t know  
11. Does/did your mother’s mother have diabetes?   Yes      No      Don’t know  
12. Does/did your mother’s father have diabetes?   Yes       No      Don’t know  
13. Does/did your father’s mother have diabetes?   Yes       No      Don’t know  
14. Does/did your father’s father have diabetes?    Yes       No      Don’t know  
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Personal Lifestyle 
1. Thinking about the things you do at work, how would you rate yourself as to the amount of physical  












5 4 3 2 1 8 
2. Now, thinking about the things you do outside of work (such as household chores, child care, family  
              care, volunteer, church activities, etc.), how would you rate yourself as to the amount of physical  











5 4 3 2 1 
 
Please circle your answer to the following questions. 
3. Do you regularly engage in strenuous activity or hard physical labor or exercise where you sweat  
             or your heart beats faster? 
Yes  (If “yes,” answer question #4 below.) 
No  (If “no,” skip to question #5.) 
4. Do you engage in strenuous activity or hard physical labor or exercise at least 3 times a week? 
Yes 
No 
5. Have you ever smoked cigarettes?           Yes   No 
6. Have you smoked more than 100 cigarettes in your lifetime?    Yes   No 
7. Do you smoke cigarettes now?            Yes   No 
8. Have you ever drunk alcohol? (Alcohol includes       Yes   No 
             beer, malt liquor, wine, wine spritzers, gin, vodka, bourbon, whiskey, 
             mixed drinks, etc.) 
9. In the last 7 days, did you drink any alcohol?        Yes   No 
10. In the last 8 to 30 days, did you drink any alcohol?       Yes   No 
11. In the last 31 to 90 days (3 months), did you drink any alcohol?    Yes   No 
12. What is the highest grade or year of school you completed? (Please circle only one item.) 
 08. Grades 1 through 8 (elementary) 15. Associate degree 
 11. Grades 9 through 11 (some high school) 16. Bachelor degree 
 12. Grade 12 or GED 
       (high school diploma or equivalency) 
18. Graduate degree or advanced professional degree 
      (Master, Ph.D., M.D., J.D., etc.) 
 13. Technical, vocational, or trade school degree 
       beyond high school 
99. Not sure 
 14. Attended college, but did not graduate  
For staff only:  Date questionnaire collected:  ___ ___/___ ___/20 ___ ___ Who completed questionnaire?  1    2    3    4    5    7 














For more information or for a copy of the study report,  
please contact: 
Michelle Harris, MS, RD, MPH 
Nutrition Program, University of Maryland 
Room 0112 Skinner Hall 
College Park, MD  20742 
Phone: 202-291-1798 / E-mail: bharris2@umd.edu 
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Appendix B. Screening Questionnaire 
Screener Questionnaire
 
Study Title:  Birthweight and Current Weight Status in African American Women and Their 
Relationship to Type 2 Diabetes 
 
 
Thank you for your interest in helping us learn more about how birthweight and current weight relate 
to type 2 diabetes and other conditions.  Please circle your answer to each question below. 
 
 
1. Are you Black American/African American?       Yes          No          Not sure 
2. Were you born in the United States?        Yes          No          Not sure 
3. Are you between the ages of 40 and 55 years?       Yes          No          Not sure 
4. Are you pregnant now?         Yes          No          Not sure 
5. Were you pregnant any time in the last 12 months?      Yes          No          Not sure 
6. Do you have type 1 diabetes?  (also called       Yes          No          Not sure 
“juvenile-onset diabetes”or “insulin-dependent diabetes”) 
7. Do you have type 2 diabetes? (also called “adult-onset      Yes          No          Not sure 
diabetes” or “non-insulin-dependent” diabetes) 
Have you had any of the conditions listed below within the past 6 months? 
8. Cancer           Yes          No          Not sure 
9. Liver disease           Yes          No          Not sure 
10. Kidney (renal) disease         Yes          No          Not sure 
11. Heart attack (myocardial infarction)        Yes          No          Not sure 
12. Stroke           Yes          No          Not sure 
13. Hepatitis (hepatitis B, hepatitis C)        Yes          No          Not sure 
14. HIV infection or AIDS         Yes          No          Not sure 
15. Please list the medicines you take:        _____________________________ 
_______________________________________________________________________________
______________________________________________________________________________ 
First name:   _______________________________________________________________________ 
Please give us a way to contact you: 
______________________________________________________________________________ ____ 
To return this form and for more information, please contact: 
Michelle Harris, MS, RD, MPH 
Nutrition Program, University of Maryland 
Room 0112 Skinner Hall 
College Park, MD  20742 
Phone: 202-291-1798 / E-mail: bharris2@umd.edu 
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Questionnaire Design Issues 
To reduce respondent burden, questionnaire items were assessed as to whether 
they explicitly addressed the research hypotheses.  Questions irrelevant to addressing 
the research questions were not included.  A self-administered questionnaire was 
selected because the relatively large proposed sample size (n= 540) prohibited the use 
of interviewers for the study.  It was anticipated that the majority of participants for 
the study would be able to read and write in English.  This proved to be true for the 
sample.  Several participants noted that the questionnaire was one of the most 
straightforward that they ever had completed for a study.  After the questionnaire was 
validated, it seemed that for most items, participants did not face ambiguity.  For 
future studies, the following items should be scrutinized and, perhaps, rewritten or 
eliminated. 
For participants with type 2 diabetes, it must be made clear whether the treatment 
regimens they follow are what their health care provider prescribed, what they 
actually practiced, or both.  The question on high lipid levels was not understood by 
many participants.  Most of those who were familiar with the term were not aware of 
their lipid status. 
Two of the items concerning menopause were difficult for participants to answer.  
The questionnaire item asking them whether they had a period within the last 12 
months would be sufficient to estimate the menopausal status of participants without 
subjecting them to the stress of not knowing how to answer the other two questions 
on menopause. 
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Breastfeeding has been shown to reduce the risk of type 2 diabetes and other 
chronic diseases later in life.132  Many of the study participants did not know whether 
or not they were breastfed as infants.  It was discovered that some women who 
thought that they had not been breastfed were actually breastfed when they later 
conferred with their mother, father, or some other relative.  Therefore, the prevalence 
of history of being breastfed was most likely underestimated for this sample. 
For family history of diabetes, several participants did not know whether their 
first-order relatives had diabetes.  A participant who was subsequently diagnosed with 
type 2 diabetes was not aware that her sister had been living with diabetes for 20 
years.  She discovered her sister’s long-term status of having diabetes after her own 
diagnosis.  The investigator concluded that family history of diabetes may be 
underestimated for this sample given the large number of family history questionnaire 
items that were answered with “Don’t know.” 
The questions on alcohol consumption proved not to be helpful for the current 
study.  Women who drank only once or twice per year could not be distinguished 
from women who drank more regularly based on the questionnaire items, especially 
given that information on quantities of alcohol consumed was not collected.  A desire 
to obtain a more thorough instrument for collecting alcohol must be balanced by the 
need to keep the instrument short and as non-invasive as possible so that participant 
burden will be kept low. 
The item on education captured women who had attended college for at least one 
semester.  Feedback on this questionnaire item from participants from all stages of the 
study (focus groups, pilot study, and full study) was positive.  The general consensus 
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was that asking whether they had attended, but had not graduated, college validated 
the contribution that African-American women who are in their forties and fifties had 
made towards the increased number of educational opportunities that younger 
minority women have.  However, the questionnaire item on education could have 
been improved by asking those who did not complete college the actual number of 
years they had completed. 
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Appendix C. Variable List and Data Dictionary (Codebook) 
 
Questionnaire and Data Collection items were collected by one investigator 
between July 2004 and January 2006.  Vital Records and State Centers for Health 
Statistics data were collected between March 2006 and June 2006.  The questionnaire was 
totally self-administered for the majority of the participants.  Only 14 of 377 participants 
received partial or total assistance with completing the questionnaire.  The reasons for this 
assistance included low literacy levels, poor eyesight, or participant request.  Data were 
entered into three text files and were analyzed using SAS version 8.2. 
Participants were African American women 38-57 years of age recruited from the 
Washington, D.C., Metropolitan Area.  Very few participants fell outside of this age range.  
Participants self-declared their race as Black American or African American.  Participants 
were born in the United States, with the exception of one participant who was born on a 
U.S. Air Force base.  Enrollment sites included faith-based organizations (churches, a 
mosque, a Black Hebrew temple/health cooperative); a health food complex, public and 
parochial schools, worksites, homes, clinics, a beauty shop, and the University lab.
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Data from Questionnaire 
 
Column Variable Name Description Category 
1-3 
3 columns 
ID Participant Identification Number 
Located at top of each page. 
N/A 




HBP High blood pressure (hypertension) 








HICHOL High blood cholesterol 
(hypercholesterolemia)? 








HILIP High blood lipids (hyperlipidemia, high blood 
fat, high blood triglyceride)? 








HEARTDX Heart disease? 








T2DM Type 2 diabetes (adult-onset diabetes or non-
insulin-dependent diabetes)? 








YRDIAGN Year learned had diabetes. 
Should be 19XX or 20XX, only. 
“Not applicable” only if participant reported 
does not have diabetes. 
Questionnaire, Page 3, Q6. 
N/A 
YYYY 








AGEDIAGN Age learned had diabetes. 
“Not applicable” only if participant reported 
does not have diabetes. 
Questionnaire, Page 3, Q7. 
N/A 








WTDIAG Weight status when learned had diabetes. 
“Not applicable only if participant reported 
does not have diabetes. 










ORALMEDS Controlling diabetes by oral diabetes 
medications (hypoglycemic agents)? 
“Not applicable only if participant reported 
does not have diabetes. 








Column Variable Name Description Category 
17 
1 column 
INSULIN Controlling diabetes by insulin? 
“Not applicable” only if participant reported 
does not have diabetes. 









DIET Controlling diabetes by diet? 
“Not applicable” only if participant reported 
does not have diabetes. 









EXERCISE Controlling diabetes by exercise? 
“Not applicable” only if participant reported 
does not have diabetes. 









LOSEWT Controlling diabetes through weight loss? 
“Not applicable” only if participant reported 
does not have diabetes. 









OTHERTRX Other treatment(s) for diabetes? 
“Not applicable” only if participant reported 
does not have diabetes. 
Write in Other: ____________________ 









GESTDM Ever have gestational diabetes (diabetes while 
pregnant)? 
“Not applicable” only if participant never 
pregnant. 









BIGBABY Ever have baby who weighed over 9 pounds at 
birth? 
“Not applicable” only if participant never 
pregnant. 









WT25 Weight at 25 years of age.  If participant 
indicates a range, take midpoint (average) age. 
To nearest 0.5 pound. 
Example: “133.5” pounds 
Questionnaire, Page 4, Q17. 
N/A 
Continuous var: use 4 
digits.  Place decimal 
point in fourth column. 
If range is given, use 
midpoint value 








WTLOSS Weight loss within last 6 months? 








Column Variable Name Description Category 
30 
1 column 
TRYLOSE Trying to lose weight within last 6 months? 








LOSTAMT How much weight lost within last 6 months? 
If participant not sure of weight loss for Q18, 
fill in “not sure” for pounds lost for Q20.  If a 
range is given, take midpoint.  Round to 
nearest whole lb., up to 99 lbs. 
Example: “42” pounds. 
Questionnaire, Page 4, Q20. 
N/A 
Continuous var: use 2 
digits. 
No decimal. 
If range is given, use 
midpoint value 








WTGAIN Weight gain within last 6 months? 








TRYGAIN Trying to gain weight within last 6 months? 








GAINAMT How much weight gained within last 6 
months? 
If participant not sure of weight gain for Q21, 
fill in “not sure” for pounds gained for Q23.  If 
a range is given, take midpoint.  Round to 
nearest whole lb., up to 99 lbs.  Example: “19” 
pounds. 
Questionnaire, Page 4, Q23. 
N/A 
Continuous var: use 2 
digits. 
No decimal. 
If range is given, use 
midpoint value 









MNPASNOW Going through menopause now? 
(For some analyses, will have to combine Q24, 
25 and 26.) 








MENOPAUS Gone through menopause (the change)? 
(For some analyses, will have to combine Q24, 
25 and 26.) 








HYSTEREC Had a hysterectomy (uterus removed)? 
For some analyses, will have to combine Q24, 
25 and 26.) 








PERIOD At least one period (menstrual cycle) within 
past 12 months? 
(This is the main question that will be used to 
define menopause.) 







Column Variable Name Description Category 
41 
1 column 
HRT On Hormone Replacement Therapy? 








BREASTFD Ever breastfed? 








MONTHSBF How long breastfed? 













BROTHERS How many brothers do/did participate have? 
Example: “12” brothers 
Questionnaire, Page 5, Q1. 
N/A 







BRODM How many brothers of participant have/had 
diabetes? 
Example: “12” brothers 
Questionnaire, Page 5, Q2. 
N/A 








SISTERS How many sisters do/did participate have? 
Example: “12” sisters 
Questionnaire, Page 5, Q3. 
N/A 







SISDM How many sisters of participant have/had 
diabetes? 
Example: “12” sisters 
Questionnaire, Page 5, Q4. 
N/A 








CHILDREN How many children does/did participate have? 
Example: “12” children 
Questionnaire, Page 5, Q5. 
N/A 







CHILDDM How many children of participant have/had 
diabetes? 
Example: “12” children 
Questionnaire, Page 5, Q6. 
N/A 







Column Variable Name Description Category 
57-58 
2 columns 
GRANDS How many grandchildren does/did participant 
have? 
Example: “12” grandchildren 
Questionnaire, Page 5, Q7. 
N/A 








GRANDSDM How many grandchildren of participant 
have/had diabetes? 
Example: “12” grandchildren 
Questionnaire, Page 5, Q8. 
N/A 








MOMDM Does/did mother of participant have diabetes? 








DADDM Does/did father of participant have diabetes? 










Does/did mother’s mother (maternal 
grandmother) of participant have diabetes? 








MOMDADDM Does/did mother’s father (maternal 
grandfather) of participant have diabetes? 








DADMOMDM Does/did father’s mother (paternal 
grandmother) of participant have diabetes? 








DADDADDM Does/did father’s father (paternal grandfather) 
of participant have diabetes? 








PAJOB At work, how participant rates self as to 
amount of physical activity she gets compared 
with other women about her same age? 
“Not applicable” if does not have a job. 
Note: Check data entry carefully since using 
consecutive numbering. 
Questionnaire, Page 6, Q1. 
5=Much more active 
4=Somewhat more 
active 
3=About the same 
2=Somewhat less 
active 






Column Variable Name Description Category 
68 
1 column 
PAOUTJOB Outside work (household chores, child care, 
family care, volunteer, and church activities, 
and so on), how participant rates self as to 
amount of physical activity she gets compared 
with other women about her same age? 
Note: Check data entry carefully since using 
consecutive numbering. 
Questionnaire, Page 6, Q2. 
5=Much more active 
4=Somewhat more 
active 
3=About the same 
2=Somewhat less 
active 






STRENU Engage in strenuous activity or hard physical 
labor where sweat or heart beats faster? 








STRENU3 Exercise or labor at least 3 times a week? 












EVRSMOKE Ever smoked cigarettes? 








SMOKE100 Ever smoke more than 100 cigarettes in 
lifetime? 








SMOKENOW Smoke cigarettes now? 








EVRDRINK Ever drink alcohol? 








DRINK7 In last 7 days, drink alcohol (beer, malt liquor, 
wine, wine spritzer, gin, vodka, bourbon, 
whiskey, mixed drinks, etc.)? 









DRNK8_30 In last 8-30 days, drink alcohol (beer, malt 
liquor, wine, wine spritzer, gin, vodka, 
bourbon, whiskey, mixed drinks, etc.)? 








DRNK31PL In past 31-90 days, drink alcohol (beer, malt 
liquor, wine, wine spritzer, gin, vodka, 
bourbon, whiskey, mixed drinks, etc.)? 







Column Variable Name Description Category 
78-79 
2 columns 
SCHOOL Highest grade or year of school completed? 
Questionnaire, Page 6, Q12. 
08=Grades 1-8 
(elementary) 
11=Grades 9-11 (some 
h.s.) 
12=Grade 12 or GED 
 (h.s. diploma or 
 equivalency) 
13=Technical, trade, or 
 vocational school 
 beyond high 
school. 
14=Attended college, 







 (Master’s, MD, 







DATEQUES Date questionnaire data collected. 





MONTHQUE Month questionnaire collected. 





DAYQUES Day (date) questionnaire collected. 





YEARQUES Year questionnaire collected. 





QUESTCOM Who completed questionnaire? 





help from  study staff 
3=Participant with 
help from  someone 
other than  study staff 
4=Study staff read all 
items to  participant 
5=Someone other than 
study  staff read all 




  Begin new codes at 369  
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Codes for Data Collection Form Data 
 
Column Variable Name Description Category 
89-91 
3 columns 
SBP1 Systolic blood pressure, measure 1 
To nearest mm Hg 
Example: “157/” 
Data Collection Form 
N/A 
Continuous var: use 3 
digits.   
92-94 
3 columns 
DBP1 Diastolic  blood pressure, measure1 
To nearest mm Hg 
Example: “/83” 
Data Collection Form 
N/A 




SBP2 Systolic blood pressure, measure 2 
To nearest mm Hg 
Example: “157/” 
Data Collection Form 
N/A 




DBP2 Diastolic blood pressure, measure 2 
To nearest mm Hg 
Example: “/83” 
Data Collection Form 
N/A 
Continuous var: use 3 
digits.   
101-103 
3 columns 
SBP3 Systolic blood pressure, measure 3 
To nearest mm Hg 
Example: “157/” 
Data Collection Form 
N/A 




DBP3 Diastolic blood pressure, measure 3 
To nearest mm Hg 
Example: “/83” 
Data Collection Form 
N/A 




SBP4 Systolic blood pressure, measure 4 
To nearest mm Hg 
Example: “157/” 
Data Collection Form 
N/A 




DBP4 Diastolic blood pressure, measure 4 
To nearest mm Hg 
Example: “/83” 
Data Collection Form 
N/A 




HT1 Height, measure 1, in centimeters 
To nearest 0.1 centimeter 
Example: “101.34” kg 





HT2 Height, measure 2, in centimeters 
To nearest 0.1 centimeter 
Example: “101.34” kg 





HT3 Height, measure 2, in centimeters 
To nearest 0.1 centimeter 
Example: “101.34” kg 





HT4 Height, measure 2, in centimeters 
To nearest 0.1 centimeter 
Example: “101.34” kg 





WT1 Weight, measure 1, in kilograms 
To nearest 0.01 kg 
Example: “101.34” cm 





WT2 Weight, measure 2, in kilogram 
To nearest 0.01 kg 
Example: “101.34” cm 






WT3 Weight, measure 2, in kilogram 
To nearest 0.01 kg 
Example: “101.34” cm 





WT4 Weight, measure 2, in kilogram 
To nearest 0.01 kg 
Example: “101.34” cm 





TAPE Tape measure 1=Tape measure 1 used 
for all circumference 
measures 
2=Tape measure 2 used 
for all circumference for 
all circumference 
measures 
3=Tape measure 2 used 
for circumference 
measures, then tape 1 
used to duplicate all 
circumference measures 




WAIST1 Waist circumference, smallest circumference, 
measure 1 
To nearest 0.1 cm 
Example: “101.34” cm 





WAIST2 Waist circumference, smallest circumference, 
measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





WAIST3 Waist circumference, smallest circumference, 
measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





WAIST4 Waist circumference, smallest circumference, 
measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTUM1 Waist circumference, one inch above umbilicus, 
measure 1 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTUM2 Waist circumference, one inch above umbilicus, 
measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTUM3 Waist circumference, one inch above umbilicus, 
measure 1 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTUM4 Waist circumference, one inch above umbilicus, 
measure 1 
To nearest 0.1 cm 
Example: “101.34” cm 






WAISTCR1 Waist circumference, midway between iliac 
crest and lower rib, measure 1 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTCR2 Waist circumference, midway between iliac 
crest and lower rib, measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTCR3 Waist circumference, midway between iliac 
crest and lower rib, measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





WAISTCR4 Waist circumference, midway between iliac 
crest and lower rib, measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





HIP1 Hip circumference measure 1 
To nearest 0.1 cm 
Example: “101.34” cm 





HIP2 Hip circumference measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





HIP3 Hip circumference measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





HIP4 Hip circumference measure 2 
To nearest 0.1 cm 
Example: “101.34” cm 





FASTING Anything to eat or drink (except water) within 
last 8 hours? 







AMTFLUID Amount of fluid drunk in last 24 hours (in cups 
or glasses). 
If a range is given, take midpoint.  Round to 
nearest cup.  Do not count drinks that contain 
caffeine (colas, coffee, regular tea.)  Example: 
“28” cups 
Data Collection Form 
N/A 
Continuous var: 2 
digits, no decimal, 
maximum 64 cups 
(which equals 4 
gallons). 
Do not count caffeine-
containing beverages or 
alcohol. 
If range is given, use 
midpoint value rounded 







FPG1 Fasting plasma glucose from glucometer 
reading, in mg/dL, at time of collection of body 
and blood pressure measures. 






DATEFPG1 Date FPG1 collected 
Example:  09/12/2004 
Data Collection Form 
MM 243-244 
2 columns 
MFPG1 Month FPG1 collected 
Data Collection Form 
DD 245-246 
2 columns 
DFPG1 Day (date) FPG1 collected 
Data Collection Form 
YYYY 247-250 
4 columns 
YFPG1 Year FPG1 collected 
Data Collection Form 
251-253 
3 columns 
FPG2 Fasting plasma glucose from glucometer 
reading, in mg/dL, at time of collection of body 
and blood pressure measures. 





DATEFPG2 Date FPG2 collected 
Example:  09/16/2004 






MMFPG2 Month FPG2 collected 






DDFPG2 Day (date) FPG2 collected 






YYFPG2 Year FPG2 collected 






NONFAST Nonfasting plasma glucose form glucometer 
reading in mg/dL.  If had something to eat, will 
still have finger stick blood measured for casual 
plasma glucose, but will be asked to return for 
fasting blood glucose within 7 days. 





DIABETES Classified as having diabetes for this study 
based on FPG levels 
No = FPG <126 mg/dL 
Yes = FPG >126 mg/dl 






VSELFRPT Self-report of physician diagnosis, with 
verification via prescription of insulin and/or 
oral hypoglycemic agent. 








ANEMIA Self-report of iron-deficiency anemia. 








DATEFORM Date data collected for blood pressure, 
anthropometrics, and non-fasting plasma 
glucose (if applicable) 
Page 6, shaded part at bottom of page. 
N/A 
MM/DD/YYYY 




MONTHFRM Month data collection form completed 
DD 270-271 
2 columns 








DAYMEAS Day of week measurement data collected 










SITE Data collection site 

















09=Zion Baptist Church 
10=Mt. Zion 
Pentecostal 
















60=Other, Private home 




















TIMEMEAS Start time (military time) for measurement data 
collection 
05:00 a.m. to 13:59 p.m., only 
Data Collection Form 
N/A 




MEDS Self-reported medications. 
Screener Form 
0=None 
1=Takes meds, but none 
on restricted list 
2=Takes meds on 
restricted list, but 
included in study 
3=Takes meds on 
restricted list; not 
included in main 
analyses. 
4=Takes meds on 
restricted list; totally 
excluded from study. 
X=Not yet coded 
284-289 
6 columns 
MOMCODE State in which mother was born plus mother’s 
first name plus mother’s surname at birth.  
Example:  Mother was born in Washington, 
D.C., and was named Sandra Jones at birth.  
DCSAJO 
Questionnaire, Page 2, Q4 and Q6 





  Begin new codes at 369  
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BWLBS_SR Self-reported birthweight in pounds (to 
nearest quarter pound). 
Example:  “11.25” pounds. 




BWOZS_SR Self-reported birthweight in ounces (to 
nearest quarter ounce, when applicable) 
Example:  “14.25” ounces. 




0.50# = 8 oz; 0.25# 
= 4 oz 
355-359 
5 columns 
BWLB_SR2 Second self-reported birthweight in pounds 
(to nearest quarter pound).  Gathered at least 
2 months after enrollment. 
Example:  “11.25” pounds. 
Self-Reported Birth Data Form. 
If guessing and second report seems vaguer 





BWOZ_SR2 Second self-reported birthweight in ounces 
(to nearest quarter ounce, when applicable).  
Gathered at least 2 months after enrollment. 
Example:  “14.25” ounces. 




0.50# = 8 oz; 0.25# 
= 4 oz 
365 
1 column 
BW_INFO Source of second self-reported birth weight. 
Document could be birth certificate, hospital 
discharge card, or entry in Bible or other 
written record.  If source is document or 
mother, use document code. 
Guess is noted when participant states that 
she is guessing or when she gives a wide 
range (>½ pound). 
0 = Guess 
1 = Document 
2 = Mother 
3 = Father 
4 = Sibling 
5 = Aunt 
6 = Uncle or Other 
Relative 
7 = Missing 
8 = Mother’s 
Friend 
9 = Don’t know 
300-303 
4 columns 
BWGMS_SR Self-reported birthweight in grams (to 
nearest 0.1 gram) 
Example: “2700” grams 








GEST_SR Self-reported gestational age at birth to the 
nearest whole week. 
Example: “31” weeks (Note: use “40” 
months for report of “full term.” 







“27” = 0-6 
months= <28 
weeks 
“31” = 7 months = 
28-31.9 weeks 
“35” = 8 months = 
32-36.9 weeks 
“40” = 9 months = 
37.0-40.9 wks 






PREMI_SR Self-reported prematurity status at birth. 













GEST_SR2 Second self-reported gestational age at birth 
to the nearest whole week. 
Example: “31” weeks (Note: use “40” 
months for report of “full term.” 







“27” = 0-6 
months= <28 
weeks 
“31” = 7 months = 
28-31.9 weeks 
“35” = 8 months = 
32-36.9 weeks 
“40” = 9 months = 
37.0-40.9 wks 






PREM_SR2 Second self-reported prematurity status at 
birth. 







MOMDIAB Did your mother have any type of diabetes 
during her pregnancy with you? 







TWINMORE Twin, triplet, or multiparous level at birth? 





   Begin new codes at 369 
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DATETOVR Date birth data request sent to Vital Records Office 
Official Birth Data Collection Form 
N/A 





DATEFRVR Date birth data request obtained from Vital Records 
Office 
Official Birth Data Collection Form 
N/A 





DOB Date of birth. 
Official Birth Data Collection Form and 





MONTHDOB Month of birth. 
Official Birth Data Collection Form and 
Questionnaire, Page 2, Q8. 
N/A 
MM 
Continuous var:  2 digits. 
327-328 
2 columns 
DAYDOB Day of birth. 
Official Birth Data Collection Form and 
Questionnaire, Page 2, Q8. 
N/A 
DD 
Continuous var  2 digits. 
329-332 
4 columns 
YEARDOB Year of birth. 
19XX 
Official Birth Data Collection Form and 
Questionnaire, Page 2, Q8. 
N/A 
YY 




STATE State where born.  See attached list. 
Study includes only women who were born in one of 
the 50 states, or the District of Columbia, of the 
U.S.A. 
Official Birth Data Collection Form and 





BWLBS_VR Birthweight in pounds (to nearest quarter pound) 
and ounces (to nearest quarter ounce, when 
applicable) 
Example: “11.75” pounds. 
Official Birth Data Collection Form 
N/A 
Continuous 
0.50# = 8 oz; 0.25# = 4 oz 
340-344 
5 columns 
BWOZS_VR Birthweight in ounces (to the nearest quarter ounce) 





BWGMS_VR Birthweight in grams (to nearest 1 gr.) 
Example: 2116 grams 





GEST_VR Gestational age at birth to the nearest whole week. 
For 1-3 days, average down.  For 4-6 days, average 
up. 
Official Birth Data Collection Form 
N/A 
Continuous 
“27” = 0-6 months= <28 
weeks 
“31” = 7 months = 28-31.9 
weeks 
“35” = 8 months = 32-37.0 
weeks 
“40” = 9 months = 37.1-
40.9 wks 




PREMI_VR Premature at birth? 
Born before completion of 37 weeks gestation? 








352 MOMDM_VR Did mother have any type of diabetes during 
pregnancy with participant? 
Official Birth Data Collection Form 
0=No or Not Indicated on 




7=No Official Document 
353 
1 column 
TWIN_VR Twin, triplet, or other multiparous level at birth? 









Codes for Calculated Data Fields 
 
Column Variable Name Description Category 
 DURATION YEARFORM – YRDIAGN N/A 
Continuous 








 HTAVG Average height in centimeters 








 BMI Body mass index based on average of height 




 OBESALL Overall obesity based on BMI 
Calculated 
1=Normal weight (<24.9) 
2=Overweight (25.0 to 29.9) 
3=Obesity (>30.0) 
 WAISTAVG Average waist circumference, to nearest 0.1 





 WCUMAVG Average waist circumference, to nearest 0.1 




 WCCRAVG Average waist circumference, to nearest 0.1 
cm, based on measures midway between iliac 








 WHR Average waist circumference (WAISTAVG) 
divided by average hip circumference 
(HIPAVG), to one decimal place.  Based on 




 WHRUM Average waist circumference (WAISTAVG) 
divided by average hip circumference 
(HIPAVG), to one decimal place.  Based on 




 WHRCR Average waist circumference (WAISTAVG) 
divided by average hip circumference 
(HIPAVG), to one decimal place.  Based on 




 OBESWC Abdominal obesity (WC >88 cm) 





 OBESWCUM Abdominal obesity (WC >88 cm) 




 OBESWCCR Abdominal obesity (WC >88 cm) 
Based on measures midway between iliac crest 





Column Variable Name Description Category 
 OBWHR Abdominal obesity (WHR >0.80).  Based on 




 OBWHRUM Abdominal obesity (WHR >0.80).  Based on 




 OBWHRCR Abdominal obesity (WHR >0.80).  Based on 





 SFPG Fasting plasma (blood) glucose converted to 
International Standard Measurements, in 
mmol/L 
Calculated value:  (FPG/18) 
N/A 
 SFPG7 Fasting plasma (blood) glucose <7 mmol/L.  





 BWLB_CVSR Birth weight in pounds.  Calculated value.  Use 
to convert birth weight reported by participant 
in grams to pounds. 
N/A 
Continuous 
 BWGM_CVSR Birth weight in grams.  Calculated value.  Use 
to convert birth weight reported by participant 
in pounds to grams. 
N/A 
Continuous 
 BWLB_CVVR Birth weight in pounds.  Calculated value.  Use 
to convert birth weight reported by vital 
records in pounds to grams. 
N/A 
Continuous 
 BWGM_CVVR Birth weight in grams.  Calculated value.  Use 
to convert birth weight reported by vital 
records in grams to pounds. 
N/A 
Continuous 
 WCUMAVG Waist average, in inches.  Based on diameter of 
waist one inch above umbilicus. 
N/A 
Continuous 
 WAISTAVIN Waist average, in inches.  Based on smallest 
diameter of waist. 




 WCUMAVGIN Waist average, in inches. Based on measures 1 
inch above umbilicus. 




 WCCRAVGIN Waist average, in inches.  Based on measures 
midway between iliac crest and lower rib. 




 HIPAVGIN Hip average, in inches. 




 HTAVGIN Height average, in inches. 








 WT25KG WT25/2.2 





Column Variable Name Description Category 
 GDMRISK Risk of developing T2DM from history of + 
and/or big baby. 
Calculated 
gdmrisk: 
1 if gestdm = 1 and bigbaby = 
1 
1 if gestdm = 1 and bigbaby = 
0 
1 if gestdm = 1 and bigbaby = 
'.' 
0 if gestdm = 0 and bigbaby = 
0 
1 if gestdm = 0 and bigbaby = 
1 
0 if gestdm = 0 and bigbaby = 
'.' 
1 if gestdm = '.' and bigbaby = 
1 
0 if gestdm = '.' and bigbaby = 
0 
‘.’ if gestdm = '.' and bigbaby 
= '.' 




1 if bw_sr <= 5.5000 
2 if 5.5001 < bw_sr < 9.0 
3 if bw_sr >= 9 




1 if bw_sr2 <= 5.5000 
2 if 5.5001 < bw_sr2 < 9.0 
3 if bw_sr2 >= 9.0 




1 if birthwt_vr <= 5.5000 
2 if 5.5001 < birthwt_vr < 9.0 
3 if birthwt_vr >= 9.0 
 BWCATEG4 Combined birth weight variable 
(BW_COMBO) as categorical variable 
Calculated 
bwcateg4: 
1 if bw_combo <= 5.5000 
2 if 5.5001 < bw_combo < 9.0 
3 if bw_comb >= 9.0 
 BWCATEG5 Combined birth weight variable 
(BW_COMBO2) as categorical variable 
Calculated 
bwcateg5: 
1 if bw_combo2 <= 5.5000 
2 if 5.5001 < bw_combo2 < 
9.0 
3 if bw_comb2 >= 9.0 
 BWCATEG6 Combined birth weight variable (BW_VALID) 
as categorical variable 
Calculated 
Bwcateg6: 
1 if bw_valid <= 5.5000 
2 if 5.5001 < bw_valid < 9.0 
3 if bw_valid >= 9.0 
 bw_combo_gm = bw_combo * 453.5 N/A; Continuous 
 bw_combo2_gm =bw_combo2 * 453.5 N/A; Continuous 
 bw_sr_gm = bw_sr * 453.5 N/A; Continuous 
 bw_sr2_gm = bw_sr2 * 453.5 N/A; Continuous 
 birthwt_vr_gm = birthwt_vr * 453.5 N/A; Continuous 
 bw_valid_gm = bw_valid * 453.5 N/A; Continuous 
 bw_combo Birthweight from vital records, verified self-
reported birth weight, or birth weight collected 




 bw_combo2 Self-reported birth weight that was verified 
with a document or a relative or some other 
source. 
N/A; Continuous 
 bw_sr Birth weight collected at enrollment. N/A; Continuous 
 155
Column Variable Name Description Category 
 bw_sr2 Self-reported birth weight that was verified 
with a document or a relative or some other 
source. 
N/A; Continuous 
 birthwt_vr Birth weight obtained from Vital Records 
Offices or State Centers for Health Statistics. 
N/A; Continuous 
 BW_VALID Validated  birth weights  Consists of vital 
records or a self-reported birth weight that was 
verified with a document or a relative or some 
other source. 
N/A; Continuous 
 FAMDM Participant reported that at least one parent 
and/or one sibling has/had diabetes. 
Derived 
1 = yes 
0 = no 
9 = Not sure 
 SMOKE Categories of smoking based on questionnaire 






 AGE Age calculated from date of birth and date that 
participant was enrolled in study; that is, when 
anthropometric and blood pressure/blood 
glucose collected. 
Calculated 
age = yearform – yeardob 
 
 AGE_YR Age in year (THIS VARIABLE IS NOT 
NEEDED FOR THIS STUDY.  ACTUALLY 
DIVIDES CURRENT AGE BY 12 
MONTHS.) 
Calculated 
age_yr = age/12 
 COLLEGE Derived from SCHOOL variable. 1 = some college or greater, 
including advanced degrees 
0 = no college; includes high 
school or less and vocational 
/trade/technical school after 
high school. 
 SMOKECAT Derived from SMOKE variable. 1 = ‘Non-smoker or former 
smoker’ 
0 = ‘Current smoker’ 
 WHR_100 WHR * 100.  Addresses issues surrounding OR 
for WHR. 
N/A; Continuous 
 SBPCAT  if sbpavg <120 sbpcat = 0 
if sbpavg >= 120 sbppcat = 1   
 DBPCAT  if dbpavg <80 dbpavg = 0 
if dbpavg >= 120 dbpcat = 1 
 SBPCATHI  if sbpavg <140 sbpcathi = 0 
if sbpavg >= 140 sbppcathi = 
1   
 DBPCATHI  if dbpavg <90 dbpcathhi = 0 




     6, 66, 6666, etc. = Refused 
 
     7, 77, 7777, etc.= Missing 
 
     8, 88, 8888, etc. = Not applicable 
 












ID Participant Identification Number 
Located at top of each page. 
N/A 












DM_MED Diabetes medications. 
Screening Questionnaire. 
“Not applicable” only if participant reported does 
not have diabetes. 
0=No diabetes meds 
1= Oral medications, only 
2= Insulin, only 
3= Oral medication + 
insulin 
4=Not taking prescribed 
dm meds 
5= MD order to 
discontinue dm meds 



























Takes vitamin, mineral, or other dietary supplement 











 Appendix D. Selected Recruitment Materials and Resources 
 
 
Visit www.capitalcommunitynews.com for a larger version of this article.  







Study Flyer, Microsoft Word Version 
 
 
The Nutrition Program 
of the 
University of Maryland  
is looking for 
African American Women for a 
Research Study 
on Birthweight and Diabetes 
 For more information 
 or to volunteer contact, 
 
 Michelle Harris, MS, RD, MPH 
 bharris2@umd.edu
 Phone: 202-291-1798 
 
http://www.agnr.umd.edu/aawhs
•You must be 38-57 years 
 of age to participate. 
•You must have type 2 diabetes.  
•You must have been born in the 
 United States. 
•You will receive a $10 gift 
certificate and a nutrition/exercise 
booklet as a “thank you.”  
•We expect this study to take less 
 than 1 hour of your time. 
•This study will involve minimal risk 
to you. 
•Call to find a location most  
 convenient for you to join the 
study. 
•All information is private and 
 confidential 
Co-Investigator: B. Michelle Harris, MS, RD, MPH 
Principal Investigator: Mira Mehta, PhD  
African American Women’s Health Study (AAWHS) 
University of Maryland Nutrition Program 
You will be asked to: 
•Have your blood pressure taken. 
•Have your height, weight, waist,   
 and hip measurements taken. 
•Have blood sugar measured 
 (finger prick).  Fast for 8 hours  
 (overnight fast—can drink water). 
•Bring a list of the medicines you take. 
•Give your written consent to obtain  
 your birth weight and other birth facts  
 from your birth certificate. 
•Fill out a questionnaire. 
Recruiting through mid-January 2006 
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Print Advertisements, Announcements, and Articles 
 
Printed Recruitment Materials: Ads, Articles, Church Bulletins, Flyers 
 
East of the River 
 
The Washington Informer 
 
The Washington City Paper 
 
The Archdiocese of Washington Catholic Standard 
 




The Prince Georges Gazette 
 
The Washington Post Metro Express 
 
Various Church Bulletins 
Saint George’s Episcopal Church 
Saint Martin’s Catholic Church 
Our Lady of Perpetual Help Catholic Church 
Saint John’s Catholic Church 
Queen’s Chapel Church 
Masjid (Mosque) Mahammed 








October 12, 2005 
DIABETES.  African-American women 38-57 years with type 2 diabetes needed for 
study, one-visit/one-hour.  Participants must live and/or work in the Greater 
Washington Metropolitan Area, including the District of Columbia; Prince George's 
and Montgomery Counties, Maryland; Northern Virginia.  Free $10-gift card.  
Flexible morning schedule.  Contact Michelle at 202-291-1798.  Study scheduled to 
be completed by end of November 2005. 
 
 
Penny Saver Wired 
http://www.mdpennysaver.com
October 2005 
African-American women 38-57 years with type 2 diabetes, one-visit/one-hour study.  
$10-gift card.  Michelle 202-291-1798, bharris2@umd.edu
 
 





University of Maryland Outlook Online 




Washington City Paper 










October 2004 to December 2005 
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Department of Nutrition and Food Science 
0112 Skinner Building 
University of Maryland 
College Park, Maryland 20742 
 




Washington, DC  200xx 
 
 
Dear Pastor XXXXXXX: 
 
Greetings.  I need your help.  I am a Ph.D. Candidate at the University of Maryland, College Park.  My 
dissertation research project is entitled, “Birthweight and Current Weight Status and Their 
Relationship to Type 2 Diabetes in African American Women.”  I need to enroll 540 U.S.-born women 
who live or work in the Greater Washington Metropolitan Area, including Alexandria.  For this study, 
270 women (the controls) will not have diabetes and 270 women (the cases) will have type 2 diabetes.  
I can enroll women only during morning hours given that this study includes a fasting blood glucose 
test from a finger stick.  Thus, participants should not have eaten for eight hours before their 
appointment.  Ideally, I would reach the goal of enrolling all my study participants before Christmas 
2004.  For this, I really do need your support and the support of others who could help me to access a 
large number of African American women between the ages of 40 to 55 years of age (plus or minus 
two years, so actually 38-57).  If enough women are willing to support this project by volunteering less 
than one hour of their time, then I will be able to conduct a successful project that would benefit the 
African American community where type 2 diabetes has reached the level of an epidemic nationwide.  
Each participant will receive a ten-dollar gift certificate for their participation in this study. 
 
Please note that participants have the choice of reporting to my lab located on the campus of the 
University of Maryland, College Park.  Another option they have is for me to report to wherever it is 
convenient for them: church.  However, this second option is only available if at least four or five 
women are will enroll during a session that would run from about 7 a.m. until around noon, with each 
women donating less than one hour of her time.  Appointments for this study can be made for any day 
of the week. 
 
I have enclosed a study flyer that describes all the steps involved for the study participants.  I have also 
enclosed a copy of the form from the University of Maryland’s Institutional Review Board (IRB) that 
authorizes me to conduct this study.  I ask that you post the study flyer and that you include my study 
in your announcements and in your weekly church bulletin.  I would be happy to meet with you and 
with members of your congregation to answer any questions that you may have regarding this study 
and/or to set up dates for me to conduct the study at your church.  Please call me at 202-291-1798 
(Study number) or 301-405-0775 (Office number) if you are interested in supporting this project.  I 
would love to include you or your church, with your permission, as supporters of this research project. 
 





B. Michelle Harris, Ph.D. Candidate 
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Sunday, August 22, 2004 
 
Time Name Contact Information (Telephone/E-mail) 
7:00   
7:00   
7:00   
8:00   
8:00   
8:00   
9:00   
9:00   
9:00   
10:00   
10:00   
10:00   
11:00   
11:00   
11:00   
11:00   
12:00   
12:00   
12:00   
12:00   
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Study Benefits to Participants 
A brief individual nutrition education session was an incentive for enrolling in 
the study.  The nutrition education component also proved to be a great tool for word-
of-mouth recruitment.  Several participants stated either during the enrollment session 
or at a later date that they were motivated to change their lifestyle because of the 
interaction they had with the investigator and/or because of the nutrition education 
materials that they read and shared with their families.  The ten-dollar gift card to a 
supermarket or health food complex was an incentive that allowed participants to 
apply their knowledge of selection of nutritious foods.  Initially, gift cards were only 
provider for redemption at a supermarket.  However, in response to health-conscious 
participants, a choice was added for gift cards that could be redeemed at a health food 
store.  Despite the prominent placement of the incentives on the study flyer, several 
participants at enrollment seemed surprised to learn that they would receive health 
education and a gift card.  This may be because many participants were recruited 
through word-of-mouth. 
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Appendix E. Informed Consent Form and IRB Approval Memorandum 
Informed Consent Form 
Study Title Birthweight and Current Weight Status in African American Women and 
Their Relationship to Type 2 Diabetes 
Statement of 
Age 
I state that I am over 18 years of age and wish to take part in a research 
study conducted by B. Michelle Harris of the Nutrition Program of the 
University of Maryland, College Park. 
Purpose The purpose of this study is to help us to learn more about how 
birthweight and current weight relate to type 2 diabetes and other 
conditions.  This study will involve African American women 40 to 55 
years of age. 
Procedures I understand that this study will involve less than one hour of my time. 
• First, my blood pressure will be measured. 
• Second, I will be weighed. 
• Third, my height, waist, and hips will be measured. 
• Fourth, one drop of blood will be taken after my finger tip is 
pricked. 
• Fifth, I will fill out a questionnaire about my own health history, 
my family’s history of diabetes, and my lifestyle. 
• Last, I will be asked to allow the researcher to collect information 
on my own birth outcome.  This will include my birthweight and 
whether I was born premature. 
Confidentiality I understand that information I provide is confidential.  My name will not 
be revealed at any time.  My information will be grouped with others’ for 
any reports.  My information will be stored in a locked drawer in the 
Nutrition Department of the University of Maryland.  Only the researchers 
will be able to open this locked drawer.  At the end of the study, this 
information will be destroyed. 
Risks I understand that there is very little risk to me in being part of this study.  
There is a very small chance of infection from the finger prick.  The 
researcher has been trained and will follow Universal Precautions (hand 
washing, gloves, etc.) to decrease these risks. 
Benefits I understand that this research will not help me personally, but that it will 
aid in the design of a study that will help with learning more about the 
health of African American women.  I will receive facts about high blood 
pressure, physical activity, and diabetes. I will receive a ten-dollar gift 
certificate if I am part of this study. 
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Medical Care I understand that the University of Maryland does not provide any 
medical or hospitalization insurance coverage for participants in this 
research study.  The University will not provide me with any 
compensation for any injury I may sustain as a result of my being part of 
this research study, except as required by law. 
Freedom to 
Withdraw 
I know that I can take as much time as I need to ask any questions and to 
discuss this study with the research team, or with my family, my friends, 
or my health care provider before I decide to take part in this study. 
I understand that I am free to ask questions or to withdraw from being 










Mira Mehta, Ph.D. 
Faculty Supervisor (Principle Investigator) 
301-405-1006 
mmehta@umd.edu 
Graduate Program in Nutrition, Room 0102 Skinner Building 
University of Maryland, College Park, Maryland  20742 
 If I have questions about my rights as a research participant or if I wish to 
report a research-related injury, I know that I can contact: 
 
Institutional Review Board Office 
University of Maryland 























UNIVERSITY OF MARYLAND 
COLLEGE PARK 
 






____________________ Date __________ 





    INSTITUTIONAL REVIEW BOARD 
 
2100 Lee Building 
College Park, Maryland 20742-5121 
301.405.4212 TEL 301.314.1475 FAX 
Reference: IRB HSR Identification Number 04-0270 
         May 19, 2004 
MEMORANDUM 
Notice of Results of Final Review by IRB on HSR Application 
 
TO:  Dr. Mira Mehta 
   Ms. B. Michelle Harris 
   Department of Nutrition and Food Science 
 
FROM: Dr. Phylis Moser-Veillon, Co-Chairperson 
   Dr. Marc Rogers, Co-Chairperson 
   Institutional Review Board 
 
PROJECT ENTITLED: 
  “Birth-weight and Current Obesity Status in African American 
  Women and their Relationship to Type 2 Diabetes. Phase 1: Survey 
  Instrument Validation Using Focus Groups. Phase 2: Pilot Study. 
  Phase 3: Full Study” 
 
The Institutional Review Board (IRB) concurs with the departmental Human Subjects 
Review Committee’s (HSRC’s) preliminary review of the application concerning the above 
referenced project.  The IRB has approved the application and the research involving human 
subjects described therein.  We ask that any future communications with our office regarding this 
research reference the IRB HSR identification numberindicated above. 
 
We also ask that you not make any changes to the approved protocol without first 
notifying and obtaining the approval of the IRB.  Also, plese report any deviations from the 
approved protocol to the Chairperson of your departmental HSRC.  If you have any questions or 
concerns, please do not hesitate to contact us at irb@deans.umd.edu.Thank you. 
 
ADDITIONAL INFORMATION REGARDING IRB/HSRC APPROVALS 
 
EXPIRATION OF IRB APPROVAL—Approval of non-exempt projects expires one year after the.  Official 
date of IRB approval; approval of exempt projects expires three years after that date.  If you expect to be 
collecting or analyzing data after the expiration of IRB approval, please contact the HSRC Chairperson in your 
department about submitting a renewal application.  (PLEASE NOTE: If you are not collecting data from 
human subjects and any on-going data analysis does notincrease the risk to subjects, a renewal application 
would not be necessary.) 
 
STUDENT RESEARCHERS—Unless otherwise requested, the IRB will send copies ofapproved paperwork to 
the supervising faculty researcher (or advisor) of a project.  We askthat such persons pass on that paperwork or a 
copy to any student researchers working on that project.  That paperwork may be needed by students in order to 
apply for graduation.  PLEASE BE ADVISED THAT THE IRB MAY NOT BE ABLE TO PROVIDE 
COPIES OF THAT PAPERWORK, particularly if several years have passed since the date of the original 
approval. 
 
Enclosures (where appropriate), will include stamped copy of informed consent forms included in application and any copies of 
the application not needed by the IRB; copies of this memorandum and any consent forms to be sent to the Chairperson of the 
Human Subjects Review Committee. 
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Appendix F. Sample Size Estimation (A Priori) 
The sample size calculations based on the Equation is conservative and may 
overestimate the sample size given that the sample population for the current study is 
restricted to one gender (female), one race (African American), and a relatively 
narrow age range (38 to 57 years).  The sample size generated from Equation 1 is 244 
per group.  This value is very close to the value obtained using the UCLA on-line 
calculator.133  From a table generated from the Equation, with α set at 0.05 (two-
sided) and β set at 0.20, and a probability, p0, equal to approximately 0.15, the sample 
size estimated to detect a two-fold risk (R = 2.0) is 207 per group.  If the probability, 
p0, were 0.10, the sample size estimate would be 282.  The mean of these two 
estimates is 245, which can be considered an extrapolation for the .13 probability for 




n = [zα (2pq)1/2 + zβ (p1q1 + p0q0)1/2]2 / (p1 – p0)2
 
zα = 1.96 
zβ = 0.84 
 
p = ½ (p1 – p0) = ½ (0.23 + 0.13) = ½ (0.36) = 0.18 
 
q = 1 – p = 1 – 0.18 = 0.82 
p0 = 0.13 
p1 = p0R/ [1 + p0 (R-1)] = 0.13 (2) / [(1 + 0.13) (2-1)] = 0.26 / 1.13 = 0.23 
q1 = 1 - p1 = 1 – 0.23 = 0.77 
q0 = 1 – p0 = 1 –0.13 = 0.87 
 
n = [ 1.96 (2 * 0.18 * 0.82)1/2 + 0.84 {(0.23 * 0.77) + (0.13 * 0.87)}1/2]2 / (0.23-0.13)2 
= 244 
 
Note: The above equation is Equation 6.1 of Schlesselman, p. 145.134
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Appendix G. Study Equipment: Scales, Blood Pressure Device, Glucometer 
The equipment used in the study was portable and feasible for a study that 
involved several enrollment sites.  The Seca self-calibrating electronic scale is a 
research-level tool and accommodated the weight of all but one participant who 
described herself as “grossly obese.”  The investigator used the weight that was 
recorded by this participant's health care provider five days before her enrollment in 
the study. 
The Road Rod stadiometer proved to be problematic at times for taking 
heights for adult women.  This stadiometer had the tendency to sway; thus, the 
investigator had to be especially diligent in assuring that standardized procedures 
were followed to maintain internal validity.  Participants whose study heights seemed 
to be as much as one-half or one inch different from their heights measured at 
medical examinations, often several years before their participation in the study, were 
reminded that heights measured in medical facilities might not always be collected in 
a standardized manner and that height may decrease for middle-age women due to 
bone loss.  Maintaining a dialogue with each participant seemed to put them at ease, 
encouraged them to comment on the study, and made them true collaborators on this 
study. 
Pilot testing equipment and procedures are important for any study.  For the 
current study, though the investigator received intensive training with measuring 
blood pressure on the electronic blood pressure device, the pilot study helped her to 
identify the need for an extra-large cuff to accommodate extremely large women. 
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The Hemocue 201 glucometer compares favorably to clinical laboratory 
glucometers.74  Analyzing blood glucose levels using the electronic digital 
glucometer was quick and convenient.  Participants appreciated the ease of donating a 
small drop of blood.  The pilot study proved to be important for the investigator to 
develop competence with operating the glucometer.  For instance, pilot study 
participants routinely exhibited blood glucose levels below 70 mg/dL.  From repeated 
measures on selected participants, it was discovered that not enough blood was drawn 
into the microcurvette for the first several participants who enrolled in the pilot study. 
Accuracy in plasma glucose measurements was maintained throughout the 
study through testing a control sample at the beginning of each study day.  The 
investigator received training on the Hemocue glucometer system through an on-site 
training session conducted by a company representative.  A CD-ROM on proper use 
of the Hemocue glucometer helped the investigator to master and maintain proper 
techniques.  It is suggested that investigators utilize all the support that companies can 
provide them in order to increase the accuracy and reliability of measurements. 
Collecting duplicate measures for all measurements except plasma blood 






Seca Model 770 
Capacity:  200 kg (440 pounds) 
Graduation:  100 g (0.2 pounds) 
Platform: 320 x 300 mm 
Weight:  6.5 kg 
Power Supply : Batteries 
 
Height 
Seca Model 214 (Road Runner™) 
Measuring Range:  25-200 cm (10-78 inches) 
Graduation:  1 mm (1/8 inch) 
Dimensions 14 x 83¼ x 16½  
Weight:   6 pounds 
 
BLOOD PRESSURE DEVICE 
ADC: http://www.adctoday.com/
American Diagnostic Corporation (ADC) Model 6014 
Advantage™ Advanced Blood Pressure Digital Device  
Power:  Batteries and AC Adapter 
Latex-Free Cuff 
 
BLOOD GLUCOSE DEVICE 
Hemocue: http://www.hemocue.com
Hemocue Blood Glucose Test System 
Hemocue Glucometer Model 201 
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Appendix H. Focus Groups: Selected Findings and Forms 
The input of focus group participants helped to improve study instruments, 
including the Screening Questionnaire, Study Questionnaire, Birth Data Collection 
Form, Study Flyer, and the Informed Consent form.  In addition, focus group 
participants selected blood pressure/diabetes handouts from among a variety of 
possible choices.  They also provided feedback on the gift card incentive.  Focus 
group participants were between the ages of 25 and 79 years (Table H1).  The 
majority had attended college, with several earning bachelor or graduate degrees. 
A total of five focus group sessions were held.  The first was conducted in a 
Midwestern city and consisted of 11 women.  Much of their information was gathered 
through a survey with several open-ended questions.  These focus group survey 
instruments are included in Appendix G.  Four other focus groups, involving a total of 
25 women, were held in the Washington, D.C., Metropolitan Area.  Notes were 
recorded from these four sessions using the focus group survey instrument as a guide 
to spark discussion. 
The focus groups found that the screening and full study questionnaires were 
clear as a whole, but could use some improvement.  Wording and/or order of a few 
questions were changed.  The format of the questionnaire was changed to leave more 
space between items so that participants could see the grouping of questions more 
easily.  In addition, the study flyer was modified slightly to make it clear that the 
study needed women without diabetes in addition to women with type 2 diabetes. 
The issue of fear of identity theft was raised by several focus group 
participants.  One participant stated that the study’s “confidentiality disclosures made 
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people feel more comfortable answering personal questions.”  She added, “Without 
confidentiality disclosures, the questions would seem invasive and possibly make 
people a little scared to answer questions because of identity theft.”  A few other 
women reported that other women would be reluctant to participate in the study or to 
give their personal information for fear of identify theft.  Women reported that they 
were relieved that their Social Security numbers were not collected for the study. 
Focus group participants selected the handouts to be used in the study.  One 
participant stated, “[I] prefer the blood pressure sheet with the heart on it.  The charts 
reinforce the information.”  Focus group participants reported that the supermarket 
gift card was “practical” and “a good thank you.” 
Table H1. Demographics for Focus Group Participants 
U.S.-Born African-American Women 25-79 Years, N=36 
 Frequency, n 
Age (years)  
 20-29  5 
 30-39 5 
 40-49 4 
 50-59 18 
 60-69 2 
 >70 2 
Region Where Focus Group Conducted  
 Greater Washington, D.C., Area 25 
 Urban Midwestern Area 11 
Education  
 Less than high school 2 
 High school or technical/trade/vocational school 8 
 Some college associate, bachelor, graduate degree 26 
Note. One focus group participate participated in more than one focus group meeting. 




Focus Group Protocol 
 
Part 1:  Introductions 
 
Hi, my name is Michelle Harris.  I am a Ph.D. Student in the Nutrition Department of the 
University of Maryland, College Park.  I am the facilitator of this group interview today.  
_____________________________ will assist me by taking notes of what you share here 
today. 
 
Thank you for taking part in this group interview this evening [morning/afternoon].  You will 
be helping us to improve a form that will be used in a future study.  That future study will be 
on how birthweight and adult weight may affect our risk for type 2 diabetes.  I will be the 
lead researcher for that study. 
 
There are no right or wrong answers.  You will be asked to complete a form on what you 
recall about your health, your family’s history of diabetes, and your birth information.  After 
you complete each section of the form, I will ask you about the questions in that section.  I 
will ask you if the question is clear as it is written.  If you feel that a question is not written 
clearly, please suggest other ways for me to write the question so that it will be clearer for 
others. 
 
We will review nine (9) pages.  One form is the separate Screener Questionnaire that will be 
used to see if a woman is eligible to take part in the study.  We will then review the four (4) 
sections of the Diabetes Study Questionnaire and a separate Birth Data Collection Form.  We 
will also review the Cover Sheet for the Diabetes Study Questionnaire.  Finally, we will 
review the Recruitment Flyers.  Depending on the time, we may or may not get through all of 
the items, but that is okay.  If we run out of time, you may contact me later to give your 
opinions about the other items.  These pages that we will review are: 
 
1. Screener Questionnaire 
2. Cover Sheet for the Diabetes Study Questionnaire 
3. Birth Information Form 
4. Personal Health History Form 
5. Family Diabetes History Form 
6. Personal Lifestyle Form 
7. Birth Data Collection Form 
8. Recruitment Flyers (two) 
 
The information you provide is private and confidential.  Your name will not be shared.  
Your information will be grouped with others’ for any reports.  Your information will be 
stored in a locked cabinet in a locked office.  There will be no taping or other electronic 
recording of this interview.  Written notes will be destroyed by shredding within two years 
after the first report is published or two years from today, whichever comes last.  By no 
means will these notes be kept for more than three years from today. 
 
To help maintain the privacy and confidentiality of everyone here today, I ask that you not 
release the names of any participants to anyone outside this meeting. 
 
This interview is scheduled to last for up to two hours.  You are free to withdraw from being 
part of this interview at any time without penalty.  If you think of something to add to your 
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comments after this interview ends, please feel free to contact me by phone, e-mail, letter, or 




4505 Fifth Street, N.W. 




B. Michelle Harris 
Department of Nutrition 
Room 0112 Skinner Building 
University of Maryland 




If you wish to contact Dr. Mira Mehta, the Principal Investigator, or the University of 
Maryland Institutional Review Board with any issues about this study, please refer to your 
Informed Consent Form. 
 
If you want a copy of any reports that result from this focus group interview, please contact 
me. 
 
Now, I will ask that you re-read the Informed Consent Form.  I will then answer any 
questions that you may have about this study or about the Consent Form.  I will need you to 




Feel free to eat or drink anything we have here before, during, or after the interview begins. 
 
Please introduce yourselves, first names, only. 
 
Part 2: Ice Breaker Activity 
 
Please write the first 2-3 words that come to mind when you think about diabetes.  Write 
them down on the paper that is in front of you.  You do not have to write your name on the 
paper.  When you finish, please pass the paper to me.  I will share with the group what 
everyone wrote. 
 
Part 3:  Review of Questionnaires 
We will now review each of the pages separately.  As you answer the questions, please 
pretend that you are a woman who is participating in the full study.  Please stop me at any 
time to ask any questions that you might have. 
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A.  Screener Questionnaire 
 
Please fill out this first form.  I will then ask you about each question separately.  
Next, I will ask you about the form as a whole.  Please answer the best that you can.  
Later, I will ask you to give your opinion on how the questions might be asked in a 
better way. 
 
1. Type size: 
What do you think about the type size? 
 
2. Reading level: 
What do you think about the reading level? 
 
3. Clearness (clarity) of questions: 
 
Questions to Participants Notes for Facilitator 
How clear or unclear are the instructions for Item 1? 
How clear or unclear is the wording of Item 1? 
How clear or unclear is the meaning of Item 1? 
What else is unclear about Item 1? 
What do you suggest that I should do to improve Items 
1? 
 
How clear or unclear are the instructions for Item 2? 
How clear or unclear is the wording of Item 2? 
How clear or unclear is the meaning of Item 2? 
What else is unclear about Item 2 




Read question and stem. 
 
 
4. Order of questions: 




5. Overall appearance of form: 




6. Other comments: 
What other comments and suggestions do you have about this form? 
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B.  Cover Sheet for Diabetes Study Questionnaire 
 
Please read this page.  I will then ask you your opinion about it.  Your opinions are 
important to me.  Remember, there are no right or wrong answers. 
 
1. Type size: 





2. Reading level: 





3. Clearness (clarity) of questions: 





4. Order of questions: 





5. Overall appearance of form: 





6. Other comments: 
What other comments and suggestions do you have about this page? 
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C.  Birth Information Form 
 
Please fill out this first page of the second form.  I will then ask you about each 
question separately.  Next, I will ask you about this page as a whole.  Please answer 
the best that you can.  Later, I will ask you to give your opinion on how the questions 
might be asked in a better way. 
 
1. Type size: 
What do you think about the type size? 
 
2. Reading level: 
What do you think about the reading level? 
 
3. Clearness (clarity) of questions: 
 
Questions to Focus Group Participants Notes for Facilitator 
How clear or unclear are the instructions for Item 1? 
How clear or unclear is the wording of Item 1? 
How clear or unclear is the meaning of Item 1? 
What else is unclear about Item 1? 
What do you suggest that I should do to improve Items 
1? 
 
How clear or unclear are the instructions for Item 2? 
How clear or unclear is the wording of Item 2? 
How clear or unclear is the meaning of Item 2? 
What else is unclear about Item 2 




Read question and stem. 
 
 
4. Order of questions: 
What do you think about the order of the questions? 
 
5. Overall appearance of this page: 
What do you think about the appearance of this page? 
 
6. Other comments: 
What other comments and suggestions do you have about this page? 
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D.  Personal Health History Form 
 
Please fill out this next page.  I will then ask you about each question separately.  
Next, I will ask you about this page as a whole.  Please answer the best that you can.  
Later, I will ask you to give your opinion on how the questions might be asked in a 
better way. 
 
1. Type size: 
What do you think about the type size? 
 
2. Reading level: 
What do you think about the reading level? 
 
3. Clearness (clarity) of questions: 
 
Questions to Focus Group Participants Notes for Facilitator 
How clear or unclear are the instructions for Item 1? 
How clear or unclear is the wording of Item 1? 
How clear or unclear is the meaning of Item 1? 
What else is unclear about Item 1? 
What do you suggest that I should do to improve Items 
1? 
 
How clear or unclear are the instructions for Item 2? 
How clear or unclear is the wording of Item 2? 
How clear or unclear is the meaning of Item 2? 
What else is unclear about Item 2 




Read question and stem. 
 
 
4. Order of questions: 




5. Overall appearance of this page: 




6. Other comments: 
What other comments and suggestions do you have about this page? 
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E.  Family Diabetes History Form 
 
Please fill out this next page.  I will then ask you about each question separately.  
Next, I will ask you about this page as a whole.  Please answer the best that you can.  
Later, I will ask you to give your opinion on how the questions might be asked in a 
better way. 
 
1. Type size: 
What do you think about the type size? 
 
2. Reading level: 
What do you think about the reading level? 
 
3. Clearness (clarity) of questions: 
 
Questions to Focus Group Participants Notes for Facilitator 
How clear or unclear are the instructions for Item 1? 
How clear or unclear is the wording of Item 1? 
How clear or unclear is the meaning of Item 1? 
What else is unclear about Item 1? 
What do you suggest that I should do to improve Items 
1? 
 
How clear or unclear are the instructions for Item 2? 
How clear or unclear is the wording of Item 2? 
How clear or unclear is the meaning of Item 2? 
What else is unclear about Item 2 




Read question and stem. 
 
 
4. Order of questions: 




5. Overall appearance of this page: 




6. Other comments: 
What other comments and suggestions do you have about this page? 
 182
F.  Personal Lifestyle Form 
 
Please fill out this first form.  I will then ask you about each question separately.  
Next, I will ask you about the form as a whole.  Please answer the best that you can.  
Later, I will ask you to give your opinion on how the questions might be asked in a 
better way. 
 
1. Type size: 
What do you think about the type size? 
 
2. Reading level: 
What do you think about the reading level? 
 
3. Clearness (clarity) of questions: 
 
Questions to Focus Group Participants Notes for Facilitator 
How clear or unclear are the instructions for Item 1? 
How clear or unclear is the wording of Item 1? 
How clear or unclear is the meaning of Item 1? 
What else is unclear about Item 1? 
What do you suggest that I should do to improve Items 
1? 
 
How clear or unclear are the instructions for Item 2? 
How clear or unclear is the wording of Item 2? 
How clear or unclear is the meaning of Item 2? 
What else is unclear about Item 2 




Read question and stem. 
 
 
4. Order of questions: 




5. Overall appearance of this page: 




6. Other comments: 
What other comments and suggestions do you have about this page? 
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G.  Birth Data Collection Form 
 
Please fill out this first form.  I will then ask you about each question separately.  
Next, I will ask you about the form as a whole.  Please answer the best that you can.  
Later, I will ask you to give your opinion on how the questions might be asked in a 
better way. 
 
1. Type size: 
What do you think about the type size? 
 
2. Reading level: 
What do you think about the reading level? 
 
3. Clearness (clarity) of questions: 
 
Questions to Focus Group Participants Notes for Facilitator 
How clear or unclear are the instructions for Item 1? 
How clear or unclear is the wording of Item 1? 
How clear or unclear is the meaning of Item 1? 
What else is unclear about Item 1? 
What do you suggest that I should do to improve 
Items 1? 
 
How clear or unclear are the instructions for Item 2? 
How clear or unclear is the wording of Item 2? 
How clear or unclear is the meaning of Item 2? 
What else is unclear about Item 2 




Read question and stem. 
 
 
4. Order of questions: 




5. Overall appearance of this page: 




6. Other comments: 
What other comments and suggestions do you have about this form? 
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H.  Recruitment Flyers 
 
Please examine this flyer.  I will then ask you your opinion about it.  Your opinions 
are important to me.  Remember, there are no right or wrong answers. 
 
1. Clearness (clarity) of messages: 





2. Order of items: 





3. Overall appearance of form: 
What do you think about the overall appearance of this flyer? 
 
 
4. Power to recruit women into the study: 
How useful do you think that this flyer will be for inviting Black American 
women 40-55 years of age into the Diabetes Study? 
 
 
5. Type size: 




6. Reading level: 








8. Other comments: 
What other ideas and suggestions do you have that would make this a more useful 
flyer for recruiting women into the study? 
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Focus Group Demographic Form 
 
1. What is your age?  _________________ 
 
2. Do you have diabetes?  (Please circle one.):  Yes              No 
 
3. What is the highest grade or year of school you completed? (Please circle only one item.) 
a. Grades 1 through 8 (elementary) f. Associate degree 
b. Grades 9 through 11 (some high school) g. Bachelor’s degree 
c. Grade 12 or GED (high school diploma 
    or equivalency) 
h. Graduate degree or advanced  
     professional degree 
    (Master, Ph.D., M.D., J.D., etc.) 
d. Technical or vocational degree beyond high school i. Not sure 
e. Attended college, but did not graduate  
 
 
1. What is your age?  _________________ 
 
2. Do you have diabetes?  (Please circle one.):  Yes              No 
 
3. What is the highest grade or year of school you completed? (Please circle only one item.) 
a. Grades 1 through 8 (elementary) f. Associate degree 
b. Grades 9 through 11 (some high school) g. Bachelor’s degree 
c. Grade 12 or GED (high school diploma 
    or equivalency) 
h. Graduate degree or advanced  
     professional degree 
    (Master, Ph.D., M.D., J.D., etc.) 
d. Technical or vocational degree beyond high school i. Not sure 
e. Attended college, but did not graduate  
 
 
1. What is your age?  _________________ 
 
2. Do you have diabetes?  (Please circle one.):  Yes              No 
 
3. What is the highest grade or year of school you completed? (Please circle only one item.) 
a. Grades 1 through 8 (elementary) f. Associate degree 
b. Grades 9 through 11 (some high school) g. Bachelor’s degree 
c. Grade 12 or GED (high school diploma 
    or equivalency) 
h. Graduate degree or advanced  
     professional degree 
    (Master, Ph.D., M.D., J.D., etc.) 
d. Technical or vocational degree beyond high school i. Not sure 




Appendix I. Vital Records and Measurements Forms 
 
Birth Data Collection Form (Data from Vital Records Offices) 
 
Participant’s Birth Name:  __________________________________________________ 
 
State of Participant’s Birth: _________________________________________________ 
 
 
Variable Value* Comments 
 

























Premature is defined as 
born before 
37 weeks gestation. 
 
 
Participant was/is a 















had T1DM or T2DM 









Please circle, if known. 
 
T1DM = type 1  diabetes 
T2DM = type 2  diabetes 




Vital Records Office Comments:   
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Blood Pressure, Current Weight, Height, Body Mass Index (BMI),  
Waist Circumference, Hip Circumference, Waist-to-Hip Ratio (WHR), Glucose Test 
 
Variable Value Comments 
Blood pressure 1 (Systolic/Diastolic)  / mm Hg, > 5 minutes after first measurement.  Measure while participant is seated. 
Blood pressure  2 (Systolic/Diastolic)  / mm Hg, > 5 minutes after first measurement.  Measure while participant is seated. 
Height 1 (cm)  To the nearest 0.1 cm 
Height, duplicate measure (cm)   
Height, average (cm)   
   
Weight 1 (kg)  To the nearest 0.01 kg 
Weight, duplicate measure (kg)   
Weight, average (kg)   
   
Body Mass Index , BMI  Based on average of height and weight, kg/cm2
   
Overall obesity, based on BMI  
  Normal weight:    BMI<24.9 
  Overweight:         BMI 25.0 to 29.9 
  Obesity:          BMI >30.0 
   
Waist circumference 1 (WC) (cm)  To the nearest 0.1 cm 
WC, duplicate (cm)   
WC, average (cm)   
   
Hip circumference 1 (cm)  To the nearest 0.1 cm 
Hip circumference, duplicate (cm)   
Hip circumference, average (cm)   
   
Waist-to-hip ratio (WHR)  Based on average waist circumference/average hip circumference 
   
Abdominal obesity, based on WC Yes No Obesity: WC >88 cm 
Abdominal obesity, based on WHR Yes No Obesity: WHR >0.80 
Diabetes Status 
 
Variable Value Source of Measurement 
Did you have anything to eat or drink (except water) 
within the last 8 hours?* 1.   No   Yes 
In the last 24 hours, how much fluid did you drink (Do 
not include alcohol, coffee, or colas)?* 2. _______ cups or glasses 
FPG** 
(mg/dL)  3.   Glucometer reading 
Diabetes 
 
  Yes 
  No 
  Undetermined 
4.   Self-report with verification via prescription 
 of insulin and/or oral hypoglycemic agent 
or 
5.   FPG** > 126 mg/dL 
*The measurer will ask participant this question before collecting blood.               **FPG, Fasting Plasma Glucose. 
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Personal Measurements Form 
 
ID Number: ___  ___  ___  Date:  ____________________  Time: ___________ 
 
Blood Pressure 1: 
 










Waist Circumference 1 (smallest diam.):   Waist Circumfer. 3 (1” above umbilicus): 
 
Waist Circumference 2 (smallest diam.):   Waist Circumfer. 4 (1” above umbilicus): 
 
Hip Circumference 1: 
 
Hip Circumference 2: 
 
Fasting plasma-equivalent glucose: 
 
Non-fasting plasma equivalent glucose: 
 









Protocol for Obtaining Birth Data from Vital Records and Vital Statistics Departments 
 
The following is an outline of procedures for collecting and protecting all birth data.  It 
addresses both physical security and security through electronic media of all birth data. 
 
1. The investigator will have obtained the requisite approval of the Institutional Review 
Board (IRB) of the University of Maryland before making any formal requests for birth 
data.  In addition, approval by the IRBs of specific states will be obtained, where 
required. 
 
2. Data requested from Vital Records and Vital Statistics Department will be limited to the 
following variables:  a) weight at birth (required), b) length at birth (if available),  
c) length of gestation (if available), d) singleton vs. twin or greater birth status,  
e) diabetes status of mother during pregnancy with study participant (if available). 
 
3. Each Vital Statistics Office will be provided with a list of participants born in their 
respective state.  Piece-meal queries will be avoided as much as possible.  De-
identification will occur immediately upon receipt of birth data from a Vital Statistics 
Office. 
 
4. Study participants will not incur any expense or inconvenience for the obtainment of their 
birth data.  The onus for obtaining documented birth data will be strictly on the 
investigator. 
 
5. Individual informed consent will be obtained from each study participant for permission 
to access personal data from their Vital Records files.  They will be informed that any 
data collected on them from Vital Records or from any other source will be confined to 
the stated purposes of this study. 
 
6. The birth data collected for this study will not be used for any purposes other than for this 
study.  Raw data will not be shared with anyone other than with those involved in the 
study.  Even then, all personal data will be de-identified.  Unique identifiers for each 
participant will be stored separately from any data that might be publicized. 
 
7. HIPAA guidelines will be followed to assure that all data collected for this study are 
adequately de-identified (Citation of HIPAA). 
 
8. The data file that contains unique identifiers will be stored on a removable disk drive (zip 
disk).  It will at no time be saved on a hard disk or transmitted electronically to anyone, 
including to the investigator, herself.  Zip disks and floppy disks that contain unique 
identifiers will also be stored under lock and key. 
 
9. Hard-copy files with unique identifiers and the removable disk will be stored together in 
a locked file cabinet that is only accessible to the investigator.  This locked file cabinet 
will be housed in a room that is only accessible to authorized staff of the Department of 
Nutrition and Food Science, University of Maryland, College Park.  Zip disks and floppy 
disks that contain unique identifiers will also be stored under lock and key. 
 
10. All raw birth data connected to identifiers will be kept under lock and key for the time 
required by law.  Access will only be available to the investigator.  Electronic copies (zip 
disk, floppy disks) also will be destroyed as soon as allowed by law.  Hard-copy data will 
be destroyed through shredding by the investigator. 
 




Appendix K. Pilot Study Descriptive Tables 
 
Table K1. Relationship Between Self-Reported Personal Health History and Type 2 
Diabetes:Pilot Study 
U.S.-Born African-American Women 26-86 Years, with and Without Type 2 Diabetes, N=21 






High blood pressurea 2(67) 6(33) 
 
 




Life Cycle Stage   





Breastfed as infant or child 3(100) 11(61) 
 
 
Premature Birthb 0 1(33) 
 
 
Twin 0 1(33) 
 
 
Family History of Diabetes 2(67) 14(78) 
 
 
Note. All data were based on self-report. 
aSelf-report of physician diagnosis of this condition 
bSelf-report: Frequency and percent for 11 participants who reported “Don’t know” are not shown. 
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Table K2. Age, Body Measurements, and Blood Pressure 
Measurements: Pilot Study 
Women 26-84 Years, N=21 
Age and Measurements Mean (SD), 
N 
Minimum-Maximum 












































Note. All measurements were taken at enrollment in study. 
Body mass index was calculated by dividing weight in kilogram by height in meters 
squared. 
Waist-to-hip ratio was calculated by dividing waist (cm) by hip (cm) circumference 
57-133 kg = 125-293 pounds 
154-172 cm = 61-68 inches; 72-134 cm = 28-53 inches; 92-150 cm = 36-59 inches 
 
 
Table K3. Weight at Age 25 Years: Pilot Study 







Weight at 25 years, kg a 6616.22) 45-114 
Note. By self-report: One participant was not included in analysis since she could not 
respond to this questionnaire item. 
45-114 kg = 99-251 pounds 
aNot reported by one participant 
Questionnaire item: “About how much did you weigh when you were 25 years of 




Table K4. Age at Diagnosis and Years Duration of Diabetes, Obesity at 
Diagnosis, and Methods for Controlling Diabetes: Pilot Study 
Women 26-84 Years, with Type 2 Diabetes, n=3 
Cases (n=3) Self-Reported Diabetes-Related Variable 
A B C 
Age at diagnosis of type 2 diabetes (years) 70 52 50 
Duration of diabetes at enrollment (years) 15 5 6 
    
Weight at diagnosis Overwt Overwt Normal 
  
Methods for controlling diabetes  
 Oral diabetes medications Yes Yes Yes 
 Insulin No No No 
 Diet change/Diet Plan No Yes Yes 
 Exercise No No Yes 
 Lose weight No Yes Yes 
 Other No No No 
Note. All data in this table were based on self-report. 
 
 
Table K5. Lifestyle Indicators: Pilot Study  
Women 26-84 Years 






Current Smoker 4(19) 0(0) 4(22) 
 




Note. All data in this table were based on self-report. 
aEngage in strenuous activity or hard physical labor where sweat or heart beats faster? 




Appendix L. Vital Records Obtained, by State 





Per Stateb  
Final Sample 
Per Statec  
















1 205 151 74% 0 0% 0% 
2 33 29 88% 19 58% 66% 
3 20 19 95% 18 90% 95% 
4 18 10 56% 0 0% 0% 
5 17 14 82% 0 0% 0% 
6 11 7 64% 0 0% 0% 
7 7 5 71% 0 0% 0% 
8 6 3 50% 0 0% 0% 
9 4 4 100% 4 100% 100% 
10 4 4 100% 3 75% 75% 
11 4 4 100% 3 75% 75% 
12 3 3 100% 0 0% 0% 
13 3 3 100% 0 0% 0% 
14 3 2 67% 2 67% 100% 
15 3 2 67% 1 33% 50% 
16 3 2 67% 0 0% 0% 
17 2 2 100% 2 100% 100% 
18 2 2 100% 2 100% 100% 
19 2 2 100% 2 100% 100% 
20 2 2 100% 0 0% 100% 
21 2 2 100% 0 0% 100% 
22 1 1 100% 1 100% 100% 
23 1 1 100% 1 100% 100% 
24 1 1 100% 1 100% 100% 
25 1 1 100% 1 100% 100% 
26 1 1 100% 1 100% 100% 
27 1 1 100% 1 100% 100% 
28 1 1 100% 1 100% 100% 
29 1 1 100% 0 0% 100% 
30 1 1 100% 0 0% 100% 
31 1 0 0% 0 0% 0% 
32 1 0 0% 0 0% 0% 
Total 365 281 100% 63   
Note. aStates were coded to protect identity of participants.  Thirty-two State Centers for Health Statistics/Vital 
Records Offices were involved in this study.  Vital records birth weights obtained from 17 states.  Collection 
of vital records birth weights was through July 2006.  bOriginal enrollment consisted of 365 women.  cThe 
final sample included women for whom verified birth weights could be obtained (n=281).  dPercent of final 
sample participants from original enrollment. 
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Appendix M. Vital Statistics: National and District of Columbia 
Tables M1 to M3 were compiled from data extracted from documents 
published by the Department of Health, Education, and Welfare (HEW) and, later, 
from the National Center for Health Statistics (NCHS).135
Table M1. Low Birth Weighta Rates and Ratios Among Blacks and Whites, by Year— 
United States, and the District of Columbia, 1950 to 1970 and 1972 
 United States District of Columbiab
Year Non-
Whitec




White Ratio All 
Races 
1950 10.3 7.1 1.5 7.6 ---d ---d ---d ---d
1951 10.1 6.6 1.5 7.1 17.0 11.2 1.5 13.9 
1952 10.7 6.6 1.6 7.8 15.1 9.1 1.7 11.9 
1953 10.9 6.6 1.7 7.2 12.1 7.1 1.7 9.9 
1954 11.0 6.4 1.7 7.1 12.8 7.8 1.6 10.4 
1955 11.4 6.5 1.8 7.2 12.9 7.7 1.7 10.6 
1956 11.7 6.4 1.9 7.2 13.0 7.1 1.8 10.7 
1957 12.2 6.5 1.9 7.4 14.0 7.4 1.9 11.6 
1958 12.7 6.5 2.0 7.5 14.4 8.9 1.6 12.5 
1959 12.8 6.8 1.9 7.7 14.1 8.1 1.7 12.1 
1960 12.8 6.8 1.9 7.7 14.4 8.2 1.8 12.5 
1961 12.9 6.9 1.9 7.8 13.8 8.9 1.6 12.3 
1962 13.0 7.0 1.9 8.0 13.8 8.6 1.6 12.3 
1963 13.5 7.1 1.9 8.1 14.0 8.3 1.7 12.3 
1964 13.8 7.1 1.9 8.1 14.1 8.1 1.7 12.6 
1965 13.7 7.2 1.9 8.3 13.5 6.1 2.2 11.5 
1966 13.8 7.2 1.9 8.3 14.9 7.0 2.1 13.4 
1967 13.5 7.1 1.9 8.2 14.3 7.0 2.0 12.9 
1968 13.6 7.1 1.9 8.2 15.3 7.6 2.0 14.1 
1969 14.4 7.0 2.1 8.1 14.2 8.5 1.7 13.3 
1970 13.8 6.8 2.0 7.9 13.2 8.9 1.5 12.5 
1972 13.5 6.5 2.1 7.7 13.4 6.6 2.0 12.5 
Notes. Based on a sample of 50% of all live births.  Births by place of residence.  From 1950-
1952, birth weight data for births in Connecticut and Massachusetts were not available.  From 
1953-1958, birth weights were not available for births in Massachusetts, only.  Beginning in 1960, 
brith weight data included Alaska and Hawaii.  For 1962-1963, figures by color excluded data for 
residents of New Jersey because this State did not require reporting of the item.  Birth weights 
were computed on the basis of original units of pounds and ounces and rounded to nearest 10 g. 
aLow birth weight was defined as 2,500 g or less, 1950-1972.  Low birth weight was defined as 
2,499 g or less beginning in 1973. 
bThe District of Columbia did not gain home rule until the Home Rule Act passed in Congress in 
1973.  A mayor and council were voted into office in 1974.136  The Federal Government exercised 
stewardship over the District of Columbia Vital Records Office until then. 
cDefinition of Non-White changed over time.  For 1950-1967 the term Non-White was used.  For 
1968-1969, the term All Other was used.  For 1970-1972 the term Negro used.  From 1980s-2001, 
the term Black was used. 





Table M2. Low Birth Weight Rates and Ratios Among 
Blacks and Whites, by Year—United States, 1980 to 2002 
Year Black White Ratio All Races 
1980 12.7 5.7 2.2 6.8 
1981 12.7 5.7 2.2 6.8 
1982 12.6 5.6 2.3 6.8 
1983 12.8 5.7 2.2 6.8 
1984 12.6 5.6 2.3 6.7 
1985 12.6 5.7 2.2 6.8 
1986 12.8 5.7 2.2 6.8 
1987 13.0 5.7 2.2 6.9 
1988 13.3 5.7 2.3 6.9 
1989 13.3 5.7 2.4 7.0 
1990 13.5 5.7 2.3 7.0 
1991 13.3 5.8 2.3 7.1 
1992 13.6 5.8 2.3 7.1 
1993 13.3 6.0 2.2 7.2 
1994 13.2 6.1 2.2 7.3 
1995 13.1 6.2 2.1 7.3 
1996 13.0 6.3 2.1 7.4 
1997 13.0 5.5 2.0 7.5 
1998 13.0 6.5 2.0 7.6 
1999 13.1 6.6 2.0 7.6 
2000 13.0 6.5 2.0 7.6 
2001 13.6 6.7 2.0 7.7 
2002 13.4 6.9 1.9 7.8 
Note.  Birth weights were computed on the basis of original 
units of pounds and ounces and rounded to nearest 10 grams. 
Source: Infant Mortality and Low Birth Weight Among 
Black and White Infants --- United States, 1980—2000 



























 Number        
2003 290,810,000 80.5 12.8      
2000e 281,422,000 81.1 12.7      
1990b 248,709,873 80.3 12.1 0.8 2.9 3.9 9.0 75.6 
1980b 226,545,805 83.1 11.7 0.6 1.5 3.0 6.4 79.6 
1970b 203,211,926 87.5 11.1 0.4 0.8 0.3 (NA) (NA) 
1960c,d 179,323,175 88.6 10.5 0.3 0.3 -- (NA) (NA) 
1950d 150,697,361 89.5 10.0 0.2 0.2 -- (NA) (NA) 
1940d 131,669,275 89.8 9.8 0.3 0.2 (X) (NA) (NA) 
Notes. “–” Represents zero or rounding to 0.0.  (X) Not applicable. (N/A), Not available. aTotals to 100% of 
population. bHispanic origin based on Spanish language. cIncludes Alaska and Hawaii for first time. dHispanic 
origin based on the White population of Spanish mother tongue. eIn thousands, rounded to the nearest one 
thousand for 2000 and 2003, only. fData for 2003 are preliminary. 























 Number        
2003         
2000 572,059 30.8 60.0 0.3 2.8 3.8 7.9  
1990b 606,900 29.6 65.8 0.2 1.8 2.5 5.4 27.4 
1980b 638,333 26.9 70.3 0.2 1.0 1.6 2.8 25.7 
1970b 756,510 27.7 71.1 0.1 0.7 0.4 (NA) (NA) 
1960c 763,956 45.2 53.9 0.1 0.6 0.2 (NA) (NA) 
1950c 802,178 64.6 35.0 -- 0.4 -- (NA) (NA) 
1940c 663,091 71.5 28.2 -- 0.2 (X) (NA) (NA) 
Notes. “–” Represents zero or rounding to 0.0. (X) Not applicable. (N/A), Not available. aTotals to 100% of 
population. bHispanic origin based on Spanish language. cHispanic origin based on the White population of 
Spanish mother tongue. dData for 2003 are preliminary. 
Source: U.S. Census Bureau.135
 
The District of Columbia holds a unique position in that its vital records 
functions were administered by the Federal Government until the mid-1970s when 
the District was granted Home Rule.136  Therefore, state and local decisions regarding 
birth certificates were under the domain of outsiders until then.  The relative 
autonomy that the District of Columbia now holds should contribute to increased 
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